data_1iyf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iyf _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.63 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.789 0.328 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -132.46 115.41 25.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.495 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 65' ' ' SER . 19.3 t -127.94 145.92 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.046 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' N ' HG12 ' A' ' 3' ' ' VAL . 6.1 m-85 -80.8 126.59 31.51 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.1 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.508 HG11 ' HB ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -95.34 112.66 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.41 0.624 . . . . 0.0 110.807 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.455 ' HD3' ' N ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -107.11 139.76 41.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.415 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 8' ' ' ASN . 25.7 t80 -101.32 155.18 18.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 7.8 t-20 . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.734 0.778 . . . . 0.0 110.195 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' HA3' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -122.41 131.34 24.41 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.958 0.379 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . 37.7 Cg_endo -66.23 123.09 10.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.273 1.982 . . . . 0.0 112.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.595 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -114.1 136.68 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.444 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 1.9 tt0 -93.09 70.25 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.8 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.646 HG21 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 177.1 154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.781 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.646 ' N ' HG21 ' A' ' 17' ' ' VAL . 1.2 p-10 -64.93 118.36 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 12.9 t -88.01 -24.11 23.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -89.76 -18.45 26.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.741 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -37.18 154.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.287 0.235 . . . . 0.0 110.767 178.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.553 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 t -18.26 142.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.499 ' CG1' ' HD2' ' A' ' 27' ' ' LYS . 19.8 tt -39.7 -39.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 113.813 -1.539 . . . . 0.0 111.684 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -68.15 -49.52 60.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.445 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 20.0 mm-40 -63.13 -54.87 31.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.538 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.547 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 2.1 pp -55.31 -56.15 23.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 111.063 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HB3' ' O ' ' A' ' 38' ' ' ALA . 7.3 mttt -56.13 -36.9 68.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.08 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.8 mm-40 -62.3 -60.57 3.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.424 HG21 ' CG2' ' A' ' 17' ' ' VAL . 7.9 t -54.05 -53.81 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.4 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.661 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 2.1 p -58.46 -71.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.307 0.575 . . . . 0.0 112.349 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.738 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -54.06 -30.88 49.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.931 -1.032 . . . . 0.0 113.17 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 33.8 tttt -66.91 -52.44 43.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.085 0.469 . . . . 0.0 109.8 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.91 -7.2 58.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.447 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -80.53 -4.6 54.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.617 0.246 . . . . 0.0 111.58 -179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.47 37.5 78.8 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.749 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -142.78 -172.65 0.32 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 113.371 -1.415 . . . . 0.0 108.867 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.749 ' HD2' ' HB ' ' A' ' 36' ' ' VAL . 86.2 Cg_endo -65.17 -152.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 122.083 1.856 . . . . 0.0 109.388 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -106.54 -70.44 0.79 Allowed 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.562 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 3.8 p-10 -118.02 22.72 12.07 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.494 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 10.2 tp60 -55.29 -63.44 1.16 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 6.9 tp -82.67 -143.33 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -129.08 142.04 51.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.212 0.529 . . . . 0.0 111.159 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HB ' ' CD1' ' A' ' 26' ' ' LEU . 9.5 t -116.82 148.84 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.759 ' O ' HG13 ' A' ' 67' ' ' VAL . 46.2 mt -140.93 159.37 23.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.64 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 23.2 t80 -136.34 157.14 47.5 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.482 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . . . 23.62 36.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 83.4 -14.63 39.31 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.869 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -92.1 119.84 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.325 0.562 . . . . 0.0 109.494 178.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' HA ' HG23 ' A' ' 44' ' ' ILE . 16.2 tt0 -67.61 134.43 51.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 50' ' ' LEU . 1.3 pp -9.77 87.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.686 ' H ' ' HB ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -118.16 120.58 38.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.901 ' O ' HG21 ' A' ' 56' ' ' VAL . 52.3 t-20 -46.24 -47.81 17.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.1 -14.14 8.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.741 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 t90 -95.39 -25.49 16.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.686 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.3 m -109.2 -30.63 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.901 HG21 ' O ' ' A' ' 52' ' ' ASN . 3.2 m -70.66 -133.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.566 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 1.5 mm100 -78.32 -36.79 45.95 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.78 -12.02 50.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.765 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.741 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 1.6 t -81.36 -78.66 0.18 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.097 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.494 ' C ' HD23 ' A' ' 61' ' ' LEU . 32.1 t70 -168.73 76.02 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.993 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.608 HD22 ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.65 150.82 37.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.25 178.19 4.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.779 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -57.33 -39.48 75.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.999 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -115.05 88.67 2.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.674 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.609 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.56 165.57 11.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.503 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -128.93 121.97 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 44' ' ' ILE . 98.7 t -117.76 137.01 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.067 0.461 . . . . 0.0 111.408 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.688 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -92.29 106.84 18.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.173 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.54 ' HA ' HG11 ' A' ' 43' ' ' VAL . 4.4 mp -99.7 138.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 42' ' ' ARG . 48.8 t . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.652 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.654 0.264 . . . . 0.0 110.792 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -132.61 114.48 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 65' ' ' SER . 20.4 t -133.15 145.5 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.372 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 3.5 m-85 -85.9 130.54 34.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.95 120.45 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.258 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -100.64 129.75 46.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.907 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 8' ' ' ASN . 8.4 t80 -100.77 155.28 18.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 4.1 t-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.679 0.752 . . . . 0.0 110.293 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.457 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -122.42 106.53 35.29 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.911 0.355 . . . . 0.0 110.978 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 16.8 Cg_exo -67.6 120.73 7.76 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.478 2.119 . . . . 0.0 111.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 3' ' ' VAL . 3.9 m -121.45 148.17 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 30.3 tt0 -93.07 75.11 4.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.681 HG23 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 178.88 152.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.891 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.681 ' N ' HG23 ' A' ' 17' ' ' VAL . 8.5 m-20 -65.41 119.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 1.4 t -85.83 -30.54 22.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.609 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -86.75 -21.52 26.52 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.711 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -33.51 150.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.253 0.346 . . . . 0.0 111.096 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.2 t -17.3 142.99 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.484 ' CG1' ' HD2' ' A' ' 27' ' ' LYS . 19.5 tt -39.69 -39.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 113.837 -1.528 . . . . 0.0 111.887 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -67.56 -49.2 64.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 2.2 mm-40 -63.0 -55.61 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.582 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.539 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 1.9 pp -55.2 -57.23 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 111.237 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 38' ' ' ALA . 12.1 mttt -56.55 -35.36 68.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.146 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.97 -59.85 4.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.461 HG23 ' CG2' ' A' ' 17' ' ' VAL . 4.3 t -54.04 -53.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.197 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.629 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -58.78 -73.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.464 0.65 . . . . 0.0 112.224 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.811 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -50.03 -27.75 6.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.939 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -69.83 -52.5 24.4 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -88.66 -5.75 57.93 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.395 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -79.73 -6.31 56.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.573 0.225 . . . . 0.0 111.589 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.47 37.2 69.31 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.756 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.41 -173.65 0.37 Allowed Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.193 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.811 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 83.0 Cg_endo -66.3 -148.87 0.02 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 122.219 1.946 . . . . 0.0 109.719 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.676 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -105.31 -68.02 0.89 Allowed 'General case' 0 N--CA 1.426 -1.656 0 O-C-N 124.277 0.986 . . . . 0.0 113.279 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 7.5 p30 -112.62 29.47 7.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.704 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 7.3 tp-100 -53.2 -76.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.631 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 2.9 tp -84.74 -138.36 0.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -131.45 139.41 49.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.366 0.603 . . . . 0.0 112.495 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.539 ' HB ' ' CD1' ' A' ' 26' ' ' LEU . 5.2 t -109.61 144.28 18.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.76 ' O ' HG13 ' A' ' 67' ' ' VAL . 4.4 mp -138.28 159.01 32.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.623 ' HB2' HG22 ' A' ' 67' ' ' VAL . 21.9 t80 -133.89 154.2 51.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . . . 26.03 34.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 85.8 -14.73 51.12 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.783 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -90.9 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.4 135.12 54.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.428 ' CB ' HD21 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -14.52 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.663 ' H ' ' HB ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -120.35 119.12 32.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.836 ' O ' HG23 ' A' ' 56' ' ' VAL . 17.0 p-10 -44.87 -47.17 11.13 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.38 -14.23 9.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.725 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.2 t90 -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -109.43 -26.01 10.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 52' ' ' ASN . 3.2 m -82.29 -133.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.533 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -73.18 -35.8 66.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -71.22 -0.17 9.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.909 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.81 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -96.71 -76.99 0.5 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.818 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.502 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -169.94 76.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.064 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.563 HD22 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -117.17 152.19 35.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.14 177.21 4.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.157 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -58.89 -38.75 79.56 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.002 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -116.53 86.7 2.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -101.66 168.2 9.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.371 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.513 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -127.96 119.78 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.76 HG13 ' O ' ' A' ' 44' ' ' ILE . 76.4 t -117.71 137.37 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 111.834 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.695 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -91.06 108.24 19.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.109 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.513 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 6.5 mt -102.9 140.99 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.631 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 17.0 t . . . . . 0 N--CA 1.436 -1.153 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.569 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.701 0.286 . . . . 0.0 110.711 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -134.09 114.27 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.141 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 15' ' ' VAL . 17.9 t -130.34 147.11 33.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.326 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.43 ' N ' HG12 ' A' ' 3' ' ' VAL . 31.5 m-85 -85.69 124.63 32.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.108 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.567 HG13 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -94.14 120.39 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.516 0.674 . . . . 0.0 110.594 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.441 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.7 mmt85 -101.79 149.1 24.52 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.264 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -115.44 156.67 25.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 121.735 0.779 . . . . 0.0 110.192 -179.227 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.441 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 111.841 -0.503 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.54 118.44 41.39 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 117.186 0.493 . . . . 0.0 110.731 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.429 ' HA ' ' CD2' ' A' ' 4' ' ' PHE . 36.2 Cg_endo -65.4 120.96 8.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.031 1.82 . . . . 0.0 111.876 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -115.62 139.53 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.597 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 3.9 tt0 -93.71 69.71 4.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.421 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG21 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 175.41 157.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.723 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.657 ' N ' HG21 ' A' ' 17' ' ' VAL . 3.5 p30 -65.62 119.84 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.449 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -87.58 -24.88 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -177.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -91.16 -23.54 20.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.644 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -35.19 153.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.267 0.354 . . . . 0.0 111.41 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.3 t -16.62 144.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.492 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -41.0 -39.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.906 -177.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 49.9 m-85 -66.92 -48.14 69.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.247 0.546 . . . . 0.0 109.604 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.441 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 36.2 mm-40 -64.81 -54.95 23.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.369 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.578 HD22 ' O ' ' A' ' 21' ' ' THR . 2.5 pp -57.14 -58.61 7.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.68 0.276 . . . . 0.0 111.178 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -51.19 -36.47 41.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.484 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 27.1 tt0 -68.7 -59.93 2.76 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.899 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.437 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 52.2 t -51.95 -52.65 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.751 0.31 . . . . 0.0 111.463 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.691 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 2.1 p -61.88 -73.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.263 0.554 . . . . 0.0 112.409 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.804 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -53.14 -25.84 14.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.368 -176.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 4.8 tttp -72.19 -52.02 18.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -85.96 -7.85 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -80.62 -6.58 58.52 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.525 0.202 . . . . 0.0 111.542 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.79 39.58 85.68 Favored Glycine 0 CA--C 1.507 -0.426 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.796 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -144.02 -172.3 0.31 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 113.488 -1.356 . . . . 0.0 109.464 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.804 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 96.0 Cg_endo -67.04 -147.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 122.403 2.069 . . . . 0.0 109.826 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.609 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -105.96 -69.82 0.81 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 124.177 0.923 . . . . 0.0 112.871 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.463 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 38.5 t70 -121.97 31.52 6.18 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.608 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -49.02 -77.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.636 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 4.6 tp -81.94 -124.71 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 17.9 mmt180 -131.51 162.36 30.44 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.449 0.568 . . . . 0.0 112.016 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.525 ' CG1' ' CG1' ' A' ' 69' ' ' ILE . 6.1 t -130.69 147.55 33.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.047 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.732 ' O ' HG11 ' A' ' 67' ' ' VAL . 37.6 mt -143.3 159.01 17.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.645 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 14.0 t80 -134.51 153.29 52.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 26.87 37.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 79.72 -12.51 28.32 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.835 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' PHE . 10.3 mtmt -91.43 123.41 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.189 0.495 . . . . 0.0 109.966 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -60.69 122.39 14.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.122 -178.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.529 ' HB2' ' CD2' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -25.05 107.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.703 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.1 mmp_? -126.66 118.94 25.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.687 ' O ' HG21 ' A' ' 56' ' ' VAL . 2.0 p-10 -41.76 -44.89 3.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.732 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -118.81 -14.36 9.49 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.644 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 14.9 m-90 -100.07 -31.83 11.23 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -107.28 -24.07 12.01 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.811 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 4.2 m -82.26 -135.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -175.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.524 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 3.6 mm-40 -68.52 -35.12 77.03 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 1.2 m-20 -74.02 6.06 3.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.146 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.811 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 4.8 t -106.22 -79.1 0.57 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.216 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.479 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -165.39 76.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.289 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.539 ' CD2' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -115.69 148.55 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.454 0.645 . . . . 0.0 112.464 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.61 175.01 5.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.098 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -56.82 -39.72 74.7 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.129 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.409 ' HA ' HG12 ' A' ' 2' ' ' ILE . 2.8 pm0 -114.43 85.62 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 50.5 m -101.1 166.58 10.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.498 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -128.96 121.07 53.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.732 HG11 ' O ' ' A' ' 44' ' ' ILE . 92.9 t -118.42 135.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.037 0.446 . . . . 0.0 111.566 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -91.88 107.49 19.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.119 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.525 ' CG1' ' CG1' ' A' ' 43' ' ' VAL . 4.0 mp -106.21 148.21 10.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.636 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 39.1 t . . . . . 0 N--CA 1.437 -1.099 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.689 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.672 0.272 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.529 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 20.3 pt -133.09 115.91 24.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' A' ' 19' ' ' SER . 22.2 t -129.23 149.28 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.232 -0.987 . . . . 0.0 112.147 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 14' ' ' PRO . 3.4 m-85 -88.84 127.22 35.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.501 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -105.87 117.99 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.498 0.666 . . . . 0.0 111.024 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.453 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.8 mmt85 -102.59 144.82 30.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -108.52 158.87 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.198 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 121.729 0.776 . . . . 0.0 110.121 -179.399 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -119.62 105.86 42.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 117.164 0.482 . . . . 0.0 110.941 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 47.4 Cg_endo -69.06 119.4 6.39 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.198 1.932 . . . . 0.0 112.062 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 3' ' ' VAL . 6.4 m -117.4 147.86 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.174 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.529 ' HA ' ' CG2' ' A' ' 2' ' ' ILE . 3.1 tt0 -91.22 71.83 6.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.4 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.689 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 178.99 154.71 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.636 ' N ' HG23 ' A' ' 17' ' ' VAL . 8.4 p30 -65.07 118.76 9.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.501 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -85.5 -25.11 27.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.593 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.56 -19.76 23.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.694 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -34.35 152.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.454 0.302 . . . . 0.0 110.836 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.5 t -18.87 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.532 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 17.5 tt -40.98 -38.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.917 -177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.534 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 43.8 m-85 -68.39 -46.98 68.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.461 ' HB2' HG21 ' A' ' 21' ' ' THR . 44.4 mm-40 -65.97 -54.44 26.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.083 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.493 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 2.7 pp -57.07 -56.05 26.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.909 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -52.22 -36.93 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.163 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.3 -60.15 3.04 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.423 HG22 ' CG2' ' A' ' 17' ' ' VAL . 32.5 t -53.35 -56.13 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.607 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.688 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 2.0 p -59.05 -74.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.32 0.581 . . . . 0.0 112.547 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.781 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -48.83 -31.01 6.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.928 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -67.03 -52.31 44.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.102 0.477 . . . . 0.0 109.719 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -85.76 -6.78 59.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -79.46 -6.96 58.02 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.626 0.25 . . . . 0.0 111.571 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.84 59.03 Favored Glycine 0 CA--C 1.505 -0.581 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.73 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -145.79 -173.41 0.36 Allowed Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.272 -1.464 . . . . 0.0 108.987 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.781 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 90.9 Cg_endo -68.2 -145.19 0.02 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 122.262 1.974 . . . . 0.0 110.004 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.672 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . . . -104.58 -65.68 1.02 Allowed 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.002 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 5.3 t0 -115.28 39.39 2.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.553 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 2.8 tp-100 -43.95 -85.26 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.46 ' N ' ' HG3' ' A' ' 40' ' ' GLN . 48.5 mt -94.19 -113.89 0.11 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' VAL . 7.6 mtp180 -130.44 126.37 36.8 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.432 0.634 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.573 HG12 HG13 ' A' ' 69' ' ' ILE . 1.4 t -96.98 139.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.745 ' O ' HG13 ' A' ' 67' ' ' VAL . 2.9 mp -138.52 159.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.605 ' HB2' HG23 ' A' ' 67' ' ' VAL . 15.7 t80 -134.76 154.57 51.53 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.468 ' HB1' ' CE2' ' A' ' 45' ' ' PHE . . . 25.21 38.02 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 80.97 -12.98 33.67 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.903 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 45' ' ' PHE . 4.4 mtmt -90.12 118.16 29.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.266 0.533 . . . . 0.0 109.764 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 24.7 tt0 -64.78 130.02 41.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.417 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -10.89 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.68 ' H ' ' HB ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -115.48 118.69 33.87 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.897 ' O ' HG21 ' A' ' 56' ' ' VAL . 10.3 p30 -46.05 -48.75 16.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.49 -14.17 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.728 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.8 t90 -95.91 -26.49 15.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.68 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.2 m -109.14 -27.15 9.75 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.897 HG21 ' O ' ' A' ' 52' ' ' ASN . 3.1 m -78.63 -134.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.517 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 8.1 pt20 -73.49 -35.88 65.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -70.56 -0.72 9.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.087 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.789 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -96.09 -78.17 0.47 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.017 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' C ' HD21 ' A' ' 61' ' ' LEU . 6.0 t0 -169.27 76.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.015 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.19 151.48 35.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 112.793 -178.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.69 177.37 4.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.041 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -39.01 77.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.887 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.411 ' HA ' HG13 ' A' ' 2' ' ' ILE . 1.3 tt0 -114.78 87.42 2.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.495 ' O ' HG12 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -101.26 167.68 10.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.253 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.535 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.9 pp -130.32 121.95 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 44' ' ' ILE . 74.4 t -117.05 136.2 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.083 0.468 . . . . 0.0 111.734 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 10.5 m-70 -93.42 106.56 18.52 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.573 HG13 HG12 ' A' ' 43' ' ' VAL . 3.2 mp -100.1 140.39 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.459 ' N ' HG21 ' A' ' 69' ' ' ILE . 44.2 t . . . . . 0 N--CA 1.436 -1.127 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.166 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.55 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.271 0.557 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.631 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 1.3 mt -143.7 112.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 65' ' ' SER . 14.2 t -137.27 150.5 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 118.836 -1.146 . . . . 0.0 112.562 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.448 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 2.5 m-85 -84.26 137.04 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' HB ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.66 116.55 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.518 0.675 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 2.9 mmt85 -104.4 148.82 25.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.636 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -123.71 157.49 33.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 121.766 0.794 . . . . 0.0 110.552 -178.702 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 CA--C 1.518 0.242 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.412 ' HB3' HG11 ' A' ' 5' ' ' VAL . 14.5 t80 -121.75 107.0 36.45 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 117.201 0.5 . . . . 0.0 110.73 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 17.0 Cg_exo -66.8 122.85 10.28 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.533 2.155 . . . . 0.0 112.338 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 3' ' ' VAL . 5.2 m -127.86 148.64 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.057 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.631 ' HA ' ' CG2' ' A' ' 2' ' ' ILE . 25.8 tt0 -91.48 77.7 5.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.017 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.663 HG23 ' N ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER 178.86 152.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.663 ' N ' HG23 ' A' ' 17' ' ' VAL . 4.1 m-20 -67.38 119.09 11.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 67' ' ' VAL . 12.9 t -87.88 -22.89 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.632 ' OD2' HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -92.09 -19.56 22.2 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.641 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -35.34 154.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.296 0.373 . . . . 0.0 110.903 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.582 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.4 t -18.12 142.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.475 ' HA ' ' CG ' ' A' ' 26' ' ' LEU . 11.1 tp -40.71 -36.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.049 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.451 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 28.3 m-85 -70.08 -47.94 59.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.32 0.581 . . . . 0.0 109.48 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.439 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 5.3 mm100 -64.4 -50.55 67.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.379 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.487 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 1.9 pp -59.93 -57.76 11.46 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.058 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 39' ' ' ASP . 20.5 pttt -51.8 -32.46 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.086 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.01 -60.71 2.29 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.694 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG23 ' CG2' ' A' ' 17' ' ' VAL . 25.5 t -54.65 -52.67 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.573 0.225 . . . . 0.0 111.394 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.668 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.2 p -57.12 -75.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.452 0.644 . . . . 0.0 111.548 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.738 ' HB1' ' HA ' ' A' ' 38' ' ' ALA . . . -46.89 -31.39 3.08 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.756 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -66.81 -57.12 7.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.977 0.418 . . . . 0.0 110.069 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 -5.23 59.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.065 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 45.8 tp60 -77.97 -10.42 59.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.654 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.55 37.71 34.6 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.751 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.8 m -147.65 -169.65 0.22 Allowed Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.077 -1.561 . . . . 0.0 108.281 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.751 ' HD2' ' HB ' ' A' ' 36' ' ' VAL . 55.0 Cg_endo -70.03 -148.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.097 0 C-N-CA 122.131 1.887 . . . . 0.0 110.649 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.738 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . . . -122.22 -46.93 2.16 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.851 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.472 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -68.77 -5.79 22.8 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.318 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.712 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 1.9 tp60 -56.27 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.705 0.764 . . . . 0.0 110.102 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -69.9 -161.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.369 -176.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.647 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 21.4 mmt-85 70.58 44.74 0.65 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.529 ' CG1' ' CG1' ' A' ' 69' ' ' ILE . 2.8 t -103.54 143.02 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.741 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.688 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.3 mp -140.51 156.18 23.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.623 ' O ' ' N ' ' A' ' 48' ' ' LYS . 16.2 t80 -129.46 151.11 50.44 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 27.41 35.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 87.82 -13.71 60.31 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.839 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -90.97 122.37 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.148 0.474 . . . . 0.0 110.013 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' HA ' HG21 ' A' ' 44' ' ' ILE . 3.2 tt0 -69.04 135.13 50.36 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -14.14 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.703 ' O ' HG11 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -119.5 115.37 23.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.821 ' O ' HG22 ' A' ' 56' ' ' VAL . 1.6 p-10 -49.1 -46.65 45.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.936 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -16.46 11.74 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.648 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 10.9 m-90 -98.54 -28.17 13.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.64 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.1 m -107.01 -25.21 11.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 52' ' ' ASN . 2.9 m -82.89 -136.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 6.5 pt20 -67.08 -33.83 76.35 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -74.04 3.66 6.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.128 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.791 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.6 t -104.08 -78.33 0.56 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.469 ' C ' HD22 ' A' ' 61' ' ' LEU . 20.8 t70 -167.04 77.6 0.18 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.96 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.632 HD21 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.31 149.05 39.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 112.974 -178.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -120.82 172.41 7.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.873 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -56.47 -38.91 72.34 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.301 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -115.03 83.25 1.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 5.8 m -102.85 172.15 6.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 61.9 mt -131.51 121.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 44' ' ' ILE . 60.4 t -117.61 132.86 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.678 ' O ' ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -92.2 109.85 21.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.71 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.529 ' CG1' ' CG1' ' A' ' 43' ' ' VAL . 3.1 mp -103.16 149.35 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 24.6 t . . . . . 0 N--CA 1.434 -1.24 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.842 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.623 0.249 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -131.14 115.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.604 HG13 ' HB2' ' A' ' 19' ' ' SER . 19.0 t -134.87 148.5 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 118.814 -1.154 . . . . 0.0 112.582 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -83.51 128.95 34.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.901 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.99 118.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.428 0.633 . . . . 0.0 110.803 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.47 147.46 27.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.734 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 8' ' ' ASN . 7.0 t80 -137.89 145.76 42.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 10.1 p-10 . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 121.845 0.831 . . . . 0.0 108.968 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 CA-C-O 120.561 -0.022 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -118.98 142.65 32.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.73 0.3 . . . . 0.0 111.192 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 95.7 Cg_endo -80.45 133.27 9.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.644 2.229 . . . . 0.0 112.341 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' VAL . 10.5 m -121.67 149.0 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 5.2 tt0 -91.75 72.48 5.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.842 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 0.8 OUTLIER -172.81 156.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.903 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 21' ' ' THR . 1.4 m-20 -68.09 114.55 6.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.604 ' HB2' HG13 ' A' ' 3' ' ' VAL . 3.6 m -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.654 ' HB3' ' CB ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -114.61 -24.01 8.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.49 0.586 . . . . 0.0 112.452 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.645 ' CA ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -32.79 153.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.715 0.634 . . . . 0.0 111.58 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -20.69 143.95 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.783 0.801 . . . . 0.0 113.061 -174.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.595 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 13.5 tt -40.03 -39.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.822 -177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.527 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 78.9 m-85 -68.69 -49.25 60.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 18.4 mm100 -59.21 -65.56 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.547 ' CD2' ' HA ' ' A' ' 23' ' ' ILE . 1.5 pt? -58.47 -50.17 74.68 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.537 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -48.39 -38.39 19.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.82 0.343 . . . . 0.0 110.616 178.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 13.8 tt0 -65.83 -62.47 1.48 Allowed 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.97 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.543 ' CG2' HG23 ' A' ' 17' ' ' VAL . 2.7 t -50.68 -48.6 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.62 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.662 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.9 p -67.03 -74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.794 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -52.5 -33.29 44.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.619 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 8.6 tttp -67.1 -51.69 51.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -80.53 -9.21 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.48 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.647 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 3.0 tp-100 -81.08 -10.16 59.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.5 36.4 49.36 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.795 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.2 m -145.23 -174.51 0.41 Allowed Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 113.584 -1.308 . . . . 0.0 109.188 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.795 ' HD2' ' HB ' ' A' ' 36' ' ' VAL . 98.0 Cg_endo -66.62 -142.36 0.01 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.837 2.358 . . . . 0.0 109.824 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . . . -104.68 -73.07 0.69 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.935 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.47 ' HB3' ' CD ' ' A' ' 27' ' ' LYS . 26.7 p-10 -120.15 26.54 9.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.532 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 36.9 tp60 -46.4 -59.26 3.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.305 0.502 . . . . 0.0 111.057 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 9.7 tp -83.2 -138.74 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.426 -0.11 . . . . 0.0 110.749 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.551 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 11.4 mtt85 -128.54 119.16 24.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.286 0.565 . . . . 0.0 111.878 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.571 ' CG1' HG13 ' A' ' 69' ' ' ILE . 2.2 t -96.03 135.68 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.959 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.762 ' O ' HG11 ' A' ' 67' ' ' VAL . 3.3 mp -137.67 163.19 31.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.654 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 8.6 t80 -136.19 154.01 51.07 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 24.25 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.19 -15.42 39.25 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.742 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -93.61 119.73 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.317 0.558 . . . . 0.0 109.732 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -64.83 134.26 53.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.005 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.46 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -21.46 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.754 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -121.72 117.59 27.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.713 ' O ' HG23 ' A' ' 56' ' ' VAL . 5.3 p-10 -40.22 -48.4 2.57 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -119.92 -14.24 8.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.699 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 11.2 t90 -97.21 -30.28 13.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.709 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -107.06 -26.3 11.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.826 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 3.0 m -83.81 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.677 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -66.77 -34.91 78.87 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 53' ' ' ASP . 3.3 m-80 -73.75 1.87 9.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.014 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.826 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 3.2 t -101.45 -77.47 0.55 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.288 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.42 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.4 t0 -165.68 78.53 0.28 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.022 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -117.74 149.22 41.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.76 173.43 7.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.734 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -57.22 -38.11 73.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.788 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.96 84.81 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.492 ' O ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.61 171.45 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 7.2 pt -129.9 121.93 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.762 HG11 ' O ' ' A' ' 44' ' ' ILE . 98.8 t -119.71 139.69 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.467 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 3.6 t-80 -97.84 105.39 17.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.317 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.571 HG13 ' CG1' ' A' ' 43' ' ' VAL . 3.0 mp -97.84 115.31 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 45.8 t . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.635 ' HE3' ' C ' ' A' ' 17' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.508 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 11.6 pt -136.37 124.66 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.748 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.527 HG13 ' HB3' ' A' ' 19' ' ' SER . 94.1 t -139.54 156.41 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.453 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 3.2 m-85 -89.92 136.28 33.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.436 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 3.0 m -101.88 118.77 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 111.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.552 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -107.98 130.82 55.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.518 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -114.22 162.57 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 121.814 0.816 . . . . 0.0 110.75 -178.371 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' CA ' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.424 ' HB3' HG22 ' A' ' 5' ' ' VAL . 35.7 t80 -124.6 116.09 26.66 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.937 0.368 . . . . 0.0 110.741 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 19.2 Cg_exo -65.42 115.64 3.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.132 1.888 . . . . 0.0 111.524 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.63 146.5 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.527 ' O ' HG13 ' A' ' 17' ' ' VAL . 8.1 tt0 -84.85 81.93 8.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.635 ' C ' ' HE3' ' A' ' 1' ' ' MET . 0.9 OUTLIER -167.37 -169.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.138 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.54 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 33.2 m-20 -113.75 112.92 24.22 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.527 ' HB3' HG13 ' A' ' 3' ' ' VAL . 23.3 t -90.01 8.32 33.12 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -122.05 -19.04 6.75 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.915 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.909 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.19 175.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 179.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 32.7 t -40.18 154.93 0.03 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.679 -0.638 . . . . 0.0 112.431 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.601 ' HA ' HD13 ' A' ' 26' ' ' LEU . 5.0 tt -45.43 -41.15 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.701 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.556 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 49.5 m-85 -63.2 -48.66 77.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.444 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.501 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 5.8 mm100 -58.82 -71.3 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.601 HD13 ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -49.79 -55.14 15.22 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.022 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -43.3 -40.3 3.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 110.58 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.2 tt0 -66.77 -61.43 1.96 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.69 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.427 ' CG1' HG22 ' A' ' 17' ' ' VAL . 60.5 t -49.01 -53.16 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.639 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.2 p -62.09 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.77 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -55.0 -40.26 69.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.89 -176.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 1.4 ttpm? -61.98 -46.91 87.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.254 0.55 . . . . 0.0 109.524 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -12.16 59.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -85.14 -1.42 56.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.095 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.92 34.93 88.64 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.795 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 m -140.26 -172.87 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 113.771 -1.215 . . . . 0.0 109.219 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.795 ' HD2' ' HB ' ' A' ' 36' ' ' VAL . 83.3 Cg_endo -65.48 -140.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 122.493 2.129 . . . . 0.0 109.625 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.665 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . . . -110.8 -74.89 0.63 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.391 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.538 ' HB2' ' CD ' ' A' ' 27' ' ' LYS . 28.7 t70 -113.03 37.82 3.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.613 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 15.7 tp60 -42.54 -68.48 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.355 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.762 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 6.6 tp -91.83 -136.25 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.155 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' VAL . 1.6 mtt85 -113.27 130.43 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.469 HG11 ' CG1' ' A' ' 69' ' ' ILE . 2.3 t -105.84 133.86 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.604 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.748 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.5 mt -140.12 162.76 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.7 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 7.3 t80 -135.52 88.55 2.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.963 0.411 . . . . 0.0 111.669 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 45' ' ' PHE . . . 77.21 31.85 0.48 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.375 0.607 . . . . 0.0 109.979 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.2 47.3 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.024 -0.989 . . . . 0.0 114.053 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.53 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 0.0 OUTLIER -90.35 117.04 28.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.697 0.749 . . . . 0.0 110.048 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.55 133.55 45.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.481 ' HB3' HD21 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -14.64 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.852 ' H ' ' HB ' ' A' ' 55' ' ' THR . 1.3 mmp_? -112.76 118.76 35.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.531 ' C ' HG13 ' A' ' 56' ' ' VAL . 5.9 t-20 -49.38 -39.84 33.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.08 -15.05 9.92 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.611 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.9 m-90 -101.76 -30.28 11.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.852 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.5 m -109.86 -30.19 7.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.909 ' CG1' ' HA ' ' A' ' 21' ' ' THR . 11.1 m -51.65 -129.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.532 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -92.8 -44.39 8.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -59.96 -16.07 27.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.952 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.611 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -63.73 -72.15 0.15 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.92 179.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.537 ' O ' HD12 ' A' ' 61' ' ' LEU . 3.4 t0 -166.4 74.94 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.564 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 10.7 mp -130.99 166.28 21.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.52 -173.48 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.042 -1.89 . . . . 0.0 108.857 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -63.54 -30.83 71.89 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.768 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HA ' HG13 ' A' ' 2' ' ' ILE . 11.1 tt0 -123.46 95.34 4.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.482 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -102.51 169.52 8.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.685 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.48 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.7 pp -132.26 123.01 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 44' ' ' ILE . 96.8 t -116.23 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.06 0.457 . . . . 0.0 111.769 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.748 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -101.21 107.19 18.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.033 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.469 ' CG1' HG11 ' A' ' 43' ' ' VAL . 3.7 mp -104.55 141.85 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.762 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 41.3 t . . . . . 0 N--CA 1.432 -1.34 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.627 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.613 ' HE3' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.595 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -138.61 112.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 15' ' ' VAL . 14.7 t -133.96 150.43 31.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.705 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 14' ' ' PRO . 4.4 m-85 -83.7 129.76 34.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.48 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -95.18 114.78 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.557 0.694 . . . . 0.0 110.858 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.86 145.3 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 17.9 t80 -139.99 148.02 41.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.598 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 121.907 0.861 . . . . 0.0 109.108 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.19 0 N-CA-C 112.941 -0.064 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.454 ' CG ' ' HD2' ' A' ' 14' ' ' PRO . 58.7 t80 -112.99 140.5 24.21 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.597 0.237 . . . . 0.0 111.116 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 13' ' ' PHE . 32.2 Cg_endo -64.02 132.52 34.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.232 1.954 . . . . 0.0 111.652 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.586 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -118.11 138.16 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.633 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.595 ' HA ' ' CG2' ' A' ' 2' ' ' ILE . 17.9 tt0 -97.4 72.34 2.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.609 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.643 HG23 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 179.61 156.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.959 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.643 ' N ' HG23 ' A' ' 17' ' ' VAL . 8.6 p30 -65.0 112.56 3.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 1.6 m -83.6 0.5 46.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.615 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -116.45 -17.52 10.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.725 0.693 . . . . 0.0 112.697 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.685 ' CA ' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -33.17 154.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.066 0.546 . . . . 0.0 111.375 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 t -20.63 143.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.726 0.774 . . . . 0.0 113.036 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.546 ' HA ' ' CD2' ' A' ' 26' ' ' LEU . 17.3 tt -37.48 -44.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.275 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -69.08 -49.22 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 19.3 mm-40 -56.23 -62.69 1.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 19' ' ' SER . 1.9 pt? -58.92 -53.04 62.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.466 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 7.4 mttt -50.67 -36.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.962 0.41 . . . . 0.0 110.455 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.35 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.4 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.435 ' CG2' HG22 ' A' ' 17' ' ' VAL . 2.2 t -52.54 -55.83 9.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 111.255 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.653 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.5 p -55.42 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.428 0.632 . . . . 0.0 112.029 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.825 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -50.24 -26.44 4.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.777 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -69.49 -54.32 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.6 -5.79 58.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.252 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.97 -5.7 54.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.79 37.48 75.81 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.76 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.43 -174.47 0.41 Allowed Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.212 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.825 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 88.6 Cg_endo -66.72 -149.79 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.559 0 C-N-CA 122.395 2.063 . . . . 0.0 109.671 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.702 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . . . -105.83 -69.9 0.8 Allowed 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.237 0.961 . . . . 0.0 113.255 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.45 25.0 10.74 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.564 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 3.1 tp60 -52.26 -73.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.609 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -82.13 -135.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -132.5 139.16 47.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 111.957 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.541 ' CG1' ' CG1' ' A' ' 69' ' ' ILE . 10.9 t -113.1 141.78 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.053 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.742 ' O ' HG11 ' A' ' 67' ' ' VAL . 4.6 mp -138.16 162.12 31.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.662 ' HB2' HG22 ' A' ' 67' ' ' VAL . 10.0 t80 -132.52 153.74 50.64 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 22.53 37.91 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.16 -15.67 37.73 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.789 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -92.15 118.58 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -66.04 136.64 56.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 2.0 pp -22.7 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.746 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -122.09 118.32 28.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.747 ' O ' HG22 ' A' ' 56' ' ' VAL . 5.1 p-10 -39.22 -48.24 1.75 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -13.32 8.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.719 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 13.8 t90 -97.15 -29.35 13.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.647 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.21 -25.7 10.93 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.787 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 3.4 m -81.81 -133.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.516 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 1.9 mm100 -73.45 -34.85 65.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -72.98 0.07 12.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.919 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -95.9 -78.03 0.47 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.883 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' C ' HD22 ' A' ' 61' ' ' LEU . 1.5 t70 -168.41 76.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.053 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.569 HD21 ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.72 151.63 36.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.723 0.773 . . . . 0.0 112.908 -178.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.82 174.31 6.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.046 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -39.21 76.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.349 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.22 83.62 1.95 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.515 ' O ' HG12 ' A' ' 3' ' ' VAL . 15.1 m -102.81 171.87 7.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.152 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.6 pp -129.58 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.742 HG11 ' O ' ' A' ' 44' ' ' ILE . 91.4 t -118.6 135.99 57.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 111.363 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 6.8 t60 -92.74 106.64 18.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 7' ' ' PHE . 4.2 mp -103.06 140.35 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.609 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 13.4 t . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.664 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.489 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 2.4 mt -122.99 118.63 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 19' ' ' SER . 10.5 t -138.02 158.39 32.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.45 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.503 ' H ' HG11 ' A' ' 3' ' ' VAL . 4.1 m-85 -94.18 119.78 33.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG13 ' CG1' ' A' ' 15' ' ' VAL . 1.5 p -86.72 118.3 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.58 144.85 40.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.922 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 2.1 p90 -138.04 151.04 47.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.133 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.79 0.805 . . . . 0.0 109.215 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.154 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -123.6 142.37 38.89 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.788 0.328 . . . . 0.0 111.323 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.43 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 36.1 Cg_endo -65.04 124.79 13.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.362 2.042 . . . . 0.0 111.212 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 3' ' ' VAL . 3.4 p -122.49 119.54 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.081 0.467 . . . . 0.0 111.433 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.489 ' HA ' ' CG2' ' A' ' 2' ' ' ILE . 7.7 tm-20 -77.35 86.3 3.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.343 0.592 . . . . 0.0 109.919 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.664 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 1.4 m -167.84 -166.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.191 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.518 ' N ' ' HE1' ' A' ' 1' ' ' MET . 2.7 p30 -103.58 104.79 14.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.617 ' HB2' HG12 ' A' ' 3' ' ' VAL . 72.0 m -88.25 4.32 46.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.856 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -122.96 -19.81 5.99 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.296 178.047 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.648 ' O ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -36.14 169.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.527 0.517 . . . . 0.0 110.752 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 21' ' ' THR . 32.2 t -33.88 148.2 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.685 0.755 . . . . 0.0 112.491 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.586 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -46.08 -36.72 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.293 -177.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.663 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 14.2 m-85 -63.65 -45.22 91.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.454 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 9.6 mm100 -67.26 -66.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.617 HD12 ' HB ' ' A' ' 43' ' ' VAL . 1.6 pp -49.48 -45.32 46.77 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.489 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.663 ' HG3' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -57.62 -37.47 73.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.481 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -63.96 -56.46 14.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.797 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.46 ' CG1' HG23 ' A' ' 17' ' ' VAL . 99.3 t -55.57 -53.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.139 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.694 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.3 p -57.67 -75.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.381 0.61 . . . . 0.0 112.358 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.876 ' HB3' ' O ' ' A' ' 37' ' ' PRO . . . -48.67 -39.12 23.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.963 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -61.42 -45.35 94.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.76 -11.27 45.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.128 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 30' ' ' VAL . 5.7 tt0 -84.34 -5.46 59.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.405 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.27 37.41 94.48 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.814 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -138.31 -171.79 0.29 Allowed Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 113.853 -1.174 . . . . 0.0 109.438 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.876 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 78.0 Cg_endo -63.51 -147.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.702 0 C-N-CA 122.377 2.051 . . . . 0.0 109.066 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -108.79 -77.78 0.6 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 123.844 0.715 . . . . 0.0 112.272 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.42 ' HB2' ' CG ' ' A' ' 27' ' ' LYS . 29.0 t70 -112.62 34.54 4.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.584 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 8.7 tp-100 -46.43 -71.1 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.744 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.8 tp -90.12 -138.6 0.14 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.582 ' O ' ' O ' ' A' ' 70' ' ' VAL . 3.5 mpp_? -112.98 135.41 53.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.392 0.615 . . . . 0.0 112.657 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.617 ' HB ' HD12 ' A' ' 26' ' ' LEU . 2.8 t -102.13 141.95 17.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.24 0.543 . . . . 0.0 111.096 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.757 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.6 mp -138.3 161.08 31.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 6.6 t80 -136.25 155.91 49.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.456 ' N ' ' CD1' ' A' ' 45' ' ' PHE . . . 40.61 28.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 111.583 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 -10.13 9.48 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.622 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' C ' HG23 ' A' ' 44' ' ' ILE . 15.3 mtmt -105.69 110.41 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.306 0.553 . . . . 0.0 110.838 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HA ' HG23 ' A' ' 44' ' ' ILE . 3.0 tm-20 -74.84 127.75 33.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.553 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 1.6 mm? -150.05 -164.35 2.0 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -105.88 175.7 5.41 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.722 0.772 . . . . 0.0 113.071 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.891 ' O ' HG22 ' A' ' 56' ' ' VAL . 4.5 p-10 -47.25 -20.08 0.17 Allowed 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.699 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -16.74 11.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.41 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.661 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 0.3 OUTLIER -108.3 -20.23 13.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -106.64 -27.41 10.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.906 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 1.5 m -79.88 -140.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.691 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 3.8 mp0 -65.81 -42.68 90.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -59.54 -14.0 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.037 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.906 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 8.4 t -84.72 -73.67 0.42 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.283 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.45 ' O ' HD21 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -170.66 84.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.658 176.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 57' ' ' GLN . 0.6 OUTLIER -119.58 157.03 29.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.92 -178.8 5.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.718 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.71 -34.16 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.526 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -124.33 91.93 3.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.148 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.595 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.32 170.29 8.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.915 0.388 . . . . 0.0 111.447 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 2.0 pp -130.43 116.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 44' ' ' ILE . 60.4 t -116.12 142.79 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.075 0.464 . . . . 0.0 111.577 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' ILE . 64.9 t-80 -106.65 108.07 19.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.087 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.518 HG21 ' CG1' ' A' ' 30' ' ' VAL . 3.0 mp -100.79 138.68 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.744 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 52.7 t . . . . . 0 N--CA 1.436 -1.158 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.11 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.584 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.828 0.347 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 12.9 pt -132.94 114.72 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.282 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 15' ' ' VAL . 21.4 t -129.37 145.58 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.4 m-85 -81.63 126.36 31.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.422 HG13 ' HB ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -93.28 113.41 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.752 0.786 . . . . 0.0 110.641 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -103.88 151.88 22.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.474 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 8' ' ' ASN . 65.6 t80 -136.0 171.88 13.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.514 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 7' ' ' PHE . 3.4 t30 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.135 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 9.0 p90 -126.71 144.32 49.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.667 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 39.1 Cg_endo -66.67 134.66 35.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.361 2.041 . . . . 0.0 111.467 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -117.65 135.78 56.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.827 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 1.4 tt0 -92.52 69.56 4.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.646 HG21 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 176.39 156.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.615 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.646 ' N ' HG21 ' A' ' 17' ' ' VAL . 3.0 m-20 -65.85 120.37 12.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 1.2 t -87.28 -26.21 23.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -87.48 -23.33 24.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.715 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -34.09 151.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.311 0.382 . . . . 0.0 111.079 179.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.581 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -17.96 143.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.504 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 6.6 tt -40.81 -39.45 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.016 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 79.7 m-85 -66.97 -47.86 70.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.267 0.556 . . . . 0.0 109.591 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 54.9 mm-40 -65.17 -55.46 18.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.224 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.689 HD23 ' HB2' ' A' ' 50' ' ' LEU . 2.4 pp -55.93 -56.73 17.16 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -52.86 -36.93 59.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.314 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -66.18 -59.29 3.89 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.544 -179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 ' CG2' ' A' ' 17' ' ' VAL . 43.0 t -52.98 -52.45 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.623 0.249 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.676 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 2.1 p -62.53 -74.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.756 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -51.61 -29.58 18.03 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.941 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 10.2 ttmt -68.27 -54.07 20.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -7.54 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.96 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -80.2 -5.4 56.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.572 0.225 . . . . 0.0 111.407 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 37.66 67.23 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.718 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -145.35 -173.63 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 113.512 -1.344 . . . . 0.0 109.237 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.756 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 95.0 Cg_endo -66.93 -144.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.331 2.021 . . . . 0.0 109.88 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.617 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -107.09 -68.05 0.91 Allowed 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.613 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -113.62 35.27 4.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.662 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 6.2 tp-100 -48.53 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.714 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp -87.33 -126.18 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 70' ' ' VAL . 20.7 mtt85 -129.01 147.95 50.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.203 0.525 . . . . 0.0 111.929 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 50' ' ' LEU . 4.0 t -116.74 146.35 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.75 ' O ' HG11 ' A' ' 67' ' ' VAL . 4.0 mp -143.57 159.2 16.81 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.587 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 21.9 t80 -135.0 156.13 49.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . . . 26.62 37.89 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 78.71 -12.44 22.24 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.978 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.573 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 0.0 OUTLIER -92.82 121.82 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.179 0.489 . . . . 0.0 109.735 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.56 130.74 46.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.7 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.689 ' HB2' HD23 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -21.66 103.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.664 ' O ' HG11 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -125.06 117.75 24.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.211 176.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.826 ' O ' HG22 ' A' ' 56' ' ' VAL . 9.4 p-10 -39.87 -46.6 2.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.5 OUTLIER -121.33 -13.56 8.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.714 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 6.2 t90 -97.59 -29.18 13.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.622 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.64 -25.21 10.99 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 52' ' ' ASN . 3.9 m -80.75 -132.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.519 1.304 . . . . 0.0 114.519 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.512 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -74.42 -34.99 63.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -72.09 0.79 8.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.771 177.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.799 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -97.21 -78.24 0.48 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.88 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.502 ' C ' HD21 ' A' ' 61' ' ' LEU . 8.6 t0 -168.68 76.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.075 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.12 151.63 35.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.567 0.698 . . . . 0.0 112.836 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -120.26 177.19 5.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.32 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -58.24 -38.29 76.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.255 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.71 85.61 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.35 165.79 10.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -127.84 120.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.75 HG11 ' O ' ' A' ' 44' ' ' ILE . 72.0 t -117.94 135.95 56.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.018 0.437 . . . . 0.0 111.668 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.671 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -91.14 106.18 18.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.012 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 7' ' ' PHE . 4.5 mp -106.62 145.26 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.714 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 11.1 t . . . . . 0 N--CA 1.435 -1.196 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.63 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.789 0.328 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.0 OUTLIER -132.46 115.41 25.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.495 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 65' ' ' SER . 19.3 t -127.94 145.92 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.046 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' N ' HG12 ' A' ' 3' ' ' VAL . 6.1 m-85 -80.8 126.59 31.51 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.1 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.508 HG11 ' HB ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -95.34 112.66 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.41 0.624 . . . . 0.0 110.807 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.455 ' HD3' ' N ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -107.11 139.76 41.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.415 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 9' ' ' SER . 25.7 t80 -101.32 155.18 18.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 7.8 t-20 -63.01 69.22 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.734 0.778 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' PHE . 14.2 t -172.0 163.55 6.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.361 -1.291 . . . . 0.0 107.743 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.89 71.59 1.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.158 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -160.52 115.51 2.23 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.406 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' HA3' ' HD2' ' A' ' 6' ' ' ARG . . . -125.52 140.6 12.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.175 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -122.41 131.34 24.41 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.958 0.379 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 4' ' ' PHE . 37.7 Cg_endo -66.23 123.09 10.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.273 1.982 . . . . 0.0 112.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.595 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -114.1 136.68 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.444 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 1.9 tt0 -93.09 70.25 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.8 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.646 HG21 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 177.1 154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.781 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.646 ' N ' HG21 ' A' ' 17' ' ' VAL . 1.2 p-10 -64.93 118.36 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 12.9 t -88.01 -24.11 23.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -89.76 -18.45 26.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.741 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -37.18 154.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.287 0.235 . . . . 0.0 110.767 178.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.553 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 t -18.26 142.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.499 ' CG1' ' HD2' ' A' ' 27' ' ' LYS . 19.8 tt -39.7 -39.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 113.813 -1.539 . . . . 0.0 111.684 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -68.15 -49.52 60.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.445 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 20.0 mm-40 -63.13 -54.87 31.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.538 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.547 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 2.1 pp -55.31 -56.15 23.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 111.063 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HB3' ' O ' ' A' ' 38' ' ' ALA . 7.3 mttt -56.13 -36.9 68.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.08 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.8 mm-40 -62.3 -60.57 3.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.424 HG21 ' CG2' ' A' ' 17' ' ' VAL . 7.9 t -54.05 -53.81 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.4 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.661 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 2.1 p -58.46 -71.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.307 0.575 . . . . 0.0 112.349 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.738 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -54.06 -30.88 49.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.931 -1.032 . . . . 0.0 113.17 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 33.8 tttt -66.91 -52.44 43.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.085 0.469 . . . . 0.0 109.8 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.91 -7.2 58.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.447 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -80.53 -4.6 54.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.617 0.246 . . . . 0.0 111.58 -179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.47 37.5 78.8 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.749 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -142.78 -172.65 0.32 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 113.371 -1.415 . . . . 0.0 108.867 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.749 ' HD2' ' HB ' ' A' ' 36' ' ' VAL . 86.2 Cg_endo -65.17 -152.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 122.083 1.856 . . . . 0.0 109.388 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -106.54 -70.44 0.79 Allowed 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.562 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 3.8 p-10 -118.02 22.72 12.07 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.494 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 10.2 tp60 -55.29 -63.44 1.16 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 72' ' ' ARG . 6.9 tp -82.67 -143.33 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -129.08 142.04 51.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.212 0.529 . . . . 0.0 111.159 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.547 ' HB ' ' CD1' ' A' ' 26' ' ' LEU . 9.5 t -116.82 148.84 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.759 ' O ' HG13 ' A' ' 67' ' ' VAL . 46.2 mt -140.93 159.37 23.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.64 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 23.2 t80 -136.34 157.14 47.5 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.482 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . . . 23.62 36.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 83.4 -14.63 39.31 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.869 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -92.1 119.84 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.325 0.562 . . . . 0.0 109.494 178.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' HA ' HG23 ' A' ' 44' ' ' ILE . 16.2 tt0 -67.61 134.43 51.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 50' ' ' LEU . 1.3 pp -9.77 87.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.686 ' H ' ' HB ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -118.16 120.58 38.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.901 ' O ' HG21 ' A' ' 56' ' ' VAL . 52.3 t-20 -46.24 -47.81 17.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.1 -14.14 8.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.741 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 t90 -95.39 -25.49 16.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.686 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.3 m -109.2 -30.63 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.901 HG21 ' O ' ' A' ' 52' ' ' ASN . 3.2 m -70.66 -133.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.566 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 1.5 mm100 -78.32 -36.79 45.95 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.78 -12.02 50.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.765 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.741 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 1.6 t -81.36 -78.66 0.18 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.097 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.494 ' C ' HD23 ' A' ' 61' ' ' LEU . 32.1 t70 -168.73 76.02 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.993 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.608 HD22 ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.65 150.82 37.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.25 178.19 4.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.779 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -57.33 -39.48 75.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.999 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -115.05 88.67 2.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.674 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.609 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.56 165.57 11.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.503 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -128.93 121.97 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 44' ' ' ILE . 98.7 t -117.76 137.01 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.067 0.461 . . . . 0.0 111.408 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.688 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -92.29 106.84 18.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.173 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.54 ' HA ' HG11 ' A' ' 43' ' ' VAL . 4.4 mp -99.7 138.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 42' ' ' ARG . 48.8 t -120.54 67.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.537 ' HB2' HG23 ' A' ' 69' ' ' ILE . 1.0 OUTLIER -85.05 164.71 18.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.468 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.485 ' HA ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -63.11 126.17 88.48 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.535 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.34 155.72 44.91 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.733 2.289 . . . . 0.0 112.775 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -87.84 138.59 31.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.634 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -109.8 104.6 13.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.943 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.7 mttm . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.976 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.652 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.654 0.264 . . . . 0.0 110.792 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -132.61 114.48 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 65' ' ' SER . 20.4 t -133.15 145.5 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.372 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 3.5 m-85 -85.9 130.54 34.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.95 120.45 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.258 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.457 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -100.64 129.75 46.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.907 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 9' ' ' SER . 8.4 t80 -100.77 155.28 18.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 4.1 t-20 -63.73 68.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.679 0.752 . . . . 0.0 110.293 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 7' ' ' PHE . 3.0 t -171.42 161.74 6.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.459 -1.246 . . . . 0.0 107.933 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -74.56 71.75 1.88 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.076 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.65 134.47 7.93 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.542 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.457 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -125.85 140.78 12.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.835 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -122.42 106.53 35.29 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.911 0.355 . . . . 0.0 110.978 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 16.8 Cg_exo -67.6 120.73 7.76 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.478 2.119 . . . . 0.0 111.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 3' ' ' VAL . 3.9 m -121.45 148.17 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 30.3 tt0 -93.07 75.11 4.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.681 HG23 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 178.88 152.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.891 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.681 ' N ' HG23 ' A' ' 17' ' ' VAL . 8.5 m-20 -65.41 119.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 1.4 t -85.83 -30.54 22.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.609 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -86.75 -21.52 26.52 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.711 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -33.51 150.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.253 0.346 . . . . 0.0 111.096 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.2 t -17.3 142.99 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.484 ' CG1' ' HD2' ' A' ' 27' ' ' LYS . 19.5 tt -39.69 -39.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 113.837 -1.528 . . . . 0.0 111.887 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -67.56 -49.2 64.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 2.2 mm-40 -63.0 -55.61 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.582 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.539 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 1.9 pp -55.2 -57.23 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 111.237 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 38' ' ' ALA . 12.1 mttt -56.55 -35.36 68.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.146 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.97 -59.85 4.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.461 HG23 ' CG2' ' A' ' 17' ' ' VAL . 4.3 t -54.04 -53.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.197 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.629 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -58.78 -73.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.464 0.65 . . . . 0.0 112.224 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.811 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -50.03 -27.75 6.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.939 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -69.83 -52.5 24.4 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -88.66 -5.75 57.93 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.395 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -79.73 -6.31 56.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.573 0.225 . . . . 0.0 111.589 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.47 37.2 69.31 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.756 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.41 -173.65 0.37 Allowed Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.193 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.811 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 83.0 Cg_endo -66.3 -148.87 0.02 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 122.219 1.946 . . . . 0.0 109.719 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.676 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -105.31 -68.02 0.89 Allowed 'General case' 0 N--CA 1.426 -1.656 0 O-C-N 124.277 0.986 . . . . 0.0 113.279 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 7.5 p30 -112.62 29.47 7.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.704 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 7.3 tp-100 -53.2 -76.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.631 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 2.9 tp -84.74 -138.36 0.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -131.45 139.41 49.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.366 0.603 . . . . 0.0 112.495 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.539 ' HB ' ' CD1' ' A' ' 26' ' ' LEU . 5.2 t -109.61 144.28 18.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.76 ' O ' HG13 ' A' ' 67' ' ' VAL . 4.4 mp -138.28 159.01 32.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.623 ' HB2' HG22 ' A' ' 67' ' ' VAL . 21.9 t80 -133.89 154.2 51.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . . . 26.03 34.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 85.8 -14.73 51.12 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.783 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -90.9 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -65.4 135.12 54.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.428 ' CB ' HD21 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -14.52 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.663 ' H ' ' HB ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -120.35 119.12 32.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.836 ' O ' HG23 ' A' ' 56' ' ' VAL . 17.0 p-10 -44.87 -47.17 11.13 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.38 -14.23 9.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.725 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.2 t90 -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -109.43 -26.01 10.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 52' ' ' ASN . 3.2 m -82.29 -133.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.533 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -73.18 -35.8 66.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -71.22 -0.17 9.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.909 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.81 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -96.71 -76.99 0.5 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.818 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.502 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -169.94 76.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.064 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.563 HD22 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -117.17 152.19 35.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.14 177.21 4.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.157 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -58.89 -38.75 79.56 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.002 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -116.53 86.7 2.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -101.66 168.2 9.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.371 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.513 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -127.96 119.78 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.76 HG13 ' O ' ' A' ' 44' ' ' ILE . 76.4 t -117.71 137.37 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 111.834 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.695 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -91.06 108.24 19.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.109 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.513 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 6.5 mt -102.9 140.99 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.631 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 17.0 t -133.76 70.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.565 ' HG2' ' HB1' ' A' ' 31' ' ' ALA . 6.4 tp-100 -119.41 86.53 2.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.172 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.427 ' HD2' ' CZ ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -126.43 149.57 67.92 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.322 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 23.6 Cg_endo -61.14 145.36 98.88 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.432 2.088 . . . . 0.0 111.476 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.98 105.8 17.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.951 0.405 . . . . 0.0 111.321 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -107.14 105.76 15.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.861 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 tttp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.872 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.569 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.701 0.286 . . . . 0.0 110.711 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -134.09 114.27 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.141 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 15' ' ' VAL . 17.9 t -130.34 147.11 33.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.326 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.43 ' N ' HG12 ' A' ' 3' ' ' VAL . 31.5 m-85 -85.69 124.63 32.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.108 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.567 HG13 ' HB ' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -94.14 120.39 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.516 0.674 . . . . 0.0 110.594 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.441 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.7 mmt85 -101.79 149.1 24.52 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.264 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' O ' ' N ' ' A' ' 9' ' ' SER . 29.9 t80 -115.44 156.67 25.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -63.91 69.39 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.735 0.779 . . . . 0.0 110.192 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' PHE . 1.4 t -170.85 162.23 7.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.972 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m -73.9 72.83 1.6 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.125 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.56 136.59 10.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.529 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.441 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -129.91 134.44 7.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.841 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -114.54 118.44 41.39 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 117.186 0.493 . . . . 0.0 110.731 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.429 ' HA ' ' CD2' ' A' ' 4' ' ' PHE . 36.2 Cg_endo -65.4 120.96 8.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.031 1.82 . . . . 0.0 111.876 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -115.62 139.53 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.597 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 3.9 tt0 -93.71 69.71 4.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.421 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG21 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 175.41 157.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.723 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.657 ' N ' HG21 ' A' ' 17' ' ' VAL . 3.5 p30 -65.62 119.84 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.449 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -87.58 -24.88 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -177.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -91.16 -23.54 20.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.644 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -35.19 153.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.267 0.354 . . . . 0.0 111.41 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.3 t -16.62 144.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.492 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -41.0 -39.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.906 -177.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.462 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 49.9 m-85 -66.92 -48.14 69.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.247 0.546 . . . . 0.0 109.604 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.441 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 36.2 mm-40 -64.81 -54.95 23.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.369 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.578 HD22 ' O ' ' A' ' 21' ' ' THR . 2.5 pp -57.14 -58.61 7.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.68 0.276 . . . . 0.0 111.178 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -51.19 -36.47 41.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.484 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 27.1 tt0 -68.7 -59.93 2.76 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.899 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.437 ' CG2' ' CG2' ' A' ' 17' ' ' VAL . 52.2 t -51.95 -52.65 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.751 0.31 . . . . 0.0 111.463 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.691 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 2.1 p -61.88 -73.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.263 0.554 . . . . 0.0 112.409 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.804 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -53.14 -25.84 14.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.368 -176.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 4.8 tttp -72.19 -52.02 18.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -85.96 -7.85 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -80.62 -6.58 58.52 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.525 0.202 . . . . 0.0 111.542 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.79 39.58 85.68 Favored Glycine 0 CA--C 1.507 -0.426 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.796 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -144.02 -172.3 0.31 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 113.488 -1.356 . . . . 0.0 109.464 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.804 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 96.0 Cg_endo -67.04 -147.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 122.403 2.069 . . . . 0.0 109.826 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.609 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -105.96 -69.82 0.81 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 124.177 0.923 . . . . 0.0 112.871 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.463 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 38.5 t70 -121.97 31.52 6.18 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.608 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -49.02 -77.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.636 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 4.6 tp -81.94 -124.71 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 17.9 mmt180 -131.51 162.36 30.44 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.449 0.568 . . . . 0.0 112.016 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.525 ' CG1' ' CG1' ' A' ' 69' ' ' ILE . 6.1 t -130.69 147.55 33.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.047 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.732 ' O ' HG11 ' A' ' 67' ' ' VAL . 37.6 mt -143.3 159.01 17.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.645 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 14.0 t80 -134.51 153.29 52.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 26.87 37.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 79.72 -12.51 28.32 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.835 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' PHE . 10.3 mtmt -91.43 123.41 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.189 0.495 . . . . 0.0 109.966 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -60.69 122.39 14.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.122 -178.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' HB2' ' CD2' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -25.05 107.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.703 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.1 mmp_? -126.66 118.94 25.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.687 ' O ' HG21 ' A' ' 56' ' ' VAL . 2.0 p-10 -41.76 -44.89 3.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.732 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -118.81 -14.36 9.49 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.644 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 14.9 m-90 -100.07 -31.83 11.23 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -107.28 -24.07 12.01 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.811 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 4.2 m -82.26 -135.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -175.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.524 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 3.6 mm-40 -68.52 -35.12 77.03 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 1.2 m-20 -74.02 6.06 3.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.146 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.811 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 4.8 t -106.22 -79.1 0.57 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.216 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.479 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -165.39 76.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.289 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.539 ' CD2' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -115.69 148.55 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.454 0.645 . . . . 0.0 112.464 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.61 175.01 5.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.098 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -56.82 -39.72 74.7 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.129 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.409 ' HA ' HG12 ' A' ' 2' ' ' ILE . 2.8 pm0 -114.43 85.62 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 50.5 m -101.1 166.58 10.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.498 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -128.96 121.07 53.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.732 HG11 ' O ' ' A' ' 44' ' ' ILE . 92.9 t -118.42 135.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.037 0.446 . . . . 0.0 111.566 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -91.88 107.49 19.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.119 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.525 ' CG1' ' CG1' ' A' ' 43' ' ' VAL . 4.0 mp -106.21 148.21 10.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.636 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 39.1 t -131.94 67.98 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.569 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -109.49 81.12 1.39 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.976 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.49 144.53 51.36 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.726 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.469 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 26.5 Cg_endo -60.92 154.66 54.75 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.558 2.172 . . . . 0.0 111.795 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.454 ' CZ2' ' NE2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -96.28 106.99 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.97 0.414 . . . . 0.0 111.176 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.19 117.39 34.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.983 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.689 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.672 0.272 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.529 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 20.3 pt -133.09 115.91 24.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.501 HG13 ' HB2' ' A' ' 19' ' ' SER . 22.2 t -129.23 149.28 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.232 -0.987 . . . . 0.0 112.147 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 14' ' ' PRO . 3.4 m-85 -88.84 127.22 35.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.501 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -105.87 117.99 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.498 0.666 . . . . 0.0 111.024 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.453 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.8 mmt85 -102.59 144.82 30.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -108.52 158.87 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.198 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -64.13 68.53 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.729 0.776 . . . . 0.0 110.121 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 7' ' ' PHE . 1.9 t -172.23 162.73 5.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.944 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.1 75.11 1.25 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.141 -1.023 . . . . 0.0 109.096 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -156.69 136.8 12.75 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.647 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -129.92 135.09 8.17 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.829 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -119.62 105.86 42.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 117.164 0.482 . . . . 0.0 110.941 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 47.4 Cg_endo -69.06 119.4 6.39 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.198 1.932 . . . . 0.0 112.062 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 3' ' ' VAL . 6.4 m -117.4 147.86 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.174 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.529 ' HA ' ' CG2' ' A' ' 2' ' ' ILE . 3.1 tt0 -91.22 71.83 6.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.4 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.689 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 178.99 154.71 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.636 ' N ' HG23 ' A' ' 17' ' ' VAL . 8.4 p30 -65.07 118.76 9.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.501 ' HB2' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -85.5 -25.11 27.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.593 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -90.56 -19.76 23.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.694 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -34.35 152.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.454 0.302 . . . . 0.0 110.836 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.5 t -18.87 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.532 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 17.5 tt -40.98 -38.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.917 -177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.534 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 43.8 m-85 -68.39 -46.98 68.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.461 ' HB2' HG21 ' A' ' 21' ' ' THR . 44.4 mm-40 -65.97 -54.44 26.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.083 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.493 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 2.7 pp -57.07 -56.05 26.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.909 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -52.22 -36.93 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.163 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.3 -60.15 3.04 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG22 ' CG2' ' A' ' 17' ' ' VAL . 32.5 t -53.35 -56.13 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.607 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.688 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 2.0 p -59.05 -74.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.32 0.581 . . . . 0.0 112.547 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.781 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -48.83 -31.01 6.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.928 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -67.03 -52.31 44.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.102 0.477 . . . . 0.0 109.719 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -85.76 -6.78 59.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -79.46 -6.96 58.02 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.626 0.25 . . . . 0.0 111.571 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.84 59.03 Favored Glycine 0 CA--C 1.505 -0.581 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.73 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -145.79 -173.41 0.36 Allowed Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.272 -1.464 . . . . 0.0 108.987 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.781 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 90.9 Cg_endo -68.2 -145.19 0.02 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 122.262 1.974 . . . . 0.0 110.004 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.672 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . . . -104.58 -65.68 1.02 Allowed 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.002 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 5.3 t0 -115.28 39.39 2.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.553 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 2.8 tp-100 -43.95 -85.26 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.695 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 48.5 mt -94.19 -113.89 0.11 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' VAL . 7.6 mtp180 -130.44 126.37 36.8 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.432 0.634 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.573 HG12 HG13 ' A' ' 69' ' ' ILE . 1.4 t -96.98 139.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.745 ' O ' HG13 ' A' ' 67' ' ' VAL . 2.9 mp -138.52 159.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.605 ' HB2' HG23 ' A' ' 67' ' ' VAL . 15.7 t80 -134.76 154.57 51.53 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' HB1' ' CE2' ' A' ' 45' ' ' PHE . . . 25.21 38.02 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 80.97 -12.98 33.67 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.903 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 45' ' ' PHE . 4.4 mtmt -90.12 118.16 29.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.266 0.533 . . . . 0.0 109.764 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 24.7 tt0 -64.78 130.02 41.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.417 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -10.89 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.68 ' H ' ' HB ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -115.48 118.69 33.87 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.897 ' O ' HG21 ' A' ' 56' ' ' VAL . 10.3 p30 -46.05 -48.75 16.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.49 -14.17 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.728 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.8 t90 -95.91 -26.49 15.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.68 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.2 m -109.14 -27.15 9.75 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.897 HG21 ' O ' ' A' ' 52' ' ' ASN . 3.1 m -78.63 -134.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.517 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 8.1 pt20 -73.49 -35.88 65.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -70.56 -0.72 9.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.087 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.789 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -96.09 -78.17 0.47 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.017 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' C ' HD21 ' A' ' 61' ' ' LEU . 6.0 t0 -169.27 76.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.015 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.594 HD23 ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.19 151.48 35.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 112.793 -178.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.69 177.37 4.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.041 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -39.01 77.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.887 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.411 ' HA ' HG13 ' A' ' 2' ' ' ILE . 1.3 tt0 -114.78 87.42 2.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.495 ' O ' HG12 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -101.26 167.68 10.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.253 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.535 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.9 pp -130.32 121.95 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 44' ' ' ILE . 74.4 t -117.05 136.2 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.083 0.468 . . . . 0.0 111.734 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 10.5 m-70 -93.42 106.56 18.52 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.613 ' CG2' ' HG3' ' A' ' 71' ' ' GLN . 3.2 mp -100.1 140.39 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.459 ' N ' HG21 ' A' ' 69' ' ' ILE . 44.2 t -140.98 72.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.166 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.695 ' HA ' ' HB2' ' A' ' 41' ' ' LEU . 3.7 pp0? -128.7 60.48 1.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.103 0.954 . . . . 0.0 109.197 177.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.49 135.22 26.28 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.391 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.0 151.85 82.52 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.363 2.042 . . . . 0.0 111.716 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 17.9 t90 -122.11 136.47 54.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -82.95 105.34 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.836 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 tttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.901 -179.873 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.55 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.271 0.557 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.631 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 1.3 mt -143.7 112.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 65' ' ' SER . 14.2 t -137.27 150.5 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 118.836 -1.146 . . . . 0.0 112.562 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 2.5 m-85 -84.26 137.04 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' HB ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.66 116.55 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.518 0.675 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 2.9 mmt85 -104.4 148.82 25.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.636 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.658 ' O ' ' N ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -123.71 157.49 33.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.28 71.45 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.766 0.794 . . . . 0.0 110.552 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.658 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -169.73 161.13 9.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.08 179.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.23 73.49 5.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.513 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.459 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 1.3 t60 -161.41 141.07 10.4 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.647 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.423 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -130.04 143.23 14.47 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.794 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.412 ' HB3' HG11 ' A' ' 5' ' ' VAL . 14.5 t80 -121.75 107.0 36.45 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 117.201 0.5 . . . . 0.0 110.73 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.448 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 17.0 Cg_exo -66.8 122.85 10.28 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.533 2.155 . . . . 0.0 112.338 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 3' ' ' VAL . 5.2 m -127.86 148.64 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.057 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.631 ' HA ' ' CG2' ' A' ' 2' ' ' ILE . 25.8 tt0 -91.48 77.7 5.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.017 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.663 HG23 ' N ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER 178.86 152.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.663 ' N ' HG23 ' A' ' 17' ' ' VAL . 4.1 m-20 -67.38 119.09 11.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 67' ' ' VAL . 12.9 t -87.88 -22.89 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.632 ' OD2' HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -92.09 -19.56 22.2 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.641 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -35.34 154.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.296 0.373 . . . . 0.0 110.903 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.582 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.4 t -18.12 142.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.475 ' HA ' ' CG ' ' A' ' 26' ' ' LEU . 11.1 tp -40.71 -36.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.049 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.451 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 28.3 m-85 -70.08 -47.94 59.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.32 0.581 . . . . 0.0 109.48 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.439 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 5.3 mm100 -64.4 -50.55 67.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.379 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' CD1' ' HB ' ' A' ' 43' ' ' VAL . 1.9 pp -59.93 -57.76 11.46 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.058 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 39' ' ' ASP . 20.5 pttt -51.8 -32.46 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.086 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.01 -60.71 2.29 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.694 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG23 ' CG2' ' A' ' 17' ' ' VAL . 25.5 t -54.65 -52.67 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.573 0.225 . . . . 0.0 111.394 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.668 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.2 p -57.12 -75.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.452 0.644 . . . . 0.0 111.548 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.738 ' HB1' ' HA ' ' A' ' 38' ' ' ALA . . . -46.89 -31.39 3.08 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.756 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -66.81 -57.12 7.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.977 0.418 . . . . 0.0 110.069 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 -5.23 59.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.065 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 45.8 tp60 -77.97 -10.42 59.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.654 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.55 37.71 34.6 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.751 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.8 m -147.65 -169.65 0.22 Allowed Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.077 -1.561 . . . . 0.0 108.281 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.751 ' HD2' ' HB ' ' A' ' 36' ' ' VAL . 55.0 Cg_endo -70.03 -148.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.097 0 C-N-CA 122.131 1.887 . . . . 0.0 110.649 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.738 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . . . -122.22 -46.93 2.16 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.851 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.472 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -68.77 -5.79 22.8 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.318 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.712 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 1.9 tp60 -56.27 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.705 0.764 . . . . 0.0 110.102 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -69.9 -161.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.369 -176.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.647 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 21.4 mmt-85 70.58 44.74 0.65 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.529 ' CG1' ' CG1' ' A' ' 69' ' ' ILE . 2.8 t -103.54 143.02 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.741 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.688 ' O ' HG12 ' A' ' 67' ' ' VAL . 4.3 mp -140.51 156.18 23.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.623 ' O ' ' N ' ' A' ' 48' ' ' LYS . 16.2 t80 -129.46 151.11 50.44 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 27.41 35.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 87.82 -13.71 60.31 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.839 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -90.97 122.37 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.148 0.474 . . . . 0.0 110.013 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' HA ' HG21 ' A' ' 44' ' ' ILE . 3.2 tt0 -69.04 135.13 50.36 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 pp -14.14 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.703 ' O ' HG11 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -119.5 115.37 23.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.821 ' O ' HG22 ' A' ' 56' ' ' VAL . 1.6 p-10 -49.1 -46.65 45.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.936 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -16.46 11.74 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.648 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 10.9 m-90 -98.54 -28.17 13.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.64 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.1 m -107.01 -25.21 11.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.821 HG22 ' O ' ' A' ' 52' ' ' ASN . 2.9 m -82.89 -136.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 6.5 pt20 -67.08 -33.83 76.35 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -74.04 3.66 6.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.128 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.791 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.6 t -104.08 -78.33 0.56 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.469 ' C ' HD22 ' A' ' 61' ' ' LEU . 20.8 t70 -167.04 77.6 0.18 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.96 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.632 HD21 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.31 149.05 39.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 112.974 -178.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -120.82 172.41 7.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.873 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -56.47 -38.91 72.34 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.301 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -115.03 83.25 1.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 5.8 m -102.85 172.15 6.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 61.9 mt -131.51 121.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 44' ' ' ILE . 60.4 t -117.61 132.86 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.678 ' O ' ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -92.2 109.85 21.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.71 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.529 ' CG1' ' CG1' ' A' ' 43' ' ' VAL . 3.1 mp -103.16 149.35 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.647 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 24.6 t -136.24 86.96 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -67.11 102.29 1.0 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.716 -178.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.453 ' HG2' ' HB2' ' A' ' 42' ' ' ARG . 1.5 ptm180 -105.33 142.09 23.97 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.031 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.91 155.0 11.76 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.375 2.05 . . . . 0.0 112.033 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -86.98 143.44 27.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.278 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -71.83 109.56 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.965 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.842 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.623 0.249 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -131.14 115.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.604 HG13 ' HB2' ' A' ' 19' ' ' SER . 19.0 t -134.87 148.5 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 118.814 -1.154 . . . . 0.0 112.582 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -83.51 128.95 34.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.901 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.99 118.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.428 0.633 . . . . 0.0 110.803 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.47 147.46 27.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.734 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 9' ' ' SER . 7.0 t80 -137.89 145.76 42.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 10.1 p-10 -66.38 71.53 0.07 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.845 0.831 . . . . 0.0 108.968 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' PHE . 2.9 t -163.93 -160.77 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.42 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 9' ' ' SER . 58.7 p -49.41 177.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -53.27 143.36 18.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.282 0.563 . . . . 0.0 111.398 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.35 170.29 54.78 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.316 -0.856 . . . . 0.0 113.081 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -118.98 142.65 32.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.73 0.3 . . . . 0.0 111.192 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 95.7 Cg_endo -80.45 133.27 9.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.644 2.229 . . . . 0.0 112.341 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' VAL . 10.5 m -121.67 149.0 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 5.2 tt0 -91.75 72.48 5.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.842 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 0.8 OUTLIER -172.81 156.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.903 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.514 ' O ' HG23 ' A' ' 21' ' ' THR . 1.4 m-20 -68.09 114.55 6.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.604 ' HB2' HG13 ' A' ' 3' ' ' VAL . 3.6 m -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.654 ' HB3' ' CB ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -114.61 -24.01 8.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.49 0.586 . . . . 0.0 112.452 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.645 ' CA ' HG11 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -32.79 153.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.715 0.634 . . . . 0.0 111.58 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -20.69 143.95 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.783 0.801 . . . . 0.0 113.061 -174.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.595 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 13.5 tt -40.03 -39.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.822 -177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.527 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 78.9 m-85 -68.69 -49.25 60.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 18.4 mm100 -59.21 -65.56 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.547 ' CD2' ' HA ' ' A' ' 23' ' ' ILE . 1.5 pt? -58.47 -50.17 74.68 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.537 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -48.39 -38.39 19.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.82 0.343 . . . . 0.0 110.616 178.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 13.8 tt0 -65.83 -62.47 1.48 Allowed 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.97 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.543 ' CG2' HG23 ' A' ' 17' ' ' VAL . 2.7 t -50.68 -48.6 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.62 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.662 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.9 p -67.03 -74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.794 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -52.5 -33.29 44.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.619 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 8.6 tttp -67.1 -51.69 51.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -80.53 -9.21 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.48 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.647 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 3.0 tp-100 -81.08 -10.16 59.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.5 36.4 49.36 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.795 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.2 m -145.23 -174.51 0.41 Allowed Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 113.584 -1.308 . . . . 0.0 109.188 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.795 ' HD2' ' HB ' ' A' ' 36' ' ' VAL . 98.0 Cg_endo -66.62 -142.36 0.01 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.837 2.358 . . . . 0.0 109.824 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . . . -104.68 -73.07 0.69 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.935 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.47 ' HB3' ' CD ' ' A' ' 27' ' ' LYS . 26.7 p-10 -120.15 26.54 9.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.532 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 36.9 tp60 -46.4 -59.26 3.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.305 0.502 . . . . 0.0 111.057 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HB2' ' N ' ' A' ' 72' ' ' ARG . 9.7 tp -83.2 -138.74 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.426 -0.11 . . . . 0.0 110.749 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.551 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 11.4 mtt85 -128.54 119.16 24.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.286 0.565 . . . . 0.0 111.878 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.571 ' CG1' HG13 ' A' ' 69' ' ' ILE . 2.2 t -96.03 135.68 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.959 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.762 ' O ' HG11 ' A' ' 67' ' ' VAL . 3.3 mp -137.67 163.19 31.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.654 ' CB ' ' HB3' ' A' ' 20' ' ' ASP . 8.6 t80 -136.19 154.01 51.07 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 24.25 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.19 -15.42 39.25 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.742 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.601 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -93.61 119.73 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.317 0.558 . . . . 0.0 109.732 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -64.83 134.26 53.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.005 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.46 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -21.46 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.754 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -121.72 117.59 27.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.713 ' O ' HG23 ' A' ' 56' ' ' VAL . 5.3 p-10 -40.22 -48.4 2.57 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.415 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -119.92 -14.24 8.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.699 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 11.2 t90 -97.21 -30.28 13.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.709 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -107.06 -26.3 11.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.826 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 3.0 m -83.81 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.677 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -66.77 -34.91 78.87 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 53' ' ' ASP . 3.3 m-80 -73.75 1.87 9.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.014 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.826 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 3.2 t -101.45 -77.47 0.55 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.288 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.42 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.4 t0 -165.68 78.53 0.28 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.022 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.677 ' HB2' ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -117.74 149.22 41.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.76 173.43 7.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.734 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -57.22 -38.11 73.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.788 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.96 84.81 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.492 ' O ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.61 171.45 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 7.2 pt -129.9 121.93 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.762 HG11 ' O ' ' A' ' 44' ' ' ILE . 98.8 t -119.71 139.69 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.467 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 3.6 t-80 -97.84 105.39 17.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.317 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.571 HG13 ' CG1' ' A' ' 43' ' ' VAL . 3.0 mp -97.84 115.31 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 45.8 t -104.09 74.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' O ' ' CE2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -86.49 168.96 13.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.266 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -71.59 132.74 85.22 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.949 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.45 154.53 46.96 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.589 2.193 . . . . 0.0 112.452 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -87.11 140.19 29.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.668 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.02 105.41 14.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.867 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.941 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.635 ' HE3' ' C ' ' A' ' 17' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.508 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 11.6 pt -136.37 124.66 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.748 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.527 HG13 ' HB3' ' A' ' 19' ' ' SER . 94.1 t -139.54 156.41 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.453 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 3.2 m-85 -89.92 136.28 33.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' O ' ' CG2' ' A' ' 5' ' ' VAL . 3.0 m -101.88 118.77 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 111.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.552 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -107.98 130.82 55.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.518 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.671 ' O ' ' N ' ' A' ' 9' ' ' SER . 8.0 p90 -114.22 162.57 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -58.43 70.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.814 0.816 . . . . 0.0 110.75 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.671 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -171.43 162.66 6.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.855 179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.94 71.14 10.66 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.823 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -160.46 131.56 5.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.587 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' CA ' ' HD2' ' A' ' 6' ' ' ARG . . . -125.58 150.84 17.49 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.148 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.424 ' HB3' HG22 ' A' ' 5' ' ' VAL . 35.7 t80 -124.6 116.09 26.66 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.937 0.368 . . . . 0.0 110.741 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.437 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 19.2 Cg_exo -65.42 115.64 3.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.132 1.888 . . . . 0.0 111.524 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.63 146.5 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.527 ' O ' HG13 ' A' ' 17' ' ' VAL . 8.1 tt0 -84.85 81.93 8.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.635 ' C ' ' HE3' ' A' ' 1' ' ' MET . 0.9 OUTLIER -167.37 -169.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.138 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.54 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 33.2 m-20 -113.75 112.92 24.22 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.527 ' HB3' HG13 ' A' ' 3' ' ' VAL . 23.3 t -90.01 8.32 33.12 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.598 ' O ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -122.05 -19.04 6.75 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.915 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.909 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.19 175.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 179.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 32.7 t -40.18 154.93 0.03 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.679 -0.638 . . . . 0.0 112.431 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.601 ' HA ' HD13 ' A' ' 26' ' ' LEU . 5.0 tt -45.43 -41.15 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.701 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.556 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 49.5 m-85 -63.2 -48.66 77.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.444 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.501 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 5.8 mm100 -58.82 -71.3 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.601 HD13 ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -49.79 -55.14 15.22 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.022 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -43.3 -40.3 3.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 110.58 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.2 tt0 -66.77 -61.43 1.96 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.69 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.427 ' CG1' HG22 ' A' ' 17' ' ' VAL . 60.5 t -49.01 -53.16 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.639 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.2 p -62.09 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.77 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -55.0 -40.26 69.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.89 -176.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 1.4 ttpm? -61.98 -46.91 87.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.254 0.55 . . . . 0.0 109.524 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -12.16 59.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -85.14 -1.42 56.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.095 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.92 34.93 88.64 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.795 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 m -140.26 -172.87 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 113.771 -1.215 . . . . 0.0 109.219 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.795 ' HD2' ' HB ' ' A' ' 36' ' ' VAL . 83.3 Cg_endo -65.48 -140.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 122.493 2.129 . . . . 0.0 109.625 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.665 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . . . -110.8 -74.89 0.63 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.391 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.538 ' HB2' ' CD ' ' A' ' 27' ' ' LYS . 28.7 t70 -113.03 37.82 3.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.613 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 15.7 tp60 -42.54 -68.48 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.355 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.762 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 6.6 tp -91.83 -136.25 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.155 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' VAL . 1.6 mtt85 -113.27 130.43 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.469 HG11 ' CG1' ' A' ' 69' ' ' ILE . 2.3 t -105.84 133.86 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.604 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.748 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.5 mt -140.12 162.76 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.7 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 7.3 t80 -135.52 88.55 2.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.963 0.411 . . . . 0.0 111.669 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 45' ' ' PHE . . . 77.21 31.85 0.48 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.375 0.607 . . . . 0.0 109.979 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.2 47.3 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.024 -0.989 . . . . 0.0 114.053 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.53 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 0.0 OUTLIER -90.35 117.04 28.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.697 0.749 . . . . 0.0 110.048 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.55 133.55 45.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.481 ' HB3' HD21 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -14.64 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.852 ' H ' ' HB ' ' A' ' 55' ' ' THR . 1.3 mmp_? -112.76 118.76 35.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.531 ' C ' HG13 ' A' ' 56' ' ' VAL . 5.9 t-20 -49.38 -39.84 33.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.08 -15.05 9.92 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.611 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.9 m-90 -101.76 -30.28 11.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.852 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.5 m -109.86 -30.19 7.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.909 ' CG1' ' HA ' ' A' ' 21' ' ' THR . 11.1 m -51.65 -129.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.532 ' N ' HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -92.8 -44.39 8.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -59.96 -16.07 27.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.952 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.611 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -63.73 -72.15 0.15 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.92 179.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.537 ' O ' HD12 ' A' ' 61' ' ' LEU . 3.4 t0 -166.4 74.94 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.564 ' CD1' ' CE2' ' A' ' 45' ' ' PHE . 10.7 mp -130.99 166.28 21.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.52 -173.48 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.042 -1.89 . . . . 0.0 108.857 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -63.54 -30.83 71.89 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.768 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.458 ' HA ' HG13 ' A' ' 2' ' ' ILE . 11.1 tt0 -123.46 95.34 4.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.482 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -102.51 169.52 8.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.685 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.48 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.7 pp -132.26 123.01 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 44' ' ' ILE . 96.8 t -116.23 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.06 0.457 . . . . 0.0 111.769 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.748 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -101.21 107.19 18.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.033 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.469 ' CG1' HG11 ' A' ' 43' ' ' VAL . 3.7 mp -104.55 141.85 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.762 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 41.3 t -143.98 77.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.627 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' CD ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -118.57 60.51 0.8 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.746 0.784 . . . . 0.0 109.504 178.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.86 140.51 30.87 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.286 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.4 ' HD3' ' HG2' ' A' ' 40' ' ' GLN . 20.4 Cg_endo -60.01 153.2 59.5 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.377 2.052 . . . . 0.0 111.534 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -125.13 138.63 54.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 0.0 110.902 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -105.41 133.63 49.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.774 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.133 -0.936 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.613 ' HE3' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.595 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -138.61 112.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 15' ' ' VAL . 14.7 t -133.96 150.43 31.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.705 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 14' ' ' PRO . 4.4 m-85 -83.7 129.76 34.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.48 ' HA ' ' CD1' ' A' ' 69' ' ' ILE . 0.4 OUTLIER -95.18 114.78 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.557 0.694 . . . . 0.0 110.858 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.86 145.3 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.572 ' O ' ' N ' ' A' ' 9' ' ' SER . 17.9 t80 -139.99 148.02 41.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.598 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -64.46 72.72 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.907 0.861 . . . . 0.0 109.108 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -163.76 -161.15 0.62 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.044 -1.434 . . . . 0.0 108.284 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.38 175.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -53.97 143.35 21.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.282 0.563 . . . . 0.0 111.309 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.3 168.53 54.59 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.941 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.454 ' CG ' ' HD2' ' A' ' 14' ' ' PRO . 58.7 t80 -112.99 140.5 24.21 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.597 0.237 . . . . 0.0 111.116 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.454 ' HD2' ' CG ' ' A' ' 13' ' ' PHE . 32.2 Cg_endo -64.02 132.52 34.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.232 1.954 . . . . 0.0 111.652 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.586 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -118.11 138.16 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.633 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.595 ' HA ' ' CG2' ' A' ' 2' ' ' ILE . 17.9 tt0 -97.4 72.34 2.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.609 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.643 HG23 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 179.61 156.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.959 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.643 ' N ' HG23 ' A' ' 17' ' ' VAL . 8.6 p30 -65.0 112.56 3.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 1.6 m -83.6 0.5 46.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.615 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -116.45 -17.52 10.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.725 0.693 . . . . 0.0 112.697 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.685 ' CA ' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -33.17 154.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.066 0.546 . . . . 0.0 111.375 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 t -20.63 143.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.726 0.774 . . . . 0.0 113.036 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.546 ' HA ' ' CD2' ' A' ' 26' ' ' LEU . 17.3 tt -37.48 -44.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.275 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -69.08 -49.22 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.462 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 19.3 mm-40 -56.23 -62.69 1.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 19' ' ' SER . 1.9 pt? -58.92 -53.04 62.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.466 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 7.4 mttt -50.67 -36.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.962 0.41 . . . . 0.0 110.455 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.35 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.4 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.435 ' CG2' HG22 ' A' ' 17' ' ' VAL . 2.2 t -52.54 -55.83 9.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 111.255 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.653 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.5 p -55.42 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.428 0.632 . . . . 0.0 112.029 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.825 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -50.24 -26.44 4.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.777 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -69.49 -54.32 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.6 -5.79 58.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.252 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.97 -5.7 54.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.79 37.48 75.81 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.76 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.43 -174.47 0.41 Allowed Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.212 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.825 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 88.6 Cg_endo -66.72 -149.79 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.559 0 C-N-CA 122.395 2.063 . . . . 0.0 109.671 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.702 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . . . -105.83 -69.9 0.8 Allowed 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.237 0.961 . . . . 0.0 113.255 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.45 25.0 10.74 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.564 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 3.1 tp60 -52.26 -73.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.609 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -82.13 -135.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -132.5 139.16 47.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 111.957 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.541 ' CG1' ' CG1' ' A' ' 69' ' ' ILE . 10.9 t -113.1 141.78 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.053 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.742 ' O ' HG11 ' A' ' 67' ' ' VAL . 4.6 mp -138.16 162.12 31.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.662 ' HB2' HG22 ' A' ' 67' ' ' VAL . 10.0 t80 -132.52 153.74 50.64 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 22.53 37.91 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.16 -15.67 37.73 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.789 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.612 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -92.15 118.58 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -66.04 136.64 56.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 2.0 pp -22.7 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.746 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -122.09 118.32 28.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.747 ' O ' HG22 ' A' ' 56' ' ' VAL . 5.1 p-10 -39.22 -48.24 1.75 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -13.32 8.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.719 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 13.8 t90 -97.15 -29.35 13.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.647 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.21 -25.7 10.93 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.787 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 3.4 m -81.81 -133.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.516 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 1.9 mm100 -73.45 -34.85 65.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -72.98 0.07 12.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.919 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.787 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -95.9 -78.03 0.47 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.883 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' C ' HD22 ' A' ' 61' ' ' LEU . 1.5 t70 -168.41 76.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.053 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.569 HD21 ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.72 151.63 36.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.723 0.773 . . . . 0.0 112.908 -178.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.82 174.31 6.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.046 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -39.21 76.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.349 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.22 83.62 1.95 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.515 ' O ' HG12 ' A' ' 3' ' ' VAL . 15.1 m -102.81 171.87 7.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.152 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.6 pp -129.58 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.742 HG11 ' O ' ' A' ' 44' ' ' ILE . 91.4 t -118.6 135.99 57.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 111.363 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 6.8 t60 -92.74 106.64 18.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 7' ' ' PHE . 4.2 mp -103.06 140.35 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.609 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 13.4 t -125.32 69.67 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.608 ' HG2' ' HB2' ' A' ' 31' ' ' ALA . 17.3 tp60 -107.91 87.76 2.57 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.245 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -130.0 143.01 47.38 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.33 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 55.7 Cg_endo -69.97 151.39 67.87 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.334 2.022 . . . . 0.0 111.513 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -90.77 105.27 17.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 111.177 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -109.04 104.91 14.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.664 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.489 ' CG2' ' HA ' ' A' ' 16' ' ' GLU . 2.4 mt -122.99 118.63 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.617 HG12 ' HB2' ' A' ' 19' ' ' SER . 10.5 t -138.02 158.39 32.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.45 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.503 ' H ' HG11 ' A' ' 3' ' ' VAL . 4.1 m-85 -94.18 119.78 33.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG13 ' CG1' ' A' ' 15' ' ' VAL . 1.5 p -86.72 118.3 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.58 144.85 40.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.922 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.1 p90 -138.04 151.04 47.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.133 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -66.76 71.92 0.09 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.79 0.805 . . . . 0.0 109.215 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -163.91 -159.43 0.5 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.085 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' SER . 11.7 m -48.95 175.8 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.91 144.73 22.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.337 0.589 . . . . 0.0 111.424 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.1 172.59 53.34 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.717 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -123.6 142.37 38.89 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.788 0.328 . . . . 0.0 111.323 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.43 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 36.1 Cg_endo -65.04 124.79 13.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.362 2.042 . . . . 0.0 111.212 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.531 ' O ' ' O ' ' A' ' 3' ' ' VAL . 3.4 p -122.49 119.54 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.081 0.467 . . . . 0.0 111.433 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.489 ' HA ' ' CG2' ' A' ' 2' ' ' ILE . 7.7 tm-20 -77.35 86.3 3.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.343 0.592 . . . . 0.0 109.919 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.664 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 1.4 m -167.84 -166.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.191 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.518 ' N ' ' HE1' ' A' ' 1' ' ' MET . 2.7 p30 -103.58 104.79 14.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.617 ' HB2' HG12 ' A' ' 3' ' ' VAL . 72.0 m -88.25 4.32 46.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.856 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -122.96 -19.81 5.99 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.296 178.047 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.648 ' O ' ' O ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -36.14 169.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.527 0.517 . . . . 0.0 110.752 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 21' ' ' THR . 32.2 t -33.88 148.2 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.685 0.755 . . . . 0.0 112.491 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.586 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -46.08 -36.72 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.293 -177.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.663 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 14.2 m-85 -63.65 -45.22 91.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.454 ' HG3' ' OG1' ' A' ' 21' ' ' THR . 9.6 mm100 -67.26 -66.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.617 HD12 ' HB ' ' A' ' 43' ' ' VAL . 1.6 pp -49.48 -45.32 46.77 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.489 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.663 ' HG3' ' O ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -57.62 -37.47 73.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.481 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -63.96 -56.46 14.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.797 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.46 ' CG1' HG23 ' A' ' 17' ' ' VAL . 99.3 t -55.57 -53.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.139 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.694 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 1.3 p -57.67 -75.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.381 0.61 . . . . 0.0 112.358 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.876 ' HB3' ' O ' ' A' ' 37' ' ' PRO . . . -48.67 -39.12 23.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.963 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -61.42 -45.35 94.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.76 -11.27 45.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.128 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 30' ' ' VAL . 5.7 tt0 -84.34 -5.46 59.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.405 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.27 37.41 94.48 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.814 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -138.31 -171.79 0.29 Allowed Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 113.853 -1.174 . . . . 0.0 109.438 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.876 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 78.0 Cg_endo -63.51 -147.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.702 0 C-N-CA 122.377 2.051 . . . . 0.0 109.066 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -108.79 -77.78 0.6 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 123.844 0.715 . . . . 0.0 112.272 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.42 ' HB2' ' CG ' ' A' ' 27' ' ' LYS . 29.0 t70 -112.62 34.54 4.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.584 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 8.7 tp-100 -46.43 -71.1 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.744 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.8 tp -90.12 -138.6 0.14 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.582 ' O ' ' O ' ' A' ' 70' ' ' VAL . 3.5 mpp_? -112.98 135.41 53.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.392 0.615 . . . . 0.0 112.657 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.617 ' HB ' HD12 ' A' ' 26' ' ' LEU . 2.8 t -102.13 141.95 17.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.24 0.543 . . . . 0.0 111.096 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.757 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.6 mp -138.3 161.08 31.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 6.6 t80 -136.25 155.91 49.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.456 ' N ' ' CD1' ' A' ' 45' ' ' PHE . . . 40.61 28.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 111.583 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 -10.13 9.48 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.622 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' C ' HG23 ' A' ' 44' ' ' ILE . 15.3 mtmt -105.69 110.41 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.306 0.553 . . . . 0.0 110.838 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HA ' HG23 ' A' ' 44' ' ' ILE . 3.0 tm-20 -74.84 127.75 33.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.553 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 1.6 mm? -150.05 -164.35 2.0 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -105.88 175.7 5.41 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.722 0.772 . . . . 0.0 113.071 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.891 ' O ' HG22 ' A' ' 56' ' ' VAL . 4.5 p-10 -47.25 -20.08 0.17 Allowed 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.699 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -16.74 11.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.41 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.661 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 0.3 OUTLIER -108.3 -20.23 13.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -106.64 -27.41 10.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.906 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 1.5 m -79.88 -140.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.691 ' HA ' ' HB2' ' A' ' 61' ' ' LEU . 3.8 mp0 -65.81 -42.68 90.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -59.54 -14.0 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.037 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.906 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 8.4 t -84.72 -73.67 0.42 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.283 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.45 ' O ' HD21 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -170.66 84.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.658 176.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.691 ' HB2' ' HA ' ' A' ' 57' ' ' GLN . 0.6 OUTLIER -119.58 157.03 29.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.92 -178.8 5.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.718 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.71 -34.16 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.526 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -124.33 91.93 3.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.148 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.595 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.32 170.29 8.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.915 0.388 . . . . 0.0 111.447 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 2.0 pp -130.43 116.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 44' ' ' ILE . 60.4 t -116.12 142.79 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.075 0.464 . . . . 0.0 111.577 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' ILE . 64.9 t-80 -106.65 108.07 19.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.087 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.518 HG21 ' CG1' ' A' ' 30' ' ' VAL . 3.0 mp -100.79 138.68 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.744 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 52.7 t -141.51 74.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.11 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -123.5 58.28 1.14 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.823 0.821 . . . . 0.0 109.279 177.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -124.49 137.86 30.04 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.139 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' N ' ' HG2' ' A' ' 40' ' ' GLN . 28.6 Cg_endo -62.52 153.52 70.79 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.371 2.047 . . . . 0.0 112.096 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.31 148.6 28.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.654 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -91.39 108.27 19.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.584 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.828 0.347 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 16' ' ' GLU . 12.9 pt -132.94 114.72 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.282 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 15' ' ' VAL . 21.4 t -129.37 145.58 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.4 m-85 -81.63 126.36 31.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.422 HG13 ' HB ' ' A' ' 15' ' ' VAL . 0.6 OUTLIER -93.28 113.41 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.752 0.786 . . . . 0.0 110.641 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 -103.88 151.88 22.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.474 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 8' ' ' ASN . 65.6 t80 -136.0 171.88 13.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.514 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.758 ' O ' ' N ' ' A' ' 10' ' ' SER . 3.4 t30 -42.76 178.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.17 79.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.238 1.018 . . . . 0.0 110.682 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.758 ' N ' ' O ' ' A' ' 8' ' ' ASN . 9.5 p -144.84 174.68 10.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.995 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -86.44 109.93 19.39 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.43 158.4 37.6 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.438 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 9.0 p90 -126.71 144.32 49.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.667 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 39.1 Cg_endo -66.67 134.66 35.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.361 2.041 . . . . 0.0 111.467 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -117.65 135.78 56.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.827 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 1.4 tt0 -92.52 69.56 4.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.646 HG21 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER 176.39 156.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.615 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.646 ' N ' HG21 ' A' ' 17' ' ' VAL . 3.0 m-20 -65.85 120.37 12.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 1.2 t -87.28 -26.21 23.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -87.48 -23.33 24.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.715 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -34.09 151.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.311 0.382 . . . . 0.0 111.079 179.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.581 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -17.96 143.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.504 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 6.6 tt -40.81 -39.45 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.016 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 79.7 m-85 -66.97 -47.86 70.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.267 0.556 . . . . 0.0 109.591 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 54.9 mm-40 -65.17 -55.46 18.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.224 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.689 HD23 ' HB2' ' A' ' 50' ' ' LEU . 2.4 pp -55.93 -56.73 17.16 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HB2' ' HA ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -52.86 -36.93 59.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.314 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -66.18 -59.29 3.89 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.544 -179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG22 ' CG2' ' A' ' 17' ' ' VAL . 43.0 t -52.98 -52.45 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.623 0.249 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.676 ' CG1' ' H ' ' A' ' 31' ' ' ALA . 2.1 p -62.53 -74.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.756 ' CB ' ' O ' ' A' ' 37' ' ' PRO . . . -51.61 -29.58 18.03 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.941 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 10.2 ttmt -68.27 -54.07 20.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -7.54 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.96 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.1 OUTLIER -80.2 -5.4 56.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.572 0.225 . . . . 0.0 111.407 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 37.66 67.23 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.718 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -145.35 -173.63 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 113.512 -1.344 . . . . 0.0 109.237 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.756 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 95.0 Cg_endo -66.93 -144.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.331 2.021 . . . . 0.0 109.88 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.617 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -107.09 -68.05 0.91 Allowed 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.613 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -113.62 35.27 4.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.662 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 6.2 tp-100 -48.53 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.714 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp -87.33 -126.18 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 70' ' ' VAL . 20.7 mtt85 -129.01 147.95 50.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.203 0.525 . . . . 0.0 111.929 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.487 HG21 ' NE2' ' A' ' 71' ' ' GLN . 4.0 t -116.74 146.35 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.75 ' O ' HG11 ' A' ' 67' ' ' VAL . 4.0 mp -143.57 159.2 16.81 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.587 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 21.9 t80 -135.0 156.13 49.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . . . 26.62 37.89 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 78.71 -12.44 22.24 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.978 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.573 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 0.0 OUTLIER -92.82 121.82 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.179 0.489 . . . . 0.0 109.735 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.56 130.74 46.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.7 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.689 ' HB2' HD23 ' A' ' 26' ' ' LEU . 0.3 OUTLIER -21.66 103.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.664 ' O ' HG11 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -125.06 117.75 24.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.211 176.361 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.826 ' O ' HG22 ' A' ' 56' ' ' VAL . 9.4 p-10 -39.87 -46.6 2.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.5 OUTLIER -121.33 -13.56 8.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.714 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 6.2 t90 -97.59 -29.18 13.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.622 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.64 -25.21 10.99 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 52' ' ' ASN . 3.9 m -80.75 -132.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.519 1.304 . . . . 0.0 114.519 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.512 ' N ' ' CG2' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -74.42 -34.99 63.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -72.09 0.79 8.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.771 177.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.799 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -97.21 -78.24 0.48 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.88 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.502 ' C ' HD21 ' A' ' 61' ' ' LEU . 8.6 t0 -168.68 76.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.075 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.12 151.63 35.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.567 0.698 . . . . 0.0 112.836 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -120.26 177.19 5.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.32 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -58.24 -38.29 76.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.255 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.71 85.61 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.35 165.79 10.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -127.84 120.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.75 HG11 ' O ' ' A' ' 44' ' ' ILE . 72.0 t -117.94 135.95 56.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.018 0.437 . . . . 0.0 111.668 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.671 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -91.14 106.18 18.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.012 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 7' ' ' PHE . 4.5 mp -106.62 145.26 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.714 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 11.1 t -133.93 72.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.516 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 1.6 tp-100 -117.39 70.69 0.79 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.229 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.494 ' HG3' ' CE1' ' A' ' 7' ' ' PHE . 13.0 mtt180 -135.66 138.7 28.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.179 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.496 ' HA ' ' HG2' ' A' ' 40' ' ' GLN . 34.6 Cg_endo -63.41 160.95 33.06 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.962 2.441 . . . . 0.0 111.97 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.38 109.75 21.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.464 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.05 109.27 20.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.648 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.789 0.328 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 64' ' ' GLN . 1.0 OUTLIER -132.46 115.41 25.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.495 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.933 HG11 HG23 ' A' ' 67' ' ' VAL . 19.3 t -127.94 145.92 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.046 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 6.1 m-85 -80.8 126.59 31.51 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.1 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.009 HG23 HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -95.34 112.66 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.41 0.624 . . . . 0.0 110.807 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HD2' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -107.11 139.76 41.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.415 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 8' ' ' ASN . 25.7 t80 -101.32 155.18 18.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 7.8 t-20 . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.734 0.778 . . . . 0.0 110.195 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -122.41 131.34 24.41 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.958 0.379 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 37.7 Cg_endo -66.23 123.09 10.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.273 1.982 . . . . 0.0 112.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -114.1 136.68 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.444 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 2' ' ' ILE . 1.9 tt0 -93.09 70.25 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.8 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 177.1 154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.781 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.459 ' HA ' ' CG2' ' A' ' 3' ' ' VAL . 1.2 p-10 -64.93 118.36 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 12.9 t -88.01 -24.11 23.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 1.025 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -89.76 -18.45 26.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.71 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -37.18 154.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.287 0.235 . . . . 0.0 110.767 178.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.553 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 t -18.26 142.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.816 HD12 HD13 ' A' ' 50' ' ' LEU . 19.8 tt -39.7 -39.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 113.813 -1.539 . . . . 0.0 111.684 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -68.15 -49.52 60.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 20.0 mm-40 -63.13 -54.87 31.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.538 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.015 HD13 ' HB ' ' A' ' 43' ' ' VAL . 2.1 pp -55.31 -56.15 23.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 111.063 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.88 ' N ' HD12 ' A' ' 26' ' ' LEU . 7.3 mttt -56.13 -36.9 68.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.08 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.8 mm-40 -62.3 -60.57 3.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 17' ' ' VAL . 7.9 t -54.05 -53.81 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.4 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.013 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -58.46 -71.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.307 0.575 . . . . 0.0 112.349 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.027 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -54.06 -30.88 49.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.931 -1.032 . . . . 0.0 113.17 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 33.8 tttt -66.91 -52.44 43.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.085 0.469 . . . . 0.0 109.8 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.91 -7.2 58.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.447 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.537 ' HG2' HG11 ' A' ' 36' ' ' VAL . 1.9 tp60 -80.53 -4.6 54.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.617 0.246 . . . . 0.0 111.58 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.47 37.5 78.8 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.809 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -142.78 -172.65 0.32 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 113.371 -1.415 . . . . 0.0 108.867 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.027 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 86.2 Cg_endo -65.17 -152.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 122.083 1.856 . . . . 0.0 109.388 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.568 ' O ' ' HB3' ' A' ' 27' ' ' LYS . . . -106.54 -70.44 0.79 Allowed 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 3.8 p-10 -118.02 22.72 12.07 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.514 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 5.2 tp-100 -55.29 -63.44 1.16 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 70' ' ' VAL . 6.9 tp -82.67 -143.33 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -129.08 142.04 51.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.212 0.529 . . . . 0.0 111.159 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.015 ' HB ' HD13 ' A' ' 26' ' ' LEU . 9.5 t -116.82 148.84 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.688 ' O ' ' O ' ' A' ' 68' ' ' HIS . 46.2 mt -140.93 159.37 23.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.961 ' HB2' HG13 ' A' ' 67' ' ' VAL . 23.2 t80 -136.34 157.14 47.5 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HE2' ' A' ' 48' ' ' LYS . . . 23.62 36.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 83.4 -14.63 39.31 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.869 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -92.1 119.84 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.325 0.562 . . . . 0.0 109.494 178.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HA ' HG23 ' A' ' 44' ' ' ILE . 16.2 tt0 -67.61 134.43 51.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.816 HD13 HD12 ' A' ' 23' ' ' ILE . 1.3 pp -9.77 87.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.891 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -118.16 120.58 38.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 52.3 t-20 -46.24 -47.81 17.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.1 -14.14 8.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.758 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 t90 -95.39 -25.49 16.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.754 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.3 m -109.2 -30.63 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.025 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.2 m -70.66 -133.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.794 ' N ' HG23 ' A' ' 56' ' ' VAL . 1.5 mm100 -78.32 -36.79 45.95 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.696 ' H ' HG23 ' A' ' 56' ' ' VAL . 15.7 t-20 -65.78 -12.02 50.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.765 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.758 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 1.6 t -81.36 -78.66 0.18 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.097 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.619 ' C ' HD23 ' A' ' 61' ' ' LEU . 32.1 t70 -168.73 76.02 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.993 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.83 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.65 150.82 37.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.25 178.19 4.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.779 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' O ' HG13 ' A' ' 2' ' ' ILE . 4.4 mm-40 -57.33 -39.48 75.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.999 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.801 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.5 pt20 -115.05 88.67 2.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.674 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.78 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.56 165.57 11.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.503 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -128.93 121.97 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.961 HG13 ' HB2' ' A' ' 45' ' ' PHE . 98.7 t -117.76 137.01 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.067 0.461 . . . . 0.0 111.408 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.688 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -92.29 106.84 18.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.173 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.009 HD13 HG23 ' A' ' 5' ' ' VAL . 4.4 mp -99.7 138.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 42' ' ' ARG . 48.8 t . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.667 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.654 0.264 . . . . 0.0 110.792 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.934 HG23 ' HA ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -132.61 114.48 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.03 HG11 HG23 ' A' ' 67' ' ' VAL . 20.4 t -133.15 145.5 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.372 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 3.5 m-85 -85.9 130.54 34.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.566 HG12 HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -103.95 120.45 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.258 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -100.64 129.75 46.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.907 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 8' ' ' ASN . 8.4 t80 -100.77 155.28 18.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 4.1 t-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.679 0.752 . . . . 0.0 110.293 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.495 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.502 ' O ' HG13 ' A' ' 5' ' ' VAL . 20.2 t80 -122.42 106.53 35.29 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.911 0.355 . . . . 0.0 110.978 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 16.8 Cg_exo -67.6 120.73 7.76 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.478 2.119 . . . . 0.0 111.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 3' ' ' VAL . 3.9 m -121.45 148.17 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.934 ' HA ' HG23 ' A' ' 2' ' ' ILE . 30.3 tt0 -93.07 75.11 4.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.041 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 178.88 152.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.891 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 21' ' ' THR . 8.5 m-20 -65.41 119.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.497 ' OG ' HD11 ' A' ' 69' ' ' ILE . 1.4 t -85.83 -30.54 22.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.97 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -86.75 -21.52 26.52 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.701 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -33.51 150.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.253 0.346 . . . . 0.0 111.096 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.2 t -17.3 142.99 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.549 ' HA ' HD21 ' A' ' 26' ' ' LEU . 19.5 tt -39.69 -39.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 113.837 -1.528 . . . . 0.0 111.887 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -67.56 -49.2 64.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 2.2 mm-40 -63.0 -55.61 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.582 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.037 HD13 ' HB ' ' A' ' 43' ' ' VAL . 1.9 pp -55.2 -57.23 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 111.237 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.876 ' N ' HD12 ' A' ' 26' ' ' LEU . 12.1 mttt -56.55 -35.36 68.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.146 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.97 -59.85 4.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.041 HG21 HG21 ' A' ' 17' ' ' VAL . 4.3 t -54.04 -53.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.197 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.977 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -58.78 -73.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.464 0.65 . . . . 0.0 112.224 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.125 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -50.03 -27.75 6.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.939 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HE3' ' HG2' ' A' ' 33' ' ' ARG . 8.1 ttpp -69.83 -52.5 24.4 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.404 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 2.4 mtt180 -88.66 -5.75 57.93 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.395 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -79.73 -6.31 56.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.573 0.225 . . . . 0.0 111.589 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.47 37.2 69.31 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.803 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.41 -173.65 0.37 Allowed Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.193 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.125 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 83.0 Cg_endo -66.3 -148.87 0.02 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 122.219 1.946 . . . . 0.0 109.719 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.646 ' O ' ' HB3' ' A' ' 27' ' ' LYS . . . -105.31 -68.02 0.89 Allowed 'General case' 0 N--CA 1.426 -1.656 0 O-C-N 124.277 0.986 . . . . 0.0 113.279 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 7.5 p30 -112.62 29.47 7.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.764 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 7.3 tp-100 -53.2 -76.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.65 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 2.9 tp -84.74 -138.36 0.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -131.45 139.41 49.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.366 0.603 . . . . 0.0 112.495 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.037 ' HB ' HD13 ' A' ' 26' ' ' LEU . 5.2 t -109.61 144.28 18.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.695 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.4 mp -138.28 159.01 32.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.934 ' CD1' HG22 ' A' ' 67' ' ' VAL . 21.9 t80 -133.89 154.2 51.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.771 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 26.03 34.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 85.8 -14.73 51.12 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.783 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.771 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -90.9 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 6.6 tt0 -65.4 135.12 54.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 43' ' ' VAL . 0.4 OUTLIER -14.52 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.857 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -120.35 119.12 32.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 17.0 p-10 -44.87 -47.17 11.13 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -119.38 -14.23 9.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.328 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.741 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.2 t90 -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.764 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -109.43 -26.01 10.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.053 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.97 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.2 m -82.29 -133.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.773 ' N ' HG23 ' A' ' 56' ' ' VAL . 3.9 mm-40 -73.18 -35.8 66.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.682 ' H ' HG23 ' A' ' 56' ' ' VAL . 4.0 m-20 -71.22 -0.17 9.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.909 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.82 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -96.71 -76.99 0.5 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.818 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.682 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -169.94 76.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.064 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.798 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -117.17 152.19 35.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.14 177.21 4.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.157 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.51 ' O ' HD12 ' A' ' 2' ' ' ILE . 8.5 mt-30 -58.89 -38.75 79.56 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.002 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -116.53 86.7 2.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.666 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -101.66 168.2 9.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.371 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.513 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -127.96 119.78 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.03 HG23 HG11 ' A' ' 3' ' ' VAL . 76.4 t -117.71 137.37 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 111.834 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.695 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -91.06 108.24 19.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.109 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.024 HG23 HG13 ' A' ' 43' ' ' VAL . 6.5 mt -102.9 140.99 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.65 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 17.0 t . . . . . 0 N--CA 1.436 -1.153 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.585 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.701 0.286 . . . . 0.0 110.711 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.869 HG22 ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -134.09 114.27 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.141 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.952 HG11 HG23 ' A' ' 67' ' ' VAL . 17.9 t -130.34 147.11 33.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.326 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.749 ' CD1' HG22 ' A' ' 66' ' ' ILE . 31.5 m-85 -85.69 124.63 32.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.108 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.875 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -94.14 120.39 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.516 0.674 . . . . 0.0 110.594 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.7 mmt85 -101.79 149.1 24.52 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.264 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -115.44 156.67 25.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 121.735 0.779 . . . . 0.0 110.192 -179.227 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.495 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 111.841 -0.503 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' HB3' HG13 ' A' ' 5' ' ' VAL . 1.2 t80 -114.54 118.44 41.39 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 117.186 0.493 . . . . 0.0 110.731 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 36.2 Cg_endo -65.4 120.96 8.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.031 1.82 . . . . 0.0 111.876 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -115.62 139.53 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.597 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.869 ' HA ' HG22 ' A' ' 2' ' ' ILE . 3.9 tt0 -93.71 69.71 4.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.421 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 175.41 157.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.723 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.689 ' OD1' HG21 ' A' ' 21' ' ' THR . 3.5 p30 -65.62 119.84 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.449 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -87.58 -24.88 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -177.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.814 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -91.16 -23.54 20.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.755 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -35.19 153.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.267 0.354 . . . . 0.0 111.41 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.3 t -16.62 144.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.822 HD11 ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -41.0 -39.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.906 -177.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.48 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 49.9 m-85 -66.92 -48.14 69.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.247 0.546 . . . . 0.0 109.604 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HB2' HG23 ' A' ' 21' ' ' THR . 36.2 mm-40 -64.81 -54.95 23.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.369 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.972 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.5 pp -57.14 -58.61 7.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.68 0.276 . . . . 0.0 111.178 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.837 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -51.19 -36.47 41.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.484 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 27.1 tt0 -68.7 -59.93 2.76 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.899 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 17' ' ' VAL . 52.2 t -51.95 -52.65 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.751 0.31 . . . . 0.0 111.463 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.061 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -61.88 -73.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.263 0.554 . . . . 0.0 112.409 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.121 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -53.14 -25.84 14.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.368 -176.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 4.8 tttp -72.19 -52.02 18.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -85.96 -7.85 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.567 ' HG2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -80.62 -6.58 58.52 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.525 0.202 . . . . 0.0 111.542 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.79 39.58 85.68 Favored Glycine 0 CA--C 1.507 -0.426 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.854 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -144.02 -172.3 0.31 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 113.488 -1.356 . . . . 0.0 109.464 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.121 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 96.0 Cg_endo -67.04 -147.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 122.403 2.069 . . . . 0.0 109.826 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -105.96 -69.82 0.81 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 124.177 0.923 . . . . 0.0 112.871 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.822 ' CG ' HD11 ' A' ' 23' ' ' ILE . 38.5 t70 -121.97 31.52 6.18 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.652 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -49.02 -77.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 4.6 tp -81.94 -124.71 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 17.9 mmt180 -131.51 162.36 30.44 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.449 0.568 . . . . 0.0 112.016 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 69' ' ' ILE . 6.1 t -130.69 147.55 33.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.047 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 68' ' ' HIS . 37.6 mt -143.3 159.01 17.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.921 ' CD1' HG22 ' A' ' 67' ' ' VAL . 14.0 t80 -134.51 153.29 52.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.765 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 26.87 37.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 79.72 -12.51 28.32 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.835 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.765 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 10.3 mtmt -91.43 123.41 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.189 0.495 . . . . 0.0 109.966 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' HA ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -60.69 122.39 14.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.122 -178.2 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.663 ' HB2' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -25.05 107.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.1 mmp_? -126.66 118.94 25.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -41.76 -44.89 3.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.732 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -118.81 -14.36 9.49 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.659 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 14.9 m-90 -100.07 -31.83 11.23 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.617 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -107.28 -24.07 12.01 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.826 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 4.2 m -82.26 -135.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -175.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.72 ' N ' HG23 ' A' ' 56' ' ' VAL . 3.6 mm-40 -68.52 -35.12 77.03 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.696 ' H ' HG23 ' A' ' 56' ' ' VAL . 1.2 m-20 -74.02 6.06 3.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.146 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.826 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 4.8 t -106.22 -79.1 0.57 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.216 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.546 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -165.39 76.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.289 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -115.69 148.55 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.454 0.645 . . . . 0.0 112.464 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.61 175.01 5.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.098 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -56.82 -39.72 74.7 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.129 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 2' ' ' ILE . 2.8 pm0 -114.43 85.62 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.793 ' C ' HG13 ' A' ' 3' ' ' VAL . 50.5 m -101.1 166.58 10.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.498 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.749 HG22 ' CD1' ' A' ' 4' ' ' PHE . 1.8 pp -128.96 121.07 53.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.952 HG23 HG11 ' A' ' 3' ' ' VAL . 92.9 t -118.42 135.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.037 0.446 . . . . 0.0 111.566 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -91.88 107.49 19.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.119 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.019 HG21 HG21 ' A' ' 30' ' ' VAL . 4.0 mp -106.21 148.21 10.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.655 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 39.1 t . . . . . 0 N--CA 1.437 -1.099 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.704 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.672 0.272 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.91 HG22 ' HA ' ' A' ' 16' ' ' GLU . 20.3 pt -133.09 115.91 24.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.048 HG11 HG23 ' A' ' 67' ' ' VAL . 22.2 t -129.23 149.28 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.232 -0.987 . . . . 0.0 112.147 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 3.4 m-85 -88.84 127.22 35.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -105.87 117.99 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.498 0.666 . . . . 0.0 111.024 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.508 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.8 mmt85 -102.59 144.82 30.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -108.52 158.87 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.198 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 121.729 0.776 . . . . 0.0 110.121 -179.399 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.451 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.8 t80 -119.62 105.86 42.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 117.164 0.482 . . . . 0.0 110.941 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 47.4 Cg_endo -69.06 119.4 6.39 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.198 1.932 . . . . 0.0 112.062 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 3' ' ' VAL . 6.4 m -117.4 147.86 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.174 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.91 ' HA ' HG22 ' A' ' 2' ' ' ILE . 3.1 tt0 -91.22 71.83 6.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.4 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.003 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 178.99 154.71 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 21' ' ' THR . 8.4 p30 -65.07 118.76 9.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.502 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -85.5 -25.11 27.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.978 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.56 -19.76 23.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.689 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -34.35 152.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.454 0.302 . . . . 0.0 110.836 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.5 t -18.87 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.532 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 17.5 tt -40.98 -38.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.917 -177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.552 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 43.8 m-85 -68.39 -46.98 68.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 44.4 mm-40 -65.97 -54.44 26.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.083 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.0 HD13 ' HB ' ' A' ' 43' ' ' VAL . 2.7 pp -57.07 -56.05 26.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.909 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.901 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.22 -36.93 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.163 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 2.2 mt-10 -66.3 -60.15 3.04 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.003 HG21 HG21 ' A' ' 17' ' ' VAL . 32.5 t -53.35 -56.13 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.607 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.067 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.0 p -59.05 -74.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.32 0.581 . . . . 0.0 112.547 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.067 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -48.83 -31.01 6.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.928 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 28' ' ' GLU . 6.9 ttmt -67.03 -52.31 44.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.102 0.477 . . . . 0.0 109.719 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -85.76 -6.78 59.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -79.46 -6.96 58.02 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.626 0.25 . . . . 0.0 111.571 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.84 59.03 Favored Glycine 0 CA--C 1.505 -0.581 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.778 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -145.79 -173.41 0.36 Allowed Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.272 -1.464 . . . . 0.0 108.987 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.054 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 90.9 Cg_endo -68.2 -145.19 0.02 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 122.262 1.974 . . . . 0.0 110.004 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.804 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -104.58 -65.68 1.02 Allowed 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.002 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 5.3 t0 -115.28 39.39 2.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.614 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 2.8 tp-100 -43.95 -85.26 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 40' ' ' GLN . 48.5 mt -94.19 -113.89 0.11 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' VAL . 7.6 mtp180 -130.44 126.37 36.8 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.432 0.634 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.002 HG13 HG23 ' A' ' 69' ' ' ILE . 1.4 t -96.98 139.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.676 ' O ' ' O ' ' A' ' 68' ' ' HIS . 2.9 mp -138.52 159.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.925 ' HB2' HG13 ' A' ' 67' ' ' VAL . 15.7 t80 -134.76 154.57 51.53 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 25.21 38.02 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 80.97 -12.98 33.67 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.903 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.748 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 4.4 mtmt -90.12 118.16 29.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.266 0.533 . . . . 0.0 109.764 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 24.7 tt0 -64.78 130.02 41.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -10.89 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.899 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -115.48 118.69 33.87 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 10.3 p30 -46.05 -48.75 16.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.49 -14.17 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.746 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.8 t90 -95.91 -26.49 15.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.761 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.2 m -109.14 -27.15 9.75 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.978 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.1 m -78.63 -134.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.785 ' N ' HG23 ' A' ' 56' ' ' VAL . 8.1 pt20 -73.49 -35.88 65.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.709 ' H ' HG23 ' A' ' 56' ' ' VAL . 2.1 m-80 -70.56 -0.72 9.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.087 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.8 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -96.09 -78.17 0.47 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.017 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.668 ' C ' HD23 ' A' ' 61' ' ' LEU . 6.0 t0 -169.27 76.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.015 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.796 HD11 ' CG ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.19 151.48 35.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 112.793 -178.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.69 177.37 4.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.041 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -39.01 77.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.887 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.44 ' HA ' HG13 ' A' ' 2' ' ' ILE . 1.3 tt0 -114.78 87.42 2.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.597 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -101.26 167.68 10.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.253 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.535 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.9 pp -130.32 121.95 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.048 HG23 HG11 ' A' ' 3' ' ' VAL . 74.4 t -117.05 136.2 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.083 0.468 . . . . 0.0 111.734 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 10.5 m-70 -93.42 106.56 18.52 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.006 ' CG2' HG21 ' A' ' 30' ' ' VAL . 3.2 mp -100.1 140.39 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 42' ' ' ARG . 44.2 t . . . . . 0 N--CA 1.436 -1.127 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.166 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.556 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.271 0.557 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.954 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.3 mt -143.7 112.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.091 HG11 HG23 ' A' ' 67' ' ' VAL . 14.2 t -137.27 150.5 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 118.836 -1.146 . . . . 0.0 112.562 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.521 ' HB2' HG23 ' A' ' 66' ' ' ILE . 2.5 m-85 -84.26 137.04 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.847 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.66 116.55 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.518 0.675 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 2.9 mmt85 -104.4 148.82 25.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.636 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -123.71 157.49 33.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 121.766 0.794 . . . . 0.0 110.552 -178.702 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 CA--C 1.518 0.242 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.5 t80 -121.75 107.0 36.45 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 117.201 0.5 . . . . 0.0 110.73 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 17.0 Cg_exo -66.8 122.85 10.28 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.533 2.155 . . . . 0.0 112.338 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 3' ' ' VAL . 5.2 m -127.86 148.64 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.057 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.954 ' HA ' HG23 ' A' ' 2' ' ' ILE . 25.8 tt0 -91.48 77.7 5.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.017 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER 178.86 152.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 21' ' ' THR . 4.1 m-20 -67.38 119.09 11.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 12.9 t -87.88 -22.89 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.91 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -92.09 -19.56 22.2 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.68 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -35.34 154.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.296 0.373 . . . . 0.0 110.903 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.582 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.4 t -18.12 142.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.101 HD12 HD11 ' A' ' 26' ' ' LEU . 11.1 tp -40.71 -36.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.049 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.465 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 28.3 m-85 -70.08 -47.94 59.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.32 0.581 . . . . 0.0 109.48 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 5.3 mm100 -64.4 -50.55 67.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.379 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.101 HD11 HD12 ' A' ' 23' ' ' ILE . 1.9 pp -59.93 -57.76 11.46 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.058 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.85 ' N ' HD12 ' A' ' 26' ' ' LEU . 20.5 pttt -51.8 -32.46 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.086 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -68.01 -60.71 2.29 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.694 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 17' ' ' VAL . 25.5 t -54.65 -52.67 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.573 0.225 . . . . 0.0 111.394 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 69' ' ' ILE . 1.2 p -57.12 -75.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.452 0.644 . . . . 0.0 111.548 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.959 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -46.89 -31.39 3.08 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.756 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 28' ' ' GLU . 1.5 ttpm? -66.81 -57.12 7.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.977 0.418 . . . . 0.0 110.069 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 -5.23 59.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.065 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 45.8 tp60 -77.97 -10.42 59.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.654 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.55 37.71 34.6 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.805 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.8 m -147.65 -169.65 0.22 Allowed Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.077 -1.561 . . . . 0.0 108.281 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.911 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 55.0 Cg_endo -70.03 -148.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.097 0 C-N-CA 122.131 1.887 . . . . 0.0 110.649 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.683 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -122.22 -46.93 2.16 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.851 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.463 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -68.77 -5.79 22.8 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.318 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.795 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 1.9 tp60 -56.27 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.705 0.764 . . . . 0.0 110.102 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.848 ' HG ' HD11 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -69.9 -161.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.369 -176.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.653 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 21.4 mmt-85 70.58 44.74 0.65 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.078 HG13 HG23 ' A' ' 69' ' ' ILE . 2.8 t -103.54 143.02 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.741 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.678 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.3 mp -140.51 156.18 23.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.941 ' CD1' HG22 ' A' ' 67' ' ' VAL . 16.2 t80 -129.46 151.11 50.44 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.821 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 27.41 35.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 87.82 -13.71 60.31 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.839 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.821 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -90.97 122.37 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.148 0.474 . . . . 0.0 110.013 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 44' ' ' ILE . 3.2 tt0 -69.04 135.13 50.36 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.046 HD13 HD13 ' A' ' 23' ' ' ILE . 1.1 pp -14.14 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.879 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -119.5 115.37 23.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 4.2 p30 -49.1 -46.65 45.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.936 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -16.46 11.74 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.664 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 10.9 m-90 -98.54 -28.17 13.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.733 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.1 m -107.01 -25.21 11.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.91 HG12 ' O ' ' A' ' 20' ' ' ASP . 2.9 m -82.89 -136.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.747 ' N ' HG23 ' A' ' 56' ' ' VAL . 6.5 pt20 -67.08 -33.83 76.35 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.681 ' H ' HG23 ' A' ' 56' ' ' VAL . 6.7 m-80 -74.04 3.66 6.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.128 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.807 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.6 t -104.08 -78.33 0.56 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.541 ' C ' HD23 ' A' ' 61' ' ' LEU . 20.8 t70 -167.04 77.6 0.18 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.96 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.813 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.31 149.05 39.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 112.974 -178.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -120.82 172.41 7.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.873 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -56.47 -38.91 72.34 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.301 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -115.03 83.25 1.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.615 ' C ' HG13 ' A' ' 3' ' ' VAL . 5.8 m -102.85 172.15 6.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 61.9 mt -131.51 121.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.091 HG23 HG11 ' A' ' 3' ' ' VAL . 60.4 t -117.61 132.86 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.678 ' O ' ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -92.2 109.85 21.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.71 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.078 HG23 HG13 ' A' ' 43' ' ' VAL . 3.1 mp -103.16 149.35 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.653 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 24.6 t . . . . . 0 N--CA 1.434 -1.24 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.713 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.623 0.249 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -131.14 115.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.12 HG11 HG23 ' A' ' 67' ' ' VAL . 19.0 t -134.87 148.5 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 118.814 -1.154 . . . . 0.0 112.582 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -83.51 128.95 34.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.901 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.656 ' CB ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.99 118.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.428 0.633 . . . . 0.0 110.803 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.47 147.46 27.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.734 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 8' ' ' ASN . 7.0 t80 -137.89 145.76 42.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 10.1 p-10 . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 121.845 0.831 . . . . 0.0 108.968 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 CA-C-O 120.561 -0.022 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.445 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.0 m-85 -118.98 142.65 32.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.73 0.3 . . . . 0.0 111.192 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 95.7 Cg_endo -80.45 133.27 9.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.644 2.229 . . . . 0.0 112.341 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 3' ' ' VAL . 10.5 m -121.67 149.0 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.894 ' HA ' HG23 ' A' ' 2' ' ' ILE . 5.2 tt0 -91.75 72.48 5.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.953 HG21 HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -172.81 156.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.903 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.555 ' OD1' HD12 ' A' ' 61' ' ' LEU . 1.4 m-20 -68.09 114.55 6.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.656 ' O ' HG11 ' A' ' 67' ' ' VAL . 3.6 m -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.95 ' OD2' HD11 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -114.61 -24.01 8.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.49 0.586 . . . . 0.0 112.452 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.71 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -32.79 153.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.715 0.634 . . . . 0.0 111.58 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -20.69 143.95 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.783 0.801 . . . . 0.0 113.061 -174.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.604 ' HA ' HD21 ' A' ' 26' ' ' LEU . 13.5 tt -40.03 -39.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.822 -177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 78.9 m-85 -68.69 -49.25 60.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 18.4 mm100 -59.21 -65.56 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.945 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.5 pt? -58.47 -50.17 74.68 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.537 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.782 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -48.39 -38.39 19.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.82 0.343 . . . . 0.0 110.616 178.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 13.8 tt0 -65.83 -62.47 1.48 Allowed 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.97 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.953 HG21 HG21 ' A' ' 17' ' ' VAL . 2.7 t -50.68 -48.6 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.62 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.978 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.9 p -67.03 -74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.978 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -52.5 -33.29 44.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.619 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 8.6 tttp -67.1 -51.69 51.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -80.53 -9.21 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.48 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.697 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 31.6 tp60 -81.08 -10.16 59.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.5 36.4 49.36 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.844 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.2 m -145.23 -174.51 0.41 Allowed Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 113.584 -1.308 . . . . 0.0 109.188 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.934 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 98.0 Cg_endo -66.62 -142.36 0.01 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.837 2.358 . . . . 0.0 109.824 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -104.68 -73.07 0.69 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.935 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.469 ' HB3' ' CD ' ' A' ' 27' ' ' LYS . 26.7 p-10 -120.15 26.54 9.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.577 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 36.9 tp60 -46.4 -59.26 3.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.305 0.502 . . . . 0.0 111.057 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 9.7 tp -83.2 -138.74 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.426 -0.11 . . . . 0.0 110.749 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.559 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 11.4 mtt85 -128.54 119.16 24.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.286 0.565 . . . . 0.0 111.878 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.017 HG13 HG23 ' A' ' 69' ' ' ILE . 2.2 t -96.03 135.68 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.959 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 68' ' ' HIS . 3.3 mp -137.67 163.19 31.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.948 ' CD1' HG22 ' A' ' 67' ' ' VAL . 8.6 t80 -136.19 154.01 51.07 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.623 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 24.25 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.19 -15.42 39.25 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.742 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.623 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -93.61 119.73 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.317 0.558 . . . . 0.0 109.732 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 44' ' ' ILE . 17.6 tt0 -64.83 134.26 53.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.005 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -21.46 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.827 ' H ' ' HB ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -121.72 117.59 27.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -40.22 -48.4 2.57 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -119.92 -14.24 8.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.616 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.716 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 11.2 t90 -97.21 -30.28 13.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.827 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -107.06 -26.3 11.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.902 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.0 m -83.81 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.721 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.77 -34.91 78.87 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.649 ' H ' HG23 ' A' ' 56' ' ' VAL . 3.3 m-80 -73.75 1.87 9.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.014 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.839 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 3.2 t -101.45 -77.47 0.55 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.288 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.43 ' O ' HD22 ' A' ' 61' ' ' LEU . 10.4 t0 -165.68 78.53 0.28 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.022 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.95 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -117.74 149.22 41.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.76 173.43 7.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.734 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -57.22 -38.11 73.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.788 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.96 84.81 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.627 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.61 171.45 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 7.2 pt -129.9 121.93 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.12 HG23 HG11 ' A' ' 3' ' ' VAL . 98.8 t -119.71 139.69 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.467 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 3.6 t-80 -97.84 105.39 17.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.317 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.017 HG23 HG13 ' A' ' 43' ' ' VAL . 3.0 mp -97.84 115.31 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 45.8 t . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.722 ' HE3' ' C ' ' A' ' 17' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.894 HG22 ' HA ' ' A' ' 16' ' ' GLU . 11.6 pt -136.37 124.66 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.748 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 15' ' ' VAL . 94.1 t -139.54 156.41 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.453 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 3.2 m-85 -89.92 136.28 33.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.647 HG22 ' HB3' ' A' ' 13' ' ' PHE . 3.0 m -101.88 118.77 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 111.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -107.98 130.82 55.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.518 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -114.22 162.57 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 121.814 0.816 . . . . 0.0 110.75 -178.371 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.536 ' CA ' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.647 ' HB3' HG22 ' A' ' 5' ' ' VAL . 35.7 t80 -124.6 116.09 26.66 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.937 0.368 . . . . 0.0 110.741 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 19.2 Cg_exo -65.42 115.64 3.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.132 1.888 . . . . 0.0 111.524 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 3' ' ' VAL . 18.1 m -121.63 146.5 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.894 ' HA ' HG22 ' A' ' 2' ' ' ILE . 8.1 tt0 -84.85 81.93 8.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -167.37 -169.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.138 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.774 ' N ' HG23 ' A' ' 17' ' ' VAL . 33.2 m-20 -113.75 112.92 24.22 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.954 ' OG ' HD11 ' A' ' 69' ' ' ILE . 23.3 t -90.01 8.32 33.12 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.928 ' OD2' HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -122.05 -19.04 6.75 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.915 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.943 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.19 175.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 179.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 32.7 t -40.18 154.93 0.03 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.679 -0.638 . . . . 0.0 112.431 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.833 HG13 HD22 ' A' ' 50' ' ' LEU . 5.0 tt -45.43 -41.15 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.701 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.589 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 49.5 m-85 -63.2 -48.66 77.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.444 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.633 ' HB2' HG23 ' A' ' 21' ' ' THR . 5.8 mm100 -58.82 -71.3 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.946 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -49.79 -55.14 15.22 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.022 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -43.3 -40.3 3.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 110.58 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.2 tt0 -66.77 -61.43 1.96 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.69 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 17' ' ' VAL . 60.5 t -49.01 -53.16 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.946 HG12 ' O ' ' A' ' 26' ' ' LEU . 1.2 p -62.09 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.945 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -55.0 -40.26 69.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.89 -176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 1.4 ttpm? -61.98 -46.91 87.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.254 0.55 . . . . 0.0 109.524 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -12.16 59.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.68 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -85.14 -1.42 56.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.095 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.92 34.93 88.64 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.846 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 m -140.26 -172.87 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 113.771 -1.215 . . . . 0.0 109.219 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.919 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 83.3 Cg_endo -65.48 -140.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 122.493 2.129 . . . . 0.0 109.625 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -110.8 -74.89 0.63 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.391 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.57 ' HB2' ' CD ' ' A' ' 27' ' ' LYS . 28.7 t70 -113.03 37.82 3.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.662 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 15.7 tp60 -42.54 -68.48 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.355 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.78 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 6.6 tp -91.83 -136.25 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.155 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' VAL . 1.6 mtt85 -113.27 130.43 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.052 HG13 HG23 ' A' ' 69' ' ' ILE . 2.3 t -105.84 133.86 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.604 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.748 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.5 mt -140.12 162.76 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.967 ' HB2' HG13 ' A' ' 67' ' ' VAL . 7.3 t80 -135.52 88.55 2.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.963 0.411 . . . . 0.0 111.669 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.744 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 77.21 31.85 0.48 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.375 0.607 . . . . 0.0 109.979 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.2 47.3 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.024 -0.989 . . . . 0.0 114.053 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.744 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -90.35 117.04 28.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.697 0.749 . . . . 0.0 110.048 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.55 133.55 45.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.833 HD22 HG13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -14.64 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.996 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.3 mmp_? -112.76 118.76 35.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.49 ' O ' HG21 ' A' ' 56' ' ' VAL . 5.9 t-20 -49.38 -39.84 33.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.08 -15.05 9.92 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.623 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.9 m-90 -101.76 -30.28 11.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.919 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.5 m -109.86 -30.19 7.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.996 HG13 ' O ' ' A' ' 51' ' ' ARG . 11.1 m -51.65 -129.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.668 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -92.8 -44.39 8.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.485 ' H ' HG23 ' A' ' 56' ' ' VAL . 4.9 m-80 -59.96 -16.07 27.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.952 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.623 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -63.73 -72.15 0.15 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.92 179.141 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.719 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.4 t0 -166.4 74.94 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.928 HD21 ' OD2' ' A' ' 20' ' ' ASP . 10.7 mp -130.99 166.28 21.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.52 -173.48 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.042 -1.89 . . . . 0.0 108.857 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -63.54 -30.83 71.89 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.768 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.492 ' HA ' HG13 ' A' ' 2' ' ' ILE . 11.1 tt0 -123.46 95.34 4.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.6 ' OG ' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -102.51 169.52 8.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.685 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.48 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.7 pp -132.26 123.01 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.967 HG13 ' HB2' ' A' ' 45' ' ' PHE . 96.8 t -116.23 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.06 0.457 . . . . 0.0 111.769 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.748 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -101.21 107.19 18.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.033 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.052 HG23 HG13 ' A' ' 43' ' ' VAL . 3.7 mp -104.55 141.85 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.78 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 41.3 t . . . . . 0 N--CA 1.432 -1.34 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.627 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.663 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.947 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -138.61 112.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.986 HG11 HG23 ' A' ' 67' ' ' VAL . 14.7 t -133.96 150.43 31.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.705 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.4 m-85 -83.7 129.76 34.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.973 HG23 HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -95.18 114.78 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.557 0.694 . . . . 0.0 110.858 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.86 145.3 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 17.9 t80 -139.99 148.02 41.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.598 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 121.907 0.861 . . . . 0.0 109.108 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.19 0 N-CA-C 112.941 -0.064 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.448 ' CG ' ' HD2' ' A' ' 14' ' ' PRO . 58.7 t80 -112.99 140.5 24.21 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.597 0.237 . . . . 0.0 111.116 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 32.2 Cg_endo -64.02 132.52 34.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.232 1.954 . . . . 0.0 111.652 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.851 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -118.11 138.16 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.633 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.947 ' HA ' HG23 ' A' ' 2' ' ' ILE . 17.9 tt0 -97.4 72.34 2.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.609 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.098 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 179.61 156.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.959 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 21' ' ' THR . 8.6 p30 -65.0 112.56 3.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 1.6 m -83.6 0.5 46.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.955 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -116.45 -17.52 10.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.725 0.693 . . . . 0.0 112.697 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.716 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -33.17 154.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.066 0.546 . . . . 0.0 111.375 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 t -20.63 143.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.726 0.774 . . . . 0.0 113.036 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.668 ' HA ' HD21 ' A' ' 26' ' ' LEU . 17.3 tt -37.48 -44.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.275 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.475 ' N ' HG23 ' A' ' 23' ' ' ILE . 3.4 m-85 -69.08 -49.22 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 19.3 mm-40 -56.23 -62.69 1.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.971 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.9 pt? -58.92 -53.04 62.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.466 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.7 ' H ' HD23 ' A' ' 26' ' ' LEU . 7.4 mttt -50.67 -36.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.962 0.41 . . . . 0.0 110.455 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.35 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.4 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.098 HG21 HG21 ' A' ' 17' ' ' VAL . 2.2 t -52.54 -55.83 9.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 111.255 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.027 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.5 p -55.42 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.428 0.632 . . . . 0.0 112.029 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.144 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -50.24 -26.44 4.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.777 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -69.49 -54.32 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.6 -5.79 58.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.252 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.97 -5.7 54.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.79 37.48 75.81 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.812 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.43 -174.47 0.41 Allowed Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.212 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.144 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 88.6 Cg_endo -66.72 -149.79 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.559 0 C-N-CA 122.395 2.063 . . . . 0.0 109.671 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -105.83 -69.9 0.8 Allowed 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.237 0.961 . . . . 0.0 113.255 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.45 25.0 10.74 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.6 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 3.1 tp60 -52.26 -73.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.626 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -82.13 -135.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -132.5 139.16 47.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 111.957 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.916 HG13 HG23 ' A' ' 69' ' ' ILE . 10.9 t -113.1 141.78 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.053 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.676 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.6 mp -138.16 162.12 31.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.92 ' CD1' HG22 ' A' ' 67' ' ' VAL . 10.0 t80 -132.52 153.74 50.64 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.781 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 22.53 37.91 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.16 -15.67 37.73 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.789 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.781 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -92.15 118.58 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' HA ' HG23 ' A' ' 44' ' ' ILE . 48.7 tt0 -66.04 136.64 56.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 50' ' ' LEU . 2.0 pp -22.7 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.836 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -122.09 118.32 28.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -39.22 -48.24 1.75 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -122.18 -13.32 8.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.736 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 13.8 t90 -97.15 -29.35 13.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.765 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.21 -25.7 10.93 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.223 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.955 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.4 m -81.81 -133.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.761 ' N ' HG23 ' A' ' 56' ' ' VAL . 1.9 mm100 -73.45 -34.85 65.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.687 ' H ' HG23 ' A' ' 56' ' ' VAL . 2.7 m-20 -72.98 0.07 12.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.919 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.797 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -95.9 -78.03 0.47 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.883 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.664 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.5 t70 -168.41 76.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.053 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.785 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.72 151.63 36.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.723 0.773 . . . . 0.0 112.908 -178.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.82 174.31 6.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.046 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.437 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -57.55 -39.21 76.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.349 -179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.22 83.62 1.95 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.732 ' C ' HG13 ' A' ' 3' ' ' VAL . 15.1 m -102.81 171.87 7.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.152 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.6 pp -129.58 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.986 HG23 HG11 ' A' ' 3' ' ' VAL . 91.4 t -118.6 135.99 57.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 111.363 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 30.0 t-80 -92.74 106.64 18.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.002 HG21 HG21 ' A' ' 30' ' ' VAL . 4.2 mp -103.06 140.35 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 13.4 t . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.791 ' HE3' ' N ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.794 HG23 ' HA ' ' A' ' 16' ' ' GLU . 2.4 mt -122.99 118.63 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.01 HG11 HG23 ' A' ' 67' ' ' VAL . 10.5 t -138.02 158.39 32.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.45 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.1 m-85 -94.18 119.78 33.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.698 HG23 HD13 ' A' ' 69' ' ' ILE . 1.5 p -86.72 118.3 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -111.58 144.85 40.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.922 179.271 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 2.1 p90 -138.04 151.04 47.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.133 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.79 0.805 . . . . 0.0 109.215 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.154 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -123.6 142.37 38.89 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.788 0.328 . . . . 0.0 111.323 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 36.1 Cg_endo -65.04 124.79 13.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.362 2.042 . . . . 0.0 111.212 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.734 HG22 HG13 ' A' ' 17' ' ' VAL . 3.4 p -122.49 119.54 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.081 0.467 . . . . 0.0 111.433 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.794 ' HA ' HG23 ' A' ' 2' ' ' ILE . 7.7 tm-20 -77.35 86.3 3.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.343 0.592 . . . . 0.0 109.919 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.895 HG21 HG21 ' A' ' 29' ' ' VAL . 1.4 m -167.84 -166.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.191 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.791 ' N ' ' HE3' ' A' ' 1' ' ' MET . 2.7 p30 -103.58 104.79 14.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.914 ' O ' HG11 ' A' ' 67' ' ' VAL . 72.0 m -88.25 4.32 46.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.953 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -122.96 -19.81 5.99 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.296 178.047 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -36.14 169.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.527 0.517 . . . . 0.0 110.752 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 21' ' ' THR . 32.2 t -33.88 148.2 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.685 0.755 . . . . 0.0 112.491 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.759 ' HA ' HD11 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -46.08 -36.72 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.293 -177.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.688 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 14.2 m-85 -63.65 -45.22 91.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.652 ' HB2' HG23 ' A' ' 21' ' ' THR . 9.6 mm100 -67.26 -66.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.963 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.6 pp -49.48 -45.32 46.77 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.489 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.902 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -57.62 -37.47 73.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.481 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -63.96 -56.46 14.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.797 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.895 HG21 HG21 ' A' ' 17' ' ' VAL . 99.3 t -55.57 -53.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.139 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.977 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.3 p -57.67 -75.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.381 0.61 . . . . 0.0 112.358 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.278 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -48.67 -39.12 23.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.963 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -61.42 -45.35 94.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.76 -11.27 45.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.128 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.656 ' O ' HG13 ' A' ' 36' ' ' VAL . 5.7 tt0 -84.34 -5.46 59.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.405 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.27 37.41 94.48 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.873 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -138.31 -171.79 0.29 Allowed Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 113.853 -1.174 . . . . 0.0 109.438 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.278 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 78.0 Cg_endo -63.51 -147.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.702 0 C-N-CA 122.377 2.051 . . . . 0.0 109.066 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.74 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -108.79 -77.78 0.6 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 123.844 0.715 . . . . 0.0 112.272 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 27' ' ' LYS . 29.0 t70 -112.62 34.54 4.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.627 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 8.7 tp-100 -46.43 -71.1 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.762 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.8 tp -90.12 -138.6 0.14 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.582 ' O ' ' O ' ' A' ' 70' ' ' VAL . 3.5 mpp_? -112.98 135.41 53.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.392 0.615 . . . . 0.0 112.657 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 69' ' ' ILE . 2.8 t -102.13 141.95 17.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.24 0.543 . . . . 0.0 111.096 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.812 HG23 ' CA ' ' A' ' 49' ' ' GLU . 2.6 mp -138.3 161.08 31.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.992 ' CD1' HG22 ' A' ' 67' ' ' VAL . 6.6 t80 -136.25 155.91 49.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.489 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 40.61 28.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 111.583 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 -10.13 9.48 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.622 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.489 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 15.3 mtmt -105.69 110.41 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.306 0.553 . . . . 0.0 110.838 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.812 ' CA ' HG23 ' A' ' 44' ' ' ILE . 3.0 tm-20 -74.84 127.75 33.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 49' ' ' GLU . 1.6 mm? -150.05 -164.35 2.0 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -105.88 175.7 5.41 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.722 0.772 . . . . 0.0 113.071 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.432 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 4.5 p-10 -47.25 -20.08 0.17 Allowed 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.699 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -16.74 11.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.41 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.675 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 0.3 OUTLIER -108.3 -20.23 13.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -106.64 -27.41 10.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.953 HG12 ' O ' ' A' ' 20' ' ' ASP . 1.5 m -79.88 -140.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.839 ' N ' HG23 ' A' ' 56' ' ' VAL . 3.8 mp0 -65.81 -42.68 90.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.594 ' H ' HG23 ' A' ' 56' ' ' VAL . 3.4 m-80 -59.54 -14.0 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.037 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.921 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 8.4 t -84.72 -73.67 0.42 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.283 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.617 ' O ' HD22 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -170.66 84.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.658 176.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.826 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -119.58 157.03 29.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.92 -178.8 5.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.718 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.71 -34.16 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.526 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -124.33 91.93 3.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.148 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.76 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.32 170.29 8.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.915 0.388 . . . . 0.0 111.447 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 2.0 pp -130.43 116.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.01 HG23 HG11 ' A' ' 3' ' ' VAL . 60.4 t -116.12 142.79 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.075 0.464 . . . . 0.0 111.577 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' ILE . 64.9 t-80 -106.65 108.07 19.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.087 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.906 HG23 HG13 ' A' ' 43' ' ' VAL . 3.0 mp -100.79 138.68 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.762 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 52.7 t . . . . . 0 N--CA 1.436 -1.158 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.11 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.597 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.828 0.347 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.776 HG22 ' HA ' ' A' ' 16' ' ' GLU . 12.9 pt -132.94 114.72 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.282 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.073 HG11 HG23 ' A' ' 67' ' ' VAL . 21.4 t -129.37 145.58 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.4 m-85 -81.63 126.36 31.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.944 HG23 HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -93.28 113.41 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.752 0.786 . . . . 0.0 110.641 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.416 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 4.7 mmt180 -103.88 151.88 22.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.474 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 8' ' ' ASN . 65.6 t80 -136.0 171.88 13.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.514 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 7' ' ' PHE . 3.4 t30 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.135 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.425 ' CE2' HG11 ' A' ' 5' ' ' VAL . 9.0 p90 -126.71 144.32 49.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.667 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 39.1 Cg_endo -66.67 134.66 35.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.361 2.041 . . . . 0.0 111.467 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -117.65 135.78 56.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.827 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.776 ' HA ' HG22 ' A' ' 2' ' ' ILE . 1.4 tt0 -92.52 69.56 4.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.989 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 176.39 156.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.615 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' O ' HG22 ' A' ' 21' ' ' THR . 3.0 m-20 -65.85 120.37 12.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.785 ' OG ' HD11 ' A' ' 69' ' ' ILE . 1.2 t -87.28 -26.21 23.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.926 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -87.48 -23.33 24.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.736 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -34.09 151.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.311 0.382 . . . . 0.0 111.079 179.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.581 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -17.96 143.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.577 ' HA ' HD21 ' A' ' 26' ' ' LEU . 6.6 tt -40.81 -39.45 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.016 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.53 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 79.7 m-85 -66.97 -47.86 70.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.267 0.556 . . . . 0.0 109.591 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 54.9 mm-40 -65.17 -55.46 18.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.224 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.953 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.4 pp -55.93 -56.73 17.16 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.887 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.86 -36.93 59.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.314 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -66.18 -59.29 3.89 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.544 -179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.989 HG21 HG21 ' A' ' 17' ' ' VAL . 43.0 t -52.98 -52.45 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.623 0.249 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.057 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -62.53 -74.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 1.057 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -51.61 -29.58 18.03 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.941 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 10.2 ttmt -68.27 -54.07 20.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -7.54 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.96 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -80.2 -5.4 56.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.572 0.225 . . . . 0.0 111.407 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 37.66 67.23 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.775 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -145.35 -173.63 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 113.512 -1.344 . . . . 0.0 109.237 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.949 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 95.0 Cg_endo -66.93 -144.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.331 2.021 . . . . 0.0 109.88 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -107.09 -68.05 0.91 Allowed 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.621 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -113.62 35.27 4.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.713 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 6.2 tp-100 -48.53 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.733 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp -87.33 -126.18 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 70' ' ' VAL . 20.7 mtt85 -129.01 147.95 50.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.203 0.525 . . . . 0.0 111.929 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.042 HG13 HG23 ' A' ' 69' ' ' ILE . 4.0 t -116.74 146.35 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.671 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.0 mp -143.57 159.2 16.81 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.94 ' CD1' HG22 ' A' ' 67' ' ' VAL . 21.9 t80 -135.0 156.13 49.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 26.62 37.89 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 78.71 -12.44 22.24 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.978 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 0.0 OUTLIER -92.82 121.82 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.179 0.489 . . . . 0.0 109.735 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG2' ' CD2' ' A' ' 50' ' ' LEU . 1.2 tt0 -62.56 130.74 46.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.7 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.552 HD13 ' H ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -21.66 103.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.758 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -125.06 117.75 24.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.211 176.361 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -39.87 -46.6 2.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.5 OUTLIER -121.33 -13.56 8.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.73 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 6.2 t90 -97.59 -29.18 13.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.741 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.64 -25.21 10.99 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.382 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.926 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.9 m -80.75 -132.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.519 1.304 . . . . 0.0 114.519 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.748 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -74.42 -34.99 63.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.699 ' H ' HG23 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -72.09 0.79 8.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.771 177.317 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.809 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -97.21 -78.24 0.48 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.88 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.657 ' C ' HD23 ' A' ' 61' ' ' LEU . 8.6 t0 -168.68 76.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.075 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.795 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.12 151.63 35.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.567 0.698 . . . . 0.0 112.836 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -120.26 177.19 5.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.32 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -58.24 -38.29 76.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.255 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.71 85.61 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.768 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.35 165.79 10.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -127.84 120.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.073 HG23 HG11 ' A' ' 3' ' ' VAL . 72.0 t -117.94 135.95 56.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.018 0.437 . . . . 0.0 111.668 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.671 ' O ' ' O ' ' A' ' 44' ' ' ILE . 4.4 t60 -91.14 106.18 18.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.012 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 1.042 HG23 HG13 ' A' ' 43' ' ' VAL . 4.5 mp -106.62 145.26 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 11.1 t . . . . . 0 N--CA 1.435 -1.196 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.648 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.789 0.328 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 64' ' ' GLN . 1.0 OUTLIER -132.46 115.41 25.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.495 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.933 HG11 HG23 ' A' ' 67' ' ' VAL . 19.3 t -127.94 145.92 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.046 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 6.1 m-85 -80.8 126.59 31.51 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.1 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.009 HG23 HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -95.34 112.66 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.41 0.624 . . . . 0.0 110.807 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HD2' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -107.11 139.76 41.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.415 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 9' ' ' SER . 25.7 t80 -101.32 155.18 18.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 7.8 t-20 -63.01 69.22 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.734 0.778 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' PHE . 14.2 t -172.0 163.55 6.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.361 -1.291 . . . . 0.0 107.743 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.89 71.59 1.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.158 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -160.52 115.51 2.23 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.406 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 6' ' ' ARG . . . -125.52 140.6 12.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.175 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -122.41 131.34 24.41 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.958 0.379 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 37.7 Cg_endo -66.23 123.09 10.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.273 1.982 . . . . 0.0 112.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -114.1 136.68 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.444 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 2' ' ' ILE . 1.9 tt0 -93.09 70.25 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.8 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 177.1 154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.781 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.459 ' HA ' ' CG2' ' A' ' 3' ' ' VAL . 1.2 p-10 -64.93 118.36 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 12.9 t -88.01 -24.11 23.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 1.025 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -89.76 -18.45 26.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.71 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -37.18 154.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.287 0.235 . . . . 0.0 110.767 178.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.553 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 t -18.26 142.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.816 HD12 HD13 ' A' ' 50' ' ' LEU . 19.8 tt -39.7 -39.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 113.813 -1.539 . . . . 0.0 111.684 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -68.15 -49.52 60.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 20.0 mm-40 -63.13 -54.87 31.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.538 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.015 HD13 ' HB ' ' A' ' 43' ' ' VAL . 2.1 pp -55.31 -56.15 23.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 111.063 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.88 ' N ' HD12 ' A' ' 26' ' ' LEU . 7.3 mttt -56.13 -36.9 68.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.08 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.8 mm-40 -62.3 -60.57 3.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 17' ' ' VAL . 7.9 t -54.05 -53.81 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.4 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.013 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -58.46 -71.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.307 0.575 . . . . 0.0 112.349 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.027 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -54.06 -30.88 49.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.931 -1.032 . . . . 0.0 113.17 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 33.8 tttt -66.91 -52.44 43.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.085 0.469 . . . . 0.0 109.8 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.91 -7.2 58.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.447 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.537 ' HG2' HG11 ' A' ' 36' ' ' VAL . 1.9 tp60 -80.53 -4.6 54.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.617 0.246 . . . . 0.0 111.58 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.47 37.5 78.8 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.809 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -142.78 -172.65 0.32 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 113.371 -1.415 . . . . 0.0 108.867 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.027 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 86.2 Cg_endo -65.17 -152.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 122.083 1.856 . . . . 0.0 109.388 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.568 ' O ' ' HB3' ' A' ' 27' ' ' LYS . . . -106.54 -70.44 0.79 Allowed 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 3.8 p-10 -118.02 22.72 12.07 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.514 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 5.2 tp-100 -55.29 -63.44 1.16 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 72' ' ' ARG . 6.9 tp -82.67 -143.33 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -129.08 142.04 51.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.212 0.529 . . . . 0.0 111.159 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.015 ' HB ' HD13 ' A' ' 26' ' ' LEU . 9.5 t -116.82 148.84 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.688 ' O ' ' O ' ' A' ' 68' ' ' HIS . 46.2 mt -140.93 159.37 23.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.961 ' HB2' HG13 ' A' ' 67' ' ' VAL . 23.2 t80 -136.34 157.14 47.5 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HE2' ' A' ' 48' ' ' LYS . . . 23.62 36.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 83.4 -14.63 39.31 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.869 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -92.1 119.84 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.325 0.562 . . . . 0.0 109.494 178.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HA ' HG23 ' A' ' 44' ' ' ILE . 16.2 tt0 -67.61 134.43 51.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.816 HD13 HD12 ' A' ' 23' ' ' ILE . 1.3 pp -9.77 87.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.891 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -118.16 120.58 38.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 52.3 t-20 -46.24 -47.81 17.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.1 -14.14 8.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.758 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 t90 -95.39 -25.49 16.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.754 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.3 m -109.2 -30.63 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.025 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.2 m -70.66 -133.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.794 ' N ' HG23 ' A' ' 56' ' ' VAL . 1.5 mm100 -78.32 -36.79 45.95 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.696 ' H ' HG23 ' A' ' 56' ' ' VAL . 15.7 t-20 -65.78 -12.02 50.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.765 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.758 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 1.6 t -81.36 -78.66 0.18 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.097 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.619 ' C ' HD23 ' A' ' 61' ' ' LEU . 32.1 t70 -168.73 76.02 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.993 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.83 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.65 150.82 37.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.25 178.19 4.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.779 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' O ' HG13 ' A' ' 2' ' ' ILE . 4.4 mm-40 -57.33 -39.48 75.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.999 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.801 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.5 pt20 -115.05 88.67 2.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.674 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.78 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.56 165.57 11.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.503 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -128.93 121.97 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.961 HG13 ' HB2' ' A' ' 45' ' ' PHE . 98.7 t -117.76 137.01 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.067 0.461 . . . . 0.0 111.408 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.688 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -92.29 106.84 18.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.173 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.009 HD13 HG23 ' A' ' 5' ' ' VAL . 4.4 mp -99.7 138.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 42' ' ' ARG . 48.8 t -120.54 67.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.595 ' HG3' ' HB2' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -85.05 164.71 18.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.468 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HA ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -63.11 126.17 88.48 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.535 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.34 155.72 44.91 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.733 2.289 . . . . 0.0 112.775 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -87.84 138.59 31.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.634 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -109.8 104.6 13.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.943 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.7 mttm . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.976 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.667 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.654 0.264 . . . . 0.0 110.792 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.934 HG23 ' HA ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -132.61 114.48 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.03 HG11 HG23 ' A' ' 67' ' ' VAL . 20.4 t -133.15 145.5 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.372 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 3.5 m-85 -85.9 130.54 34.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.566 HG12 HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -103.95 120.45 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.258 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -100.64 129.75 46.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.907 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 9' ' ' SER . 8.4 t80 -100.77 155.28 18.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 4.1 t-20 -63.73 68.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.679 0.752 . . . . 0.0 110.293 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 7' ' ' PHE . 3.0 t -171.42 161.74 6.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.459 -1.246 . . . . 0.0 107.933 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -74.56 71.75 1.88 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.076 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.65 134.47 7.93 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.542 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.495 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -125.85 140.78 12.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.835 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.502 ' O ' HG13 ' A' ' 5' ' ' VAL . 20.2 t80 -122.42 106.53 35.29 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.911 0.355 . . . . 0.0 110.978 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 16.8 Cg_exo -67.6 120.73 7.76 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.478 2.119 . . . . 0.0 111.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 3' ' ' VAL . 3.9 m -121.45 148.17 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.934 ' HA ' HG23 ' A' ' 2' ' ' ILE . 30.3 tt0 -93.07 75.11 4.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.041 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 178.88 152.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.891 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 21' ' ' THR . 8.5 m-20 -65.41 119.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.497 ' OG ' HD11 ' A' ' 69' ' ' ILE . 1.4 t -85.83 -30.54 22.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.97 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -86.75 -21.52 26.52 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.701 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -33.51 150.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.253 0.346 . . . . 0.0 111.096 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.2 t -17.3 142.99 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.549 ' HA ' HD21 ' A' ' 26' ' ' LEU . 19.5 tt -39.69 -39.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 113.837 -1.528 . . . . 0.0 111.887 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -67.56 -49.2 64.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 2.2 mm-40 -63.0 -55.61 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.582 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.037 HD13 ' HB ' ' A' ' 43' ' ' VAL . 1.9 pp -55.2 -57.23 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 111.237 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.876 ' N ' HD12 ' A' ' 26' ' ' LEU . 12.1 mttt -56.55 -35.36 68.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.146 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.97 -59.85 4.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.041 HG21 HG21 ' A' ' 17' ' ' VAL . 4.3 t -54.04 -53.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.197 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.977 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -58.78 -73.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.464 0.65 . . . . 0.0 112.224 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.125 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -50.03 -27.75 6.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.939 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HE3' ' HG2' ' A' ' 33' ' ' ARG . 8.1 ttpp -69.83 -52.5 24.4 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.404 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 2.4 mtt180 -88.66 -5.75 57.93 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.395 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -79.73 -6.31 56.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.573 0.225 . . . . 0.0 111.589 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.47 37.2 69.31 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.803 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.41 -173.65 0.37 Allowed Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.193 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.125 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 83.0 Cg_endo -66.3 -148.87 0.02 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 122.219 1.946 . . . . 0.0 109.719 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.646 ' O ' ' HB3' ' A' ' 27' ' ' LYS . . . -105.31 -68.02 0.89 Allowed 'General case' 0 N--CA 1.426 -1.656 0 O-C-N 124.277 0.986 . . . . 0.0 113.279 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 7.5 p30 -112.62 29.47 7.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.764 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 7.3 tp-100 -53.2 -76.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.655 HD23 ' HG3' ' A' ' 72' ' ' ARG . 2.9 tp -84.74 -138.36 0.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -131.45 139.41 49.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.366 0.603 . . . . 0.0 112.495 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.037 ' HB ' HD13 ' A' ' 26' ' ' LEU . 5.2 t -109.61 144.28 18.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.695 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.4 mp -138.28 159.01 32.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.934 ' CD1' HG22 ' A' ' 67' ' ' VAL . 21.9 t80 -133.89 154.2 51.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.771 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 26.03 34.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 85.8 -14.73 51.12 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.783 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.771 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -90.9 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 6.6 tt0 -65.4 135.12 54.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 43' ' ' VAL . 0.4 OUTLIER -14.52 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.857 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -120.35 119.12 32.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 17.0 p-10 -44.87 -47.17 11.13 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -119.38 -14.23 9.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.328 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.741 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.2 t90 -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.764 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -109.43 -26.01 10.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.97 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.2 m -82.29 -133.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.773 ' N ' HG23 ' A' ' 56' ' ' VAL . 3.9 mm-40 -73.18 -35.8 66.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.682 ' H ' HG23 ' A' ' 56' ' ' VAL . 4.0 m-20 -71.22 -0.17 9.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.909 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.82 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -96.71 -76.99 0.5 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.818 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.682 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -169.94 76.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.064 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.798 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -117.17 152.19 35.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.14 177.21 4.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.157 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.51 ' O ' HD12 ' A' ' 2' ' ' ILE . 8.5 mt-30 -58.89 -38.75 79.56 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.002 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -116.53 86.7 2.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.666 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -101.66 168.2 9.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.371 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.513 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -127.96 119.78 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.03 HG23 HG11 ' A' ' 3' ' ' VAL . 76.4 t -117.71 137.37 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 111.834 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.695 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -91.06 108.24 19.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.109 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.024 HG23 HG13 ' A' ' 43' ' ' VAL . 6.5 mt -102.9 140.99 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.65 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 17.0 t -133.76 70.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.776 ' HB3' HG21 ' A' ' 30' ' ' VAL . 6.4 tp-100 -119.41 86.53 2.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.172 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.655 ' HG3' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -126.43 149.57 67.92 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.322 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 23.6 Cg_endo -61.14 145.36 98.88 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.432 2.088 . . . . 0.0 111.476 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.98 105.8 17.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.951 0.405 . . . . 0.0 111.321 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -107.14 105.76 15.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.861 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 tttp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.872 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.585 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.701 0.286 . . . . 0.0 110.711 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.869 HG22 ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -134.09 114.27 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.141 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.952 HG11 HG23 ' A' ' 67' ' ' VAL . 17.9 t -130.34 147.11 33.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.326 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.749 ' CD1' HG22 ' A' ' 66' ' ' ILE . 31.5 m-85 -85.69 124.63 32.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.108 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.875 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -94.14 120.39 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.516 0.674 . . . . 0.0 110.594 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.7 mmt85 -101.79 149.1 24.52 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.264 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' O ' ' N ' ' A' ' 9' ' ' SER . 29.9 t80 -115.44 156.67 25.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -63.91 69.39 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.735 0.779 . . . . 0.0 110.192 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' PHE . 1.4 t -170.85 162.23 7.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.972 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m -73.9 72.83 1.6 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.125 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.56 136.59 10.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.529 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.495 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -129.91 134.44 7.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.841 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' HB3' HG13 ' A' ' 5' ' ' VAL . 1.2 t80 -114.54 118.44 41.39 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 117.186 0.493 . . . . 0.0 110.731 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 36.2 Cg_endo -65.4 120.96 8.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.031 1.82 . . . . 0.0 111.876 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -115.62 139.53 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.597 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.869 ' HA ' HG22 ' A' ' 2' ' ' ILE . 3.9 tt0 -93.71 69.71 4.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.421 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 175.41 157.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.723 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.689 ' OD1' HG21 ' A' ' 21' ' ' THR . 3.5 p30 -65.62 119.84 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.449 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -87.58 -24.88 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -177.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.814 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -91.16 -23.54 20.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.755 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -35.19 153.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.267 0.354 . . . . 0.0 111.41 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.3 t -16.62 144.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.822 HD11 ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -41.0 -39.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.906 -177.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.48 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 49.9 m-85 -66.92 -48.14 69.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.247 0.546 . . . . 0.0 109.604 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HB2' HG23 ' A' ' 21' ' ' THR . 36.2 mm-40 -64.81 -54.95 23.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.369 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.972 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.5 pp -57.14 -58.61 7.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.68 0.276 . . . . 0.0 111.178 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.837 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -51.19 -36.47 41.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.484 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 27.1 tt0 -68.7 -59.93 2.76 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.899 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 17' ' ' VAL . 52.2 t -51.95 -52.65 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.751 0.31 . . . . 0.0 111.463 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.061 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -61.88 -73.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.263 0.554 . . . . 0.0 112.409 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.121 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -53.14 -25.84 14.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.368 -176.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 4.8 tttp -72.19 -52.02 18.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -85.96 -7.85 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.567 ' HG2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -80.62 -6.58 58.52 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.525 0.202 . . . . 0.0 111.542 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.79 39.58 85.68 Favored Glycine 0 CA--C 1.507 -0.426 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.92 HG21 ' O ' ' A' ' 71' ' ' GLN . 1.3 m -144.02 -172.3 0.31 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 113.488 -1.356 . . . . 0.0 109.464 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.121 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 96.0 Cg_endo -67.04 -147.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 122.403 2.069 . . . . 0.0 109.826 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -105.96 -69.82 0.81 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 124.177 0.923 . . . . 0.0 112.871 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.822 ' CG ' HD11 ' A' ' 23' ' ' ILE . 38.5 t70 -121.97 31.52 6.18 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.652 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -49.02 -77.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 4.6 tp -81.94 -124.71 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 17.9 mmt180 -131.51 162.36 30.44 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.449 0.568 . . . . 0.0 112.016 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 69' ' ' ILE . 6.1 t -130.69 147.55 33.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.047 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 68' ' ' HIS . 37.6 mt -143.3 159.01 17.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.921 ' CD1' HG22 ' A' ' 67' ' ' VAL . 14.0 t80 -134.51 153.29 52.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.765 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 26.87 37.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 79.72 -12.51 28.32 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.835 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.765 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 10.3 mtmt -91.43 123.41 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.189 0.495 . . . . 0.0 109.966 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' HA ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -60.69 122.39 14.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.122 -178.2 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.663 ' HB2' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -25.05 107.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.1 mmp_? -126.66 118.94 25.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -41.76 -44.89 3.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.732 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -118.81 -14.36 9.49 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.659 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 14.9 m-90 -100.07 -31.83 11.23 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.617 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -107.28 -24.07 12.01 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.826 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 4.2 m -82.26 -135.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -175.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.72 ' N ' HG23 ' A' ' 56' ' ' VAL . 3.6 mm-40 -68.52 -35.12 77.03 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.696 ' H ' HG23 ' A' ' 56' ' ' VAL . 1.2 m-20 -74.02 6.06 3.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.146 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.826 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 4.8 t -106.22 -79.1 0.57 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.216 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.546 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -165.39 76.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.289 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -115.69 148.55 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.454 0.645 . . . . 0.0 112.464 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.61 175.01 5.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.098 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -56.82 -39.72 74.7 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.129 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 2' ' ' ILE . 2.8 pm0 -114.43 85.62 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.793 ' C ' HG13 ' A' ' 3' ' ' VAL . 50.5 m -101.1 166.58 10.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.498 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.749 HG22 ' CD1' ' A' ' 4' ' ' PHE . 1.8 pp -128.96 121.07 53.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.952 HG23 HG11 ' A' ' 3' ' ' VAL . 92.9 t -118.42 135.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.037 0.446 . . . . 0.0 111.566 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -91.88 107.49 19.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.119 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.019 HG21 HG21 ' A' ' 30' ' ' VAL . 4.0 mp -106.21 148.21 10.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.655 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 39.1 t -131.94 67.98 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.92 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -109.49 81.12 1.39 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.976 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.49 144.53 51.36 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.726 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 26.5 Cg_endo -60.92 154.66 54.75 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.558 2.172 . . . . 0.0 111.795 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.454 ' CZ2' ' NE2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -96.28 106.99 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.97 0.414 . . . . 0.0 111.176 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.19 117.39 34.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.983 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.704 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.672 0.272 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.91 HG22 ' HA ' ' A' ' 16' ' ' GLU . 20.3 pt -133.09 115.91 24.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.048 HG11 HG23 ' A' ' 67' ' ' VAL . 22.2 t -129.23 149.28 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.232 -0.987 . . . . 0.0 112.147 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 3.4 m-85 -88.84 127.22 35.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -105.87 117.99 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.498 0.666 . . . . 0.0 111.024 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.508 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.8 mmt85 -102.59 144.82 30.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -108.52 158.87 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.198 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -64.13 68.53 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.729 0.776 . . . . 0.0 110.121 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 7' ' ' PHE . 1.9 t -172.23 162.73 5.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.944 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.1 75.11 1.25 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.141 -1.023 . . . . 0.0 109.096 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -156.69 136.8 12.75 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.647 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -129.92 135.09 8.17 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.829 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.451 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.8 t80 -119.62 105.86 42.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 117.164 0.482 . . . . 0.0 110.941 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 47.4 Cg_endo -69.06 119.4 6.39 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.198 1.932 . . . . 0.0 112.062 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 3' ' ' VAL . 6.4 m -117.4 147.86 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.174 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.91 ' HA ' HG22 ' A' ' 2' ' ' ILE . 3.1 tt0 -91.22 71.83 6.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.4 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.003 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 178.99 154.71 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 21' ' ' THR . 8.4 p30 -65.07 118.76 9.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.502 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -85.5 -25.11 27.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.978 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.56 -19.76 23.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.689 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -34.35 152.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.454 0.302 . . . . 0.0 110.836 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.5 t -18.87 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.532 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 17.5 tt -40.98 -38.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.917 -177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.552 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 43.8 m-85 -68.39 -46.98 68.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 44.4 mm-40 -65.97 -54.44 26.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.083 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.0 HD13 ' HB ' ' A' ' 43' ' ' VAL . 2.7 pp -57.07 -56.05 26.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.909 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.901 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.22 -36.93 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.163 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 2.2 mt-10 -66.3 -60.15 3.04 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.003 HG21 HG21 ' A' ' 17' ' ' VAL . 32.5 t -53.35 -56.13 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.607 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.067 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.0 p -59.05 -74.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.32 0.581 . . . . 0.0 112.547 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.067 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -48.83 -31.01 6.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.928 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 28' ' ' GLU . 6.9 ttmt -67.03 -52.31 44.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.102 0.477 . . . . 0.0 109.719 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -85.76 -6.78 59.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -79.46 -6.96 58.02 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.626 0.25 . . . . 0.0 111.571 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.84 59.03 Favored Glycine 0 CA--C 1.505 -0.581 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.778 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -145.79 -173.41 0.36 Allowed Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.272 -1.464 . . . . 0.0 108.987 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.054 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 90.9 Cg_endo -68.2 -145.19 0.02 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 122.262 1.974 . . . . 0.0 110.004 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.804 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -104.58 -65.68 1.02 Allowed 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.002 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 5.3 t0 -115.28 39.39 2.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.614 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 2.8 tp-100 -43.95 -85.26 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.696 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 48.5 mt -94.19 -113.89 0.11 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' VAL . 7.6 mtp180 -130.44 126.37 36.8 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.432 0.634 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.002 HG13 HG23 ' A' ' 69' ' ' ILE . 1.4 t -96.98 139.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.676 ' O ' ' O ' ' A' ' 68' ' ' HIS . 2.9 mp -138.52 159.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.925 ' HB2' HG13 ' A' ' 67' ' ' VAL . 15.7 t80 -134.76 154.57 51.53 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 25.21 38.02 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 80.97 -12.98 33.67 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.903 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.748 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 4.4 mtmt -90.12 118.16 29.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.266 0.533 . . . . 0.0 109.764 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 24.7 tt0 -64.78 130.02 41.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -10.89 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.899 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -115.48 118.69 33.87 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 10.3 p30 -46.05 -48.75 16.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.49 -14.17 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.746 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.8 t90 -95.91 -26.49 15.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.761 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.2 m -109.14 -27.15 9.75 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.978 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.1 m -78.63 -134.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.785 ' N ' HG23 ' A' ' 56' ' ' VAL . 8.1 pt20 -73.49 -35.88 65.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.709 ' H ' HG23 ' A' ' 56' ' ' VAL . 2.1 m-80 -70.56 -0.72 9.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.087 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.8 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -96.09 -78.17 0.47 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.017 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.668 ' C ' HD23 ' A' ' 61' ' ' LEU . 6.0 t0 -169.27 76.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.015 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.796 HD11 ' CG ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.19 151.48 35.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 112.793 -178.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.69 177.37 4.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.041 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -39.01 77.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.887 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.44 ' HA ' HG13 ' A' ' 2' ' ' ILE . 1.3 tt0 -114.78 87.42 2.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.597 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -101.26 167.68 10.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.253 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.535 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.9 pp -130.32 121.95 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.048 HG23 HG11 ' A' ' 3' ' ' VAL . 74.4 t -117.05 136.2 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.083 0.468 . . . . 0.0 111.734 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 10.5 m-70 -93.42 106.56 18.52 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.006 ' CG2' HG21 ' A' ' 30' ' ' VAL . 3.2 mp -100.1 140.39 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 42' ' ' ARG . 44.2 t -140.98 72.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.166 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.798 ' OE1' ' HB2' ' A' ' 31' ' ' ALA . 3.7 pp0? -128.7 60.48 1.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.103 0.954 . . . . 0.0 109.197 177.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.49 135.22 26.28 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.391 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' N ' ' HG2' ' A' ' 40' ' ' GLN . 30.5 Cg_endo -63.0 151.85 82.52 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.363 2.042 . . . . 0.0 111.716 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 17.9 t90 -122.11 136.47 54.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -82.95 105.34 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.836 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 tttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.901 -179.873 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.556 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.271 0.557 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.954 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.3 mt -143.7 112.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.091 HG11 HG23 ' A' ' 67' ' ' VAL . 14.2 t -137.27 150.5 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 118.836 -1.146 . . . . 0.0 112.562 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.521 ' HB2' HG23 ' A' ' 66' ' ' ILE . 2.5 m-85 -84.26 137.04 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.847 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.66 116.55 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.518 0.675 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 2.9 mmt85 -104.4 148.82 25.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.636 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.658 ' O ' ' N ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -123.71 157.49 33.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.28 71.45 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.766 0.794 . . . . 0.0 110.552 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.658 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -169.73 161.13 9.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.08 179.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.23 73.49 5.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.513 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.476 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 1.3 t60 -161.41 141.07 10.4 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.647 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -130.04 143.23 14.47 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.794 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.5 t80 -121.75 107.0 36.45 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 117.201 0.5 . . . . 0.0 110.73 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 17.0 Cg_exo -66.8 122.85 10.28 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.533 2.155 . . . . 0.0 112.338 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 3' ' ' VAL . 5.2 m -127.86 148.64 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.057 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.954 ' HA ' HG23 ' A' ' 2' ' ' ILE . 25.8 tt0 -91.48 77.7 5.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.017 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER 178.86 152.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 21' ' ' THR . 4.1 m-20 -67.38 119.09 11.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 12.9 t -87.88 -22.89 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.91 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -92.09 -19.56 22.2 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.68 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -35.34 154.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.296 0.373 . . . . 0.0 110.903 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.582 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.4 t -18.12 142.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.101 HD12 HD11 ' A' ' 26' ' ' LEU . 11.1 tp -40.71 -36.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.049 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.465 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 28.3 m-85 -70.08 -47.94 59.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.32 0.581 . . . . 0.0 109.48 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 5.3 mm100 -64.4 -50.55 67.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.379 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.101 HD11 HD12 ' A' ' 23' ' ' ILE . 1.9 pp -59.93 -57.76 11.46 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.058 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.85 ' N ' HD12 ' A' ' 26' ' ' LEU . 20.5 pttt -51.8 -32.46 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.086 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -68.01 -60.71 2.29 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.694 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 17' ' ' VAL . 25.5 t -54.65 -52.67 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.573 0.225 . . . . 0.0 111.394 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 69' ' ' ILE . 1.2 p -57.12 -75.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.452 0.644 . . . . 0.0 111.548 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.959 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -46.89 -31.39 3.08 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.756 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 28' ' ' GLU . 1.5 ttpm? -66.81 -57.12 7.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.977 0.418 . . . . 0.0 110.069 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 -5.23 59.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.065 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 45.8 tp60 -77.97 -10.42 59.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.654 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.55 37.71 34.6 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.805 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.8 m -147.65 -169.65 0.22 Allowed Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.077 -1.561 . . . . 0.0 108.281 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.911 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 55.0 Cg_endo -70.03 -148.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.097 0 C-N-CA 122.131 1.887 . . . . 0.0 110.649 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.683 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -122.22 -46.93 2.16 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.851 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.463 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -68.77 -5.79 22.8 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.318 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.795 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 1.9 tp60 -56.27 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.705 0.764 . . . . 0.0 110.102 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.848 ' HG ' HD11 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -69.9 -161.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.369 -176.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.653 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 21.4 mmt-85 70.58 44.74 0.65 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.078 HG13 HG23 ' A' ' 69' ' ' ILE . 2.8 t -103.54 143.02 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.741 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.678 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.3 mp -140.51 156.18 23.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.941 ' CD1' HG22 ' A' ' 67' ' ' VAL . 16.2 t80 -129.46 151.11 50.44 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.821 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 27.41 35.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 87.82 -13.71 60.31 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.839 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.821 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -90.97 122.37 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.148 0.474 . . . . 0.0 110.013 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 44' ' ' ILE . 3.2 tt0 -69.04 135.13 50.36 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.046 HD13 HD13 ' A' ' 23' ' ' ILE . 1.1 pp -14.14 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.879 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -119.5 115.37 23.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 4.2 p30 -49.1 -46.65 45.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.936 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -16.46 11.74 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.664 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 10.9 m-90 -98.54 -28.17 13.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.733 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.1 m -107.01 -25.21 11.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.91 HG12 ' O ' ' A' ' 20' ' ' ASP . 2.9 m -82.89 -136.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.747 ' N ' HG23 ' A' ' 56' ' ' VAL . 6.5 pt20 -67.08 -33.83 76.35 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.681 ' H ' HG23 ' A' ' 56' ' ' VAL . 6.7 m-80 -74.04 3.66 6.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.128 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.807 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.6 t -104.08 -78.33 0.56 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.541 ' C ' HD23 ' A' ' 61' ' ' LEU . 20.8 t70 -167.04 77.6 0.18 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.96 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.813 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.31 149.05 39.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 112.974 -178.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -120.82 172.41 7.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.873 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -56.47 -38.91 72.34 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.301 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -115.03 83.25 1.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.615 ' C ' HG13 ' A' ' 3' ' ' VAL . 5.8 m -102.85 172.15 6.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 61.9 mt -131.51 121.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.091 HG23 HG11 ' A' ' 3' ' ' VAL . 60.4 t -117.61 132.86 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.678 ' O ' ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -92.2 109.85 21.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.71 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.078 HG23 HG13 ' A' ' 43' ' ' VAL . 3.1 mp -103.16 149.35 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.653 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 24.6 t -136.24 86.96 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.545 ' HB3' ' HB3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -67.11 102.29 1.0 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.716 -178.361 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' N ' ' HG3' ' A' ' 40' ' ' GLN . 1.5 ptm180 -105.33 142.09 23.97 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.031 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.91 155.0 11.76 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.375 2.05 . . . . 0.0 112.033 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -86.98 143.44 27.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.278 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -71.83 109.56 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.965 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.713 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.623 0.249 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -131.14 115.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.12 HG11 HG23 ' A' ' 67' ' ' VAL . 19.0 t -134.87 148.5 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 118.814 -1.154 . . . . 0.0 112.582 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -83.51 128.95 34.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.901 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.656 ' CB ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.99 118.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.428 0.633 . . . . 0.0 110.803 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.47 147.46 27.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.734 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 9' ' ' SER . 7.0 t80 -137.89 145.76 42.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 10.1 p-10 -66.38 71.53 0.07 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.845 0.831 . . . . 0.0 108.968 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' PHE . 2.9 t -163.93 -160.77 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.42 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 9' ' ' SER . 58.7 p -49.41 177.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -53.27 143.36 18.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.282 0.563 . . . . 0.0 111.398 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.35 170.29 54.78 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.316 -0.856 . . . . 0.0 113.081 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.445 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.0 m-85 -118.98 142.65 32.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.73 0.3 . . . . 0.0 111.192 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 95.7 Cg_endo -80.45 133.27 9.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.644 2.229 . . . . 0.0 112.341 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 3' ' ' VAL . 10.5 m -121.67 149.0 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.894 ' HA ' HG23 ' A' ' 2' ' ' ILE . 5.2 tt0 -91.75 72.48 5.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.953 HG21 HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -172.81 156.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.903 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' OD1' HD12 ' A' ' 61' ' ' LEU . 1.4 m-20 -68.09 114.55 6.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.656 ' O ' HG11 ' A' ' 67' ' ' VAL . 3.6 m -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.95 ' OD2' HD11 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -114.61 -24.01 8.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.49 0.586 . . . . 0.0 112.452 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.71 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -32.79 153.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.715 0.634 . . . . 0.0 111.58 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -20.69 143.95 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.783 0.801 . . . . 0.0 113.061 -174.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.604 ' HA ' HD21 ' A' ' 26' ' ' LEU . 13.5 tt -40.03 -39.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.822 -177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 78.9 m-85 -68.69 -49.25 60.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 18.4 mm100 -59.21 -65.56 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.945 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.5 pt? -58.47 -50.17 74.68 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.537 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.782 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -48.39 -38.39 19.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.82 0.343 . . . . 0.0 110.616 178.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 13.8 tt0 -65.83 -62.47 1.48 Allowed 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.97 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.953 HG21 HG21 ' A' ' 17' ' ' VAL . 2.7 t -50.68 -48.6 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.62 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.978 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.9 p -67.03 -74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.978 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -52.5 -33.29 44.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.619 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 8.6 tttp -67.1 -51.69 51.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -80.53 -9.21 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.48 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.697 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 31.6 tp60 -81.08 -10.16 59.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.5 36.4 49.36 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.844 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.2 m -145.23 -174.51 0.41 Allowed Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 113.584 -1.308 . . . . 0.0 109.188 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.934 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 98.0 Cg_endo -66.62 -142.36 0.01 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.837 2.358 . . . . 0.0 109.824 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -104.68 -73.07 0.69 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.935 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.469 ' HB3' ' CD ' ' A' ' 27' ' ' LYS . 26.7 p-10 -120.15 26.54 9.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.577 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 36.9 tp60 -46.4 -59.26 3.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.305 0.502 . . . . 0.0 111.057 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.504 ' HB2' ' N ' ' A' ' 72' ' ' ARG . 9.7 tp -83.2 -138.74 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.426 -0.11 . . . . 0.0 110.749 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.559 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 11.4 mtt85 -128.54 119.16 24.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.286 0.565 . . . . 0.0 111.878 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.017 HG13 HG23 ' A' ' 69' ' ' ILE . 2.2 t -96.03 135.68 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.959 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 68' ' ' HIS . 3.3 mp -137.67 163.19 31.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.948 ' CD1' HG22 ' A' ' 67' ' ' VAL . 8.6 t80 -136.19 154.01 51.07 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.623 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 24.25 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.19 -15.42 39.25 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.742 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.623 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -93.61 119.73 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.317 0.558 . . . . 0.0 109.732 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 44' ' ' ILE . 17.6 tt0 -64.83 134.26 53.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.005 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -21.46 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.827 ' H ' ' HB ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -121.72 117.59 27.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -40.22 -48.4 2.57 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -119.92 -14.24 8.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.616 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.716 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 11.2 t90 -97.21 -30.28 13.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.827 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -107.06 -26.3 11.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.902 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.0 m -83.81 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.721 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.77 -34.91 78.87 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.649 ' H ' HG23 ' A' ' 56' ' ' VAL . 3.3 m-80 -73.75 1.87 9.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.014 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.839 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 3.2 t -101.45 -77.47 0.55 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.288 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.43 ' O ' HD22 ' A' ' 61' ' ' LEU . 10.4 t0 -165.68 78.53 0.28 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.022 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.95 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -117.74 149.22 41.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.76 173.43 7.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.734 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -57.22 -38.11 73.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.788 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.96 84.81 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.627 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.61 171.45 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 7.2 pt -129.9 121.93 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.12 HG23 HG11 ' A' ' 3' ' ' VAL . 98.8 t -119.71 139.69 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.467 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 3.6 t-80 -97.84 105.39 17.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.317 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.017 HG23 HG13 ' A' ' 43' ' ' VAL . 3.0 mp -97.84 115.31 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 45.8 t -104.09 74.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' O ' ' CE2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -86.49 168.96 13.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.266 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.511 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -71.59 132.74 85.22 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.949 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.45 154.53 46.96 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.589 2.193 . . . . 0.0 112.452 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -87.11 140.19 29.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.668 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.02 105.41 14.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.867 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.941 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.722 ' HE3' ' C ' ' A' ' 17' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.894 HG22 ' HA ' ' A' ' 16' ' ' GLU . 11.6 pt -136.37 124.66 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.748 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 15' ' ' VAL . 94.1 t -139.54 156.41 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.453 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 3.2 m-85 -89.92 136.28 33.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.647 HG22 ' HB3' ' A' ' 13' ' ' PHE . 3.0 m -101.88 118.77 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 111.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -107.98 130.82 55.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.518 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.671 ' O ' ' N ' ' A' ' 9' ' ' SER . 8.0 p90 -114.22 162.57 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -58.43 70.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.814 0.816 . . . . 0.0 110.75 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.671 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -171.43 162.66 6.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.855 179.084 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.94 71.14 10.66 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.823 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -160.46 131.56 5.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.587 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.536 ' CA ' ' HD2' ' A' ' 6' ' ' ARG . . . -125.58 150.84 17.49 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.148 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.647 ' HB3' HG22 ' A' ' 5' ' ' VAL . 35.7 t80 -124.6 116.09 26.66 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.937 0.368 . . . . 0.0 110.741 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 19.2 Cg_exo -65.42 115.64 3.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.132 1.888 . . . . 0.0 111.524 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 3' ' ' VAL . 18.1 m -121.63 146.5 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.894 ' HA ' HG22 ' A' ' 2' ' ' ILE . 8.1 tt0 -84.85 81.93 8.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -167.37 -169.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.138 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.774 ' N ' HG23 ' A' ' 17' ' ' VAL . 33.2 m-20 -113.75 112.92 24.22 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.954 ' OG ' HD11 ' A' ' 69' ' ' ILE . 23.3 t -90.01 8.32 33.12 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.928 ' OD2' HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -122.05 -19.04 6.75 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.915 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.943 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.19 175.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 179.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 32.7 t -40.18 154.93 0.03 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.679 -0.638 . . . . 0.0 112.431 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.833 HG13 HD22 ' A' ' 50' ' ' LEU . 5.0 tt -45.43 -41.15 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.701 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.589 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 49.5 m-85 -63.2 -48.66 77.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.444 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.633 ' HB2' HG23 ' A' ' 21' ' ' THR . 5.8 mm100 -58.82 -71.3 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.946 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -49.79 -55.14 15.22 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.022 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -43.3 -40.3 3.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 110.58 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.2 tt0 -66.77 -61.43 1.96 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.69 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 17' ' ' VAL . 60.5 t -49.01 -53.16 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.946 HG12 ' O ' ' A' ' 26' ' ' LEU . 1.2 p -62.09 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.945 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -55.0 -40.26 69.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.89 -176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 1.4 ttpm? -61.98 -46.91 87.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.254 0.55 . . . . 0.0 109.524 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -12.16 59.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.68 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -85.14 -1.42 56.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.095 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.92 34.93 88.64 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.846 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 m -140.26 -172.87 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 113.771 -1.215 . . . . 0.0 109.219 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.919 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 83.3 Cg_endo -65.48 -140.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 122.493 2.129 . . . . 0.0 109.625 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -110.8 -74.89 0.63 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.391 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.57 ' HB2' ' CD ' ' A' ' 27' ' ' LYS . 28.7 t70 -113.03 37.82 3.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.662 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 15.7 tp60 -42.54 -68.48 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.355 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.78 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 6.6 tp -91.83 -136.25 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.155 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' VAL . 1.6 mtt85 -113.27 130.43 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.052 HG13 HG23 ' A' ' 69' ' ' ILE . 2.3 t -105.84 133.86 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.604 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.748 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.5 mt -140.12 162.76 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.967 ' HB2' HG13 ' A' ' 67' ' ' VAL . 7.3 t80 -135.52 88.55 2.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.963 0.411 . . . . 0.0 111.669 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.744 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 77.21 31.85 0.48 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.375 0.607 . . . . 0.0 109.979 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.2 47.3 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.024 -0.989 . . . . 0.0 114.053 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.744 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -90.35 117.04 28.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.697 0.749 . . . . 0.0 110.048 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.55 133.55 45.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.833 HD22 HG13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -14.64 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.996 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.3 mmp_? -112.76 118.76 35.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.49 ' O ' HG21 ' A' ' 56' ' ' VAL . 5.9 t-20 -49.38 -39.84 33.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.08 -15.05 9.92 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.623 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.9 m-90 -101.76 -30.28 11.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.919 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.5 m -109.86 -30.19 7.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.996 HG13 ' O ' ' A' ' 51' ' ' ARG . 11.1 m -51.65 -129.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.668 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -92.8 -44.39 8.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.485 ' H ' HG23 ' A' ' 56' ' ' VAL . 4.9 m-80 -59.96 -16.07 27.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.952 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.623 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -63.73 -72.15 0.15 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.92 179.141 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.719 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.4 t0 -166.4 74.94 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.928 HD21 ' OD2' ' A' ' 20' ' ' ASP . 10.7 mp -130.99 166.28 21.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.52 -173.48 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.042 -1.89 . . . . 0.0 108.857 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -63.54 -30.83 71.89 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.768 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.492 ' HA ' HG13 ' A' ' 2' ' ' ILE . 11.1 tt0 -123.46 95.34 4.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.6 ' OG ' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -102.51 169.52 8.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.685 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.48 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.7 pp -132.26 123.01 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.967 HG13 ' HB2' ' A' ' 45' ' ' PHE . 96.8 t -116.23 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.06 0.457 . . . . 0.0 111.769 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.748 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -101.21 107.19 18.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.033 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.052 HG23 HG13 ' A' ' 43' ' ' VAL . 3.7 mp -104.55 141.85 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.78 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 41.3 t -143.98 77.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.627 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.524 ' NE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -118.57 60.51 0.8 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.746 0.784 . . . . 0.0 109.504 178.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.737 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -120.86 140.51 30.87 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.286 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' N ' ' HG2' ' A' ' 40' ' ' GLN . 20.4 Cg_endo -60.01 153.2 59.5 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.377 2.052 . . . . 0.0 111.534 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -125.13 138.63 54.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 0.0 110.902 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -105.41 133.63 49.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.774 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.133 -0.936 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.663 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.947 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -138.61 112.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.986 HG11 HG23 ' A' ' 67' ' ' VAL . 14.7 t -133.96 150.43 31.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.705 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.4 m-85 -83.7 129.76 34.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.973 HG23 HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -95.18 114.78 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.557 0.694 . . . . 0.0 110.858 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.86 145.3 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 17.9 t80 -139.99 148.02 41.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.598 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -64.46 72.72 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.907 0.861 . . . . 0.0 109.108 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -163.76 -161.15 0.62 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.044 -1.434 . . . . 0.0 108.284 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.38 175.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -53.97 143.35 21.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.282 0.563 . . . . 0.0 111.309 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.3 168.53 54.59 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.941 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' CG ' ' HD2' ' A' ' 14' ' ' PRO . 58.7 t80 -112.99 140.5 24.21 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.597 0.237 . . . . 0.0 111.116 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 32.2 Cg_endo -64.02 132.52 34.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.232 1.954 . . . . 0.0 111.652 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.851 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -118.11 138.16 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.633 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.947 ' HA ' HG23 ' A' ' 2' ' ' ILE . 17.9 tt0 -97.4 72.34 2.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.609 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.098 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 179.61 156.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.959 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 21' ' ' THR . 8.6 p30 -65.0 112.56 3.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 1.6 m -83.6 0.5 46.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.955 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -116.45 -17.52 10.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.725 0.693 . . . . 0.0 112.697 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.716 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -33.17 154.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.066 0.546 . . . . 0.0 111.375 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 t -20.63 143.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.726 0.774 . . . . 0.0 113.036 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.668 ' HA ' HD21 ' A' ' 26' ' ' LEU . 17.3 tt -37.48 -44.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.275 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.475 ' N ' HG23 ' A' ' 23' ' ' ILE . 3.4 m-85 -69.08 -49.22 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 19.3 mm-40 -56.23 -62.69 1.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.971 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.9 pt? -58.92 -53.04 62.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.466 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.7 ' H ' HD23 ' A' ' 26' ' ' LEU . 7.4 mttt -50.67 -36.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.962 0.41 . . . . 0.0 110.455 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.35 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.4 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.098 HG21 HG21 ' A' ' 17' ' ' VAL . 2.2 t -52.54 -55.83 9.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 111.255 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.027 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.5 p -55.42 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.428 0.632 . . . . 0.0 112.029 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.144 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -50.24 -26.44 4.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.777 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -69.49 -54.32 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.6 -5.79 58.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.252 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.97 -5.7 54.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.79 37.48 75.81 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.812 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.43 -174.47 0.41 Allowed Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.212 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.144 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 88.6 Cg_endo -66.72 -149.79 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.559 0 C-N-CA 122.395 2.063 . . . . 0.0 109.671 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -105.83 -69.9 0.8 Allowed 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.237 0.961 . . . . 0.0 113.255 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.45 25.0 10.74 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.6 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 3.1 tp60 -52.26 -73.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.692 HD23 ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -82.13 -135.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -132.5 139.16 47.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 111.957 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.916 HG13 HG23 ' A' ' 69' ' ' ILE . 10.9 t -113.1 141.78 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.053 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.676 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.6 mp -138.16 162.12 31.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.92 ' CD1' HG22 ' A' ' 67' ' ' VAL . 10.0 t80 -132.52 153.74 50.64 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.781 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 22.53 37.91 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.16 -15.67 37.73 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.789 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.781 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -92.15 118.58 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' HA ' HG23 ' A' ' 44' ' ' ILE . 48.7 tt0 -66.04 136.64 56.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.858 HD12 ' O ' ' A' ' 50' ' ' LEU . 2.0 pp -22.7 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.836 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -122.09 118.32 28.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -39.22 -48.24 1.75 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -122.18 -13.32 8.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.736 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 13.8 t90 -97.15 -29.35 13.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.765 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.21 -25.7 10.93 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.223 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.955 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.4 m -81.81 -133.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.761 ' N ' HG23 ' A' ' 56' ' ' VAL . 1.9 mm100 -73.45 -34.85 65.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.687 ' H ' HG23 ' A' ' 56' ' ' VAL . 2.7 m-20 -72.98 0.07 12.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.919 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.797 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -95.9 -78.03 0.47 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.883 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.664 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.5 t70 -168.41 76.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.053 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.785 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.72 151.63 36.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.723 0.773 . . . . 0.0 112.908 -178.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.82 174.31 6.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.046 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -57.55 -39.21 76.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.349 -179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.22 83.62 1.95 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.732 ' C ' HG13 ' A' ' 3' ' ' VAL . 15.1 m -102.81 171.87 7.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.152 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.6 pp -129.58 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.986 HG23 HG11 ' A' ' 3' ' ' VAL . 91.4 t -118.6 135.99 57.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 111.363 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 30.0 t-80 -92.74 106.64 18.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.002 HG21 HG21 ' A' ' 30' ' ' VAL . 4.2 mp -103.06 140.35 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 13.4 t -125.32 69.67 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.928 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 6.3 tp-100 -107.91 87.76 2.57 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.245 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.692 ' HG3' HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -130.0 143.01 47.38 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.33 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 55.7 Cg_endo -69.97 151.39 67.87 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.334 2.022 . . . . 0.0 111.513 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -90.77 105.27 17.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 111.177 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -109.04 104.91 14.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.791 ' HE3' ' N ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.794 HG23 ' HA ' ' A' ' 16' ' ' GLU . 2.4 mt -122.99 118.63 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.01 HG11 HG23 ' A' ' 67' ' ' VAL . 10.5 t -138.02 158.39 32.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.45 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.1 m-85 -94.18 119.78 33.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.698 HG23 HD13 ' A' ' 69' ' ' ILE . 1.5 p -86.72 118.3 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -111.58 144.85 40.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.922 179.271 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.1 p90 -138.04 151.04 47.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.133 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -66.76 71.92 0.09 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.79 0.805 . . . . 0.0 109.215 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -163.91 -159.43 0.5 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.085 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' SER . 11.7 m -48.95 175.8 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.91 144.73 22.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.337 0.589 . . . . 0.0 111.424 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.1 172.59 53.34 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.717 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -123.6 142.37 38.89 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.788 0.328 . . . . 0.0 111.323 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 36.1 Cg_endo -65.04 124.79 13.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.362 2.042 . . . . 0.0 111.212 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.734 HG22 HG13 ' A' ' 17' ' ' VAL . 3.4 p -122.49 119.54 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.081 0.467 . . . . 0.0 111.433 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.794 ' HA ' HG23 ' A' ' 2' ' ' ILE . 7.7 tm-20 -77.35 86.3 3.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.343 0.592 . . . . 0.0 109.919 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.895 HG21 HG21 ' A' ' 29' ' ' VAL . 1.4 m -167.84 -166.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.191 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.791 ' N ' ' HE3' ' A' ' 1' ' ' MET . 2.7 p30 -103.58 104.79 14.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.914 ' O ' HG11 ' A' ' 67' ' ' VAL . 72.0 m -88.25 4.32 46.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.953 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -122.96 -19.81 5.99 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.296 178.047 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -36.14 169.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.527 0.517 . . . . 0.0 110.752 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 21' ' ' THR . 32.2 t -33.88 148.2 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.685 0.755 . . . . 0.0 112.491 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.759 ' HA ' HD11 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -46.08 -36.72 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.293 -177.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.688 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 14.2 m-85 -63.65 -45.22 91.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.652 ' HB2' HG23 ' A' ' 21' ' ' THR . 9.6 mm100 -67.26 -66.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.963 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.6 pp -49.48 -45.32 46.77 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.489 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.902 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -57.62 -37.47 73.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.481 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -63.96 -56.46 14.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.797 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.895 HG21 HG21 ' A' ' 17' ' ' VAL . 99.3 t -55.57 -53.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.139 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.977 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.3 p -57.67 -75.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.381 0.61 . . . . 0.0 112.358 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.278 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -48.67 -39.12 23.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.963 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -61.42 -45.35 94.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.76 -11.27 45.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.128 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.656 ' O ' HG13 ' A' ' 36' ' ' VAL . 5.7 tt0 -84.34 -5.46 59.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.405 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.27 37.41 94.48 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.873 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -138.31 -171.79 0.29 Allowed Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 113.853 -1.174 . . . . 0.0 109.438 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.278 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 78.0 Cg_endo -63.51 -147.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.702 0 C-N-CA 122.377 2.051 . . . . 0.0 109.066 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.74 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -108.79 -77.78 0.6 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 123.844 0.715 . . . . 0.0 112.272 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 27' ' ' LYS . 29.0 t70 -112.62 34.54 4.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.627 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 8.7 tp-100 -46.43 -71.1 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.762 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.8 tp -90.12 -138.6 0.14 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.582 ' O ' ' O ' ' A' ' 70' ' ' VAL . 3.5 mpp_? -112.98 135.41 53.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.392 0.615 . . . . 0.0 112.657 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 69' ' ' ILE . 2.8 t -102.13 141.95 17.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.24 0.543 . . . . 0.0 111.096 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.812 HG23 ' CA ' ' A' ' 49' ' ' GLU . 2.6 mp -138.3 161.08 31.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.992 ' CD1' HG22 ' A' ' 67' ' ' VAL . 6.6 t80 -136.25 155.91 49.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.489 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 40.61 28.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 111.583 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 -10.13 9.48 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.622 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.489 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 15.3 mtmt -105.69 110.41 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.306 0.553 . . . . 0.0 110.838 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.812 ' CA ' HG23 ' A' ' 44' ' ' ILE . 3.0 tm-20 -74.84 127.75 33.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 49' ' ' GLU . 1.6 mm? -150.05 -164.35 2.0 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -105.88 175.7 5.41 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.722 0.772 . . . . 0.0 113.071 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.432 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 4.5 p-10 -47.25 -20.08 0.17 Allowed 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.699 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -16.74 11.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.41 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.675 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 0.3 OUTLIER -108.3 -20.23 13.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -106.64 -27.41 10.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.953 HG12 ' O ' ' A' ' 20' ' ' ASP . 1.5 m -79.88 -140.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.839 ' N ' HG23 ' A' ' 56' ' ' VAL . 3.8 mp0 -65.81 -42.68 90.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.594 ' H ' HG23 ' A' ' 56' ' ' VAL . 3.4 m-80 -59.54 -14.0 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.037 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.921 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 8.4 t -84.72 -73.67 0.42 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.283 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.617 ' O ' HD22 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -170.66 84.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.658 176.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.826 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -119.58 157.03 29.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.92 -178.8 5.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.718 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.71 -34.16 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.526 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -124.33 91.93 3.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.148 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.76 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.32 170.29 8.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.915 0.388 . . . . 0.0 111.447 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 2.0 pp -130.43 116.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.01 HG23 HG11 ' A' ' 3' ' ' VAL . 60.4 t -116.12 142.79 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.075 0.464 . . . . 0.0 111.577 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' ILE . 64.9 t-80 -106.65 108.07 19.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.087 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.906 HG23 HG13 ' A' ' 43' ' ' VAL . 3.0 mp -100.79 138.68 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.762 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 52.7 t -141.51 74.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.11 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.962 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -123.5 58.28 1.14 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.823 0.821 . . . . 0.0 109.279 177.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' O ' HD22 ' A' ' 41' ' ' LEU . 9.3 ptm180 -124.49 137.86 30.04 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.139 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.453 ' N ' ' HG2' ' A' ' 40' ' ' GLN . 28.6 Cg_endo -62.52 153.52 70.79 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.371 2.047 . . . . 0.0 112.096 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.31 148.6 28.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.654 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -91.39 108.27 19.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.597 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.828 0.347 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.776 HG22 ' HA ' ' A' ' 16' ' ' GLU . 12.9 pt -132.94 114.72 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.282 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.073 HG11 HG23 ' A' ' 67' ' ' VAL . 21.4 t -129.37 145.58 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.4 m-85 -81.63 126.36 31.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.944 HG23 HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -93.28 113.41 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.752 0.786 . . . . 0.0 110.641 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.416 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 4.7 mmt180 -103.88 151.88 22.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.474 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 8' ' ' ASN . 65.6 t80 -136.0 171.88 13.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.514 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.758 ' O ' ' N ' ' A' ' 10' ' ' SER . 3.4 t30 -42.76 178.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.17 79.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.238 1.018 . . . . 0.0 110.682 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.758 ' N ' ' O ' ' A' ' 8' ' ' ASN . 9.5 p -144.84 174.68 10.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.995 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -86.44 109.93 19.39 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.43 158.4 37.6 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.438 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.425 ' CE2' HG11 ' A' ' 5' ' ' VAL . 9.0 p90 -126.71 144.32 49.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.667 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 39.1 Cg_endo -66.67 134.66 35.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.361 2.041 . . . . 0.0 111.467 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -117.65 135.78 56.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.827 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.776 ' HA ' HG22 ' A' ' 2' ' ' ILE . 1.4 tt0 -92.52 69.56 4.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.989 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 176.39 156.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.615 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' O ' HG22 ' A' ' 21' ' ' THR . 3.0 m-20 -65.85 120.37 12.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.785 ' OG ' HD11 ' A' ' 69' ' ' ILE . 1.2 t -87.28 -26.21 23.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.926 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -87.48 -23.33 24.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.736 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -34.09 151.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.311 0.382 . . . . 0.0 111.079 179.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.581 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -17.96 143.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.577 ' HA ' HD21 ' A' ' 26' ' ' LEU . 6.6 tt -40.81 -39.45 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.016 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.53 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 79.7 m-85 -66.97 -47.86 70.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.267 0.556 . . . . 0.0 109.591 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 54.9 mm-40 -65.17 -55.46 18.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.224 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.953 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.4 pp -55.93 -56.73 17.16 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.887 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.86 -36.93 59.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.314 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -66.18 -59.29 3.89 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.544 -179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.989 HG21 HG21 ' A' ' 17' ' ' VAL . 43.0 t -52.98 -52.45 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.623 0.249 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.057 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -62.53 -74.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 1.057 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -51.61 -29.58 18.03 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.941 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 10.2 ttmt -68.27 -54.07 20.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -7.54 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.96 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -80.2 -5.4 56.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.572 0.225 . . . . 0.0 111.407 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 37.66 67.23 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.865 HG21 ' O ' ' A' ' 71' ' ' GLN . 1.1 m -145.35 -173.63 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 113.512 -1.344 . . . . 0.0 109.237 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.949 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 95.0 Cg_endo -66.93 -144.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.331 2.021 . . . . 0.0 109.88 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -107.09 -68.05 0.91 Allowed 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.621 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -113.62 35.27 4.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.713 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 6.2 tp-100 -48.53 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.733 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp -87.33 -126.18 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 70' ' ' VAL . 20.7 mtt85 -129.01 147.95 50.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.203 0.525 . . . . 0.0 111.929 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.042 HG13 HG23 ' A' ' 69' ' ' ILE . 4.0 t -116.74 146.35 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.671 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.0 mp -143.57 159.2 16.81 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.94 ' CD1' HG22 ' A' ' 67' ' ' VAL . 21.9 t80 -135.0 156.13 49.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 26.62 37.89 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 78.71 -12.44 22.24 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.978 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 0.0 OUTLIER -92.82 121.82 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.179 0.489 . . . . 0.0 109.735 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG2' ' CD2' ' A' ' 50' ' ' LEU . 1.2 tt0 -62.56 130.74 46.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.7 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.552 HD13 ' H ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -21.66 103.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.758 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -125.06 117.75 24.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.211 176.361 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -39.87 -46.6 2.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.5 OUTLIER -121.33 -13.56 8.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.73 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 6.2 t90 -97.59 -29.18 13.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.741 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.64 -25.21 10.99 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.926 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.9 m -80.75 -132.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.519 1.304 . . . . 0.0 114.519 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.748 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -74.42 -34.99 63.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.699 ' H ' HG23 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -72.09 0.79 8.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.771 177.317 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.809 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -97.21 -78.24 0.48 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.88 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.657 ' C ' HD23 ' A' ' 61' ' ' LEU . 8.6 t0 -168.68 76.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.075 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.795 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.12 151.63 35.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.567 0.698 . . . . 0.0 112.836 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -120.26 177.19 5.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.32 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -58.24 -38.29 76.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.255 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.71 85.61 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.768 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.35 165.79 10.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -127.84 120.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.073 HG23 HG11 ' A' ' 3' ' ' VAL . 72.0 t -117.94 135.95 56.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.018 0.437 . . . . 0.0 111.668 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.671 ' O ' ' O ' ' A' ' 44' ' ' ILE . 4.4 t60 -91.14 106.18 18.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.012 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 1.042 HG23 HG13 ' A' ' 43' ' ' VAL . 4.5 mp -106.62 145.26 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 11.1 t -133.93 72.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.865 ' O ' HG21 ' A' ' 36' ' ' VAL . 1.6 tp-100 -117.39 70.69 0.79 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.229 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' ' CE1' ' A' ' 7' ' ' PHE . 13.0 mtt180 -135.66 138.7 28.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.179 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 34.6 Cg_endo -63.41 160.95 33.06 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.962 2.441 . . . . 0.0 111.97 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.38 109.75 21.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.464 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.05 109.27 20.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.648 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.789 0.328 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 64' ' ' GLN . 1.0 OUTLIER -132.46 115.41 25.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.495 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.933 HG11 HG23 ' A' ' 67' ' ' VAL . 19.3 t -127.94 145.92 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.046 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 6.1 m-85 -80.8 126.59 31.51 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.1 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.009 HG23 HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -95.34 112.66 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.41 0.624 . . . . 0.0 110.807 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HD2' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -107.11 139.76 41.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.415 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 8' ' ' ASN . 25.7 t80 -101.32 155.18 18.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 7.8 t-20 . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.734 0.778 . . . . 0.0 110.195 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -122.41 131.34 24.41 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.958 0.379 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 37.7 Cg_endo -66.23 123.09 10.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.273 1.982 . . . . 0.0 112.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -114.1 136.68 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.444 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 2' ' ' ILE . 1.9 tt0 -93.09 70.25 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.8 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 177.1 154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.781 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.459 ' HA ' ' CG2' ' A' ' 3' ' ' VAL . 1.2 p-10 -64.93 118.36 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 12.9 t -88.01 -24.11 23.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 1.025 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -89.76 -18.45 26.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.71 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -37.18 154.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.287 0.235 . . . . 0.0 110.767 178.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.553 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 t -18.26 142.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.816 HD12 HD13 ' A' ' 50' ' ' LEU . 19.8 tt -39.7 -39.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 113.813 -1.539 . . . . 0.0 111.684 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -68.15 -49.52 60.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 20.0 mm-40 -63.13 -54.87 31.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.538 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.015 HD13 ' HB ' ' A' ' 43' ' ' VAL . 2.1 pp -55.31 -56.15 23.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 111.063 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.88 ' N ' HD12 ' A' ' 26' ' ' LEU . 7.3 mttt -56.13 -36.9 68.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.08 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.8 mm-40 -62.3 -60.57 3.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 17' ' ' VAL . 7.9 t -54.05 -53.81 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.4 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.013 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -58.46 -71.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.307 0.575 . . . . 0.0 112.349 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.027 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -54.06 -30.88 49.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.931 -1.032 . . . . 0.0 113.17 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 33.8 tttt -66.91 -52.44 43.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.085 0.469 . . . . 0.0 109.8 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.91 -7.2 58.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.447 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.537 ' HG2' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.53 -4.6 54.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.617 0.246 . . . . 0.0 111.58 -179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.47 37.5 78.8 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.809 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -142.78 -172.65 0.32 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 113.371 -1.415 . . . . 0.0 108.867 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.027 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 86.2 Cg_endo -65.17 -152.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 122.083 1.856 . . . . 0.0 109.388 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.568 ' O ' ' HB3' ' A' ' 27' ' ' LYS . . . -106.54 -70.44 0.79 Allowed 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 3.8 p-10 -118.02 22.72 12.07 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.514 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 10.2 tp60 -55.29 -63.44 1.16 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 70' ' ' VAL . 6.9 tp -82.67 -143.33 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -129.08 142.04 51.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.212 0.529 . . . . 0.0 111.159 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.015 ' HB ' HD13 ' A' ' 26' ' ' LEU . 9.5 t -116.82 148.84 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.688 ' O ' ' O ' ' A' ' 68' ' ' HIS . 46.2 mt -140.93 159.37 23.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.961 ' HB2' HG13 ' A' ' 67' ' ' VAL . 23.2 t80 -136.34 157.14 47.5 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HE2' ' A' ' 48' ' ' LYS . . . 23.62 36.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 83.4 -14.63 39.31 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.869 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -92.1 119.84 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.325 0.562 . . . . 0.0 109.494 178.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HA ' HG23 ' A' ' 44' ' ' ILE . 16.2 tt0 -67.61 134.43 51.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.816 HD13 HD12 ' A' ' 23' ' ' ILE . 1.3 pp -9.77 87.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.891 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -118.16 120.58 38.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 52.3 t-20 -46.24 -47.81 17.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.1 -14.14 8.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.758 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 t90 -95.39 -25.49 16.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.754 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.3 m -109.2 -30.63 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.025 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.2 m -70.66 -133.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.794 ' N ' HG23 ' A' ' 56' ' ' VAL . 1.5 mm100 -78.32 -36.79 45.95 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.696 ' H ' HG23 ' A' ' 56' ' ' VAL . 15.7 t-20 -65.78 -12.02 50.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.765 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.758 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 1.6 t -81.36 -78.66 0.18 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.097 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.619 ' C ' HD23 ' A' ' 61' ' ' LEU . 32.1 t70 -168.73 76.02 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.993 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.83 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.65 150.82 37.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.25 178.19 4.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.779 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' O ' HG13 ' A' ' 2' ' ' ILE . 4.4 mm-40 -57.33 -39.48 75.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.999 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.801 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.5 pt20 -115.05 88.67 2.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.674 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.78 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.56 165.57 11.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.503 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -128.93 121.97 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.961 HG13 ' HB2' ' A' ' 45' ' ' PHE . 98.7 t -117.76 137.01 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.067 0.461 . . . . 0.0 111.408 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.688 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -92.29 106.84 18.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.173 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.009 HD13 HG23 ' A' ' 5' ' ' VAL . 4.4 mp -99.7 138.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 42' ' ' ARG . 48.8 t . . . . . 0 N--CA 1.44 -0.929 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.667 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.654 0.264 . . . . 0.0 110.792 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.934 HG23 ' HA ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -132.61 114.48 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.03 HG11 HG23 ' A' ' 67' ' ' VAL . 20.4 t -133.15 145.5 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.372 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 3.5 m-85 -85.9 130.54 34.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.566 HG12 HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -103.95 120.45 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.258 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -100.64 129.75 46.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.907 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 8' ' ' ASN . 8.4 t80 -100.77 155.28 18.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 4.1 t-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.679 0.752 . . . . 0.0 110.293 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.495 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.502 ' O ' HG13 ' A' ' 5' ' ' VAL . 20.2 t80 -122.42 106.53 35.29 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.911 0.355 . . . . 0.0 110.978 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 16.8 Cg_exo -67.6 120.73 7.76 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.478 2.119 . . . . 0.0 111.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 3' ' ' VAL . 3.9 m -121.45 148.17 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.934 ' HA ' HG23 ' A' ' 2' ' ' ILE . 30.3 tt0 -93.07 75.11 4.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.041 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 178.88 152.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.891 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 21' ' ' THR . 8.5 m-20 -65.41 119.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.497 ' OG ' HD11 ' A' ' 69' ' ' ILE . 1.4 t -85.83 -30.54 22.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.97 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -86.75 -21.52 26.52 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.701 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -33.51 150.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.253 0.346 . . . . 0.0 111.096 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.2 t -17.3 142.99 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.549 ' HA ' HD21 ' A' ' 26' ' ' LEU . 19.5 tt -39.69 -39.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 113.837 -1.528 . . . . 0.0 111.887 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -67.56 -49.2 64.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 2.2 mm-40 -63.0 -55.61 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.582 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.037 HD13 ' HB ' ' A' ' 43' ' ' VAL . 1.9 pp -55.2 -57.23 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 111.237 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.876 ' N ' HD12 ' A' ' 26' ' ' LEU . 12.1 mttt -56.55 -35.36 68.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.146 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.97 -59.85 4.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.041 HG21 HG21 ' A' ' 17' ' ' VAL . 4.3 t -54.04 -53.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.197 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.977 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -58.78 -73.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.464 0.65 . . . . 0.0 112.224 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.125 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -50.03 -27.75 6.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.939 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HE3' ' HG2' ' A' ' 33' ' ' ARG . 8.1 ttpp -69.83 -52.5 24.4 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.404 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 2.4 mtt180 -88.66 -5.75 57.93 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.395 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -79.73 -6.31 56.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.573 0.225 . . . . 0.0 111.589 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.47 37.2 69.31 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.803 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.41 -173.65 0.37 Allowed Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.193 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.125 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 83.0 Cg_endo -66.3 -148.87 0.02 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 122.219 1.946 . . . . 0.0 109.719 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.646 ' O ' ' HB3' ' A' ' 27' ' ' LYS . . . -105.31 -68.02 0.89 Allowed 'General case' 0 N--CA 1.426 -1.656 0 O-C-N 124.277 0.986 . . . . 0.0 113.279 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 7.5 p30 -112.62 29.47 7.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.764 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 7.3 tp-100 -53.2 -76.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.65 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 2.9 tp -84.74 -138.36 0.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -131.45 139.41 49.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.366 0.603 . . . . 0.0 112.495 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.037 ' HB ' HD13 ' A' ' 26' ' ' LEU . 5.2 t -109.61 144.28 18.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.695 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.4 mp -138.28 159.01 32.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.934 ' CD1' HG22 ' A' ' 67' ' ' VAL . 21.9 t80 -133.89 154.2 51.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.771 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 26.03 34.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 85.8 -14.73 51.12 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.783 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.771 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -90.9 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 6.6 tt0 -65.4 135.12 54.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 43' ' ' VAL . 0.4 OUTLIER -14.52 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.857 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -120.35 119.12 32.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 17.0 p-10 -44.87 -47.17 11.13 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -119.38 -14.23 9.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.741 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.2 t90 -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.764 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -109.43 -26.01 10.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.97 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.2 m -82.29 -133.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.773 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -73.18 -35.8 66.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.682 ' H ' HG23 ' A' ' 56' ' ' VAL . 4.0 m-20 -71.22 -0.17 9.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.909 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.82 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -96.71 -76.99 0.5 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.818 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.682 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -169.94 76.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.064 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.798 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -117.17 152.19 35.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.14 177.21 4.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.157 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.51 ' O ' HD12 ' A' ' 2' ' ' ILE . 8.5 mt-30 -58.89 -38.75 79.56 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.002 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -116.53 86.7 2.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.666 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -101.66 168.2 9.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.371 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.513 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -127.96 119.78 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.03 HG23 HG11 ' A' ' 3' ' ' VAL . 76.4 t -117.71 137.37 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 111.834 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.695 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -91.06 108.24 19.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.109 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.024 HG23 HG13 ' A' ' 43' ' ' VAL . 6.5 mt -102.9 140.99 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.65 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 17.0 t . . . . . 0 N--CA 1.436 -1.153 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.585 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.701 0.286 . . . . 0.0 110.711 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.869 HG22 ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -134.09 114.27 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.141 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.952 HG11 HG23 ' A' ' 67' ' ' VAL . 17.9 t -130.34 147.11 33.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.326 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.749 ' CD1' HG22 ' A' ' 66' ' ' ILE . 31.5 m-85 -85.69 124.63 32.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.108 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.875 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -94.14 120.39 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.516 0.674 . . . . 0.0 110.594 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.7 mmt85 -101.79 149.1 24.52 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.264 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -115.44 156.67 25.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 121.735 0.779 . . . . 0.0 110.192 -179.227 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.495 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 111.841 -0.503 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' HB3' HG13 ' A' ' 5' ' ' VAL . 1.2 t80 -114.54 118.44 41.39 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 117.186 0.493 . . . . 0.0 110.731 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 36.2 Cg_endo -65.4 120.96 8.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.031 1.82 . . . . 0.0 111.876 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -115.62 139.53 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.597 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.869 ' HA ' HG22 ' A' ' 2' ' ' ILE . 3.9 tt0 -93.71 69.71 4.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.421 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 175.41 157.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.723 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.689 ' OD1' HG21 ' A' ' 21' ' ' THR . 3.5 p30 -65.62 119.84 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.449 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -87.58 -24.88 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -177.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.814 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -91.16 -23.54 20.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.755 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -35.19 153.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.267 0.354 . . . . 0.0 111.41 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.3 t -16.62 144.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.822 HD11 ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -41.0 -39.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.906 -177.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.48 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 49.9 m-85 -66.92 -48.14 69.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.247 0.546 . . . . 0.0 109.604 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HB2' HG23 ' A' ' 21' ' ' THR . 36.2 mm-40 -64.81 -54.95 23.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.369 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.972 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.5 pp -57.14 -58.61 7.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.68 0.276 . . . . 0.0 111.178 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.837 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -51.19 -36.47 41.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.484 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 27.1 tt0 -68.7 -59.93 2.76 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.899 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 17' ' ' VAL . 52.2 t -51.95 -52.65 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.751 0.31 . . . . 0.0 111.463 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.061 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -61.88 -73.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.263 0.554 . . . . 0.0 112.409 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.121 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -53.14 -25.84 14.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.368 -176.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 4.8 tttp -72.19 -52.02 18.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -85.96 -7.85 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.567 ' HG2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -80.62 -6.58 58.52 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.525 0.202 . . . . 0.0 111.542 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.79 39.58 85.68 Favored Glycine 0 CA--C 1.507 -0.426 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.854 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -144.02 -172.3 0.31 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 113.488 -1.356 . . . . 0.0 109.464 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.121 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 96.0 Cg_endo -67.04 -147.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 122.403 2.069 . . . . 0.0 109.826 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -105.96 -69.82 0.81 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 124.177 0.923 . . . . 0.0 112.871 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.822 ' CG ' HD11 ' A' ' 23' ' ' ILE . 38.5 t70 -121.97 31.52 6.18 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.652 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -49.02 -77.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 4.6 tp -81.94 -124.71 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 17.9 mmt180 -131.51 162.36 30.44 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.449 0.568 . . . . 0.0 112.016 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 69' ' ' ILE . 6.1 t -130.69 147.55 33.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.047 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 68' ' ' HIS . 37.6 mt -143.3 159.01 17.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.921 ' CD1' HG22 ' A' ' 67' ' ' VAL . 14.0 t80 -134.51 153.29 52.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.765 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 26.87 37.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 79.72 -12.51 28.32 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.835 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.765 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 10.3 mtmt -91.43 123.41 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.189 0.495 . . . . 0.0 109.966 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' HA ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -60.69 122.39 14.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.122 -178.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.663 ' HB2' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -25.05 107.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.1 mmp_? -126.66 118.94 25.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -41.76 -44.89 3.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.732 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -118.81 -14.36 9.49 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.659 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 14.9 m-90 -100.07 -31.83 11.23 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.617 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -107.28 -24.07 12.01 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.826 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 4.2 m -82.26 -135.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -175.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.72 ' N ' HG23 ' A' ' 56' ' ' VAL . 3.6 mm-40 -68.52 -35.12 77.03 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.696 ' H ' HG23 ' A' ' 56' ' ' VAL . 1.2 m-20 -74.02 6.06 3.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.146 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.826 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 4.8 t -106.22 -79.1 0.57 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.216 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.546 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -165.39 76.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.289 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -115.69 148.55 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.454 0.645 . . . . 0.0 112.464 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.61 175.01 5.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.098 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -56.82 -39.72 74.7 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.129 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 2' ' ' ILE . 2.8 pm0 -114.43 85.62 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.793 ' C ' HG13 ' A' ' 3' ' ' VAL . 50.5 m -101.1 166.58 10.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.498 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.749 HG22 ' CD1' ' A' ' 4' ' ' PHE . 1.8 pp -128.96 121.07 53.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.952 HG23 HG11 ' A' ' 3' ' ' VAL . 92.9 t -118.42 135.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.037 0.446 . . . . 0.0 111.566 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -91.88 107.49 19.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.119 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.019 HG21 HG21 ' A' ' 30' ' ' VAL . 4.0 mp -106.21 148.21 10.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.655 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 39.1 t . . . . . 0 N--CA 1.437 -1.099 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.704 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.672 0.272 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.91 HG22 ' HA ' ' A' ' 16' ' ' GLU . 20.3 pt -133.09 115.91 24.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.048 HG11 HG23 ' A' ' 67' ' ' VAL . 22.2 t -129.23 149.28 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.232 -0.987 . . . . 0.0 112.147 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 3.4 m-85 -88.84 127.22 35.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -105.87 117.99 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.498 0.666 . . . . 0.0 111.024 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.508 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.8 mmt85 -102.59 144.82 30.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -108.52 158.87 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.198 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 121.729 0.776 . . . . 0.0 110.121 -179.399 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.453 -0.229 0 N-CA-C 111.829 -0.509 . . . . 0.0 111.829 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.451 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.8 t80 -119.62 105.86 42.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 117.164 0.482 . . . . 0.0 110.941 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 47.4 Cg_endo -69.06 119.4 6.39 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.198 1.932 . . . . 0.0 112.062 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 3' ' ' VAL . 6.4 m -117.4 147.86 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.174 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.91 ' HA ' HG22 ' A' ' 2' ' ' ILE . 3.1 tt0 -91.22 71.83 6.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.4 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.003 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 178.99 154.71 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 21' ' ' THR . 8.4 p30 -65.07 118.76 9.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.502 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -85.5 -25.11 27.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.978 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.56 -19.76 23.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.689 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -34.35 152.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.454 0.302 . . . . 0.0 110.836 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.5 t -18.87 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.532 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 17.5 tt -40.98 -38.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.917 -177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.552 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 43.8 m-85 -68.39 -46.98 68.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 44.4 mm-40 -65.97 -54.44 26.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.083 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.0 HD13 ' HB ' ' A' ' 43' ' ' VAL . 2.7 pp -57.07 -56.05 26.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.909 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.901 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.22 -36.93 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.163 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 2.2 mt-10 -66.3 -60.15 3.04 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.003 HG21 HG21 ' A' ' 17' ' ' VAL . 32.5 t -53.35 -56.13 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.607 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.067 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.0 p -59.05 -74.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.32 0.581 . . . . 0.0 112.547 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.067 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -48.83 -31.01 6.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.928 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 28' ' ' GLU . 6.9 ttmt -67.03 -52.31 44.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.102 0.477 . . . . 0.0 109.719 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -85.76 -6.78 59.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -79.46 -6.96 58.02 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.626 0.25 . . . . 0.0 111.571 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.84 59.03 Favored Glycine 0 CA--C 1.505 -0.581 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.778 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -145.79 -173.41 0.36 Allowed Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.272 -1.464 . . . . 0.0 108.987 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.054 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 90.9 Cg_endo -68.2 -145.19 0.02 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 122.262 1.974 . . . . 0.0 110.004 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.804 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -104.58 -65.68 1.02 Allowed 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.002 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 5.3 t0 -115.28 39.39 2.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.614 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 2.8 tp-100 -43.95 -85.26 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.454 ' N ' ' HG3' ' A' ' 40' ' ' GLN . 48.5 mt -94.19 -113.89 0.11 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' VAL . 7.6 mtp180 -130.44 126.37 36.8 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.432 0.634 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.002 HG13 HG23 ' A' ' 69' ' ' ILE . 1.4 t -96.98 139.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.676 ' O ' ' O ' ' A' ' 68' ' ' HIS . 2.9 mp -138.52 159.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.925 ' HB2' HG13 ' A' ' 67' ' ' VAL . 15.7 t80 -134.76 154.57 51.53 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 25.21 38.02 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 80.97 -12.98 33.67 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.903 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.748 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 4.4 mtmt -90.12 118.16 29.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.266 0.533 . . . . 0.0 109.764 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 24.7 tt0 -64.78 130.02 41.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -10.89 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.899 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -115.48 118.69 33.87 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 10.3 p30 -46.05 -48.75 16.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.49 -14.17 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.746 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.8 t90 -95.91 -26.49 15.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.761 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.2 m -109.14 -27.15 9.75 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.978 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.1 m -78.63 -134.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.785 ' N ' HG23 ' A' ' 56' ' ' VAL . 8.1 pt20 -73.49 -35.88 65.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.709 ' H ' HG23 ' A' ' 56' ' ' VAL . 2.0 m120 -70.56 -0.72 9.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.087 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.8 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -96.09 -78.17 0.47 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.017 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.668 ' C ' HD23 ' A' ' 61' ' ' LEU . 6.0 t0 -169.27 76.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.015 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.796 HD11 ' CG ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.19 151.48 35.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 112.793 -178.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.69 177.37 4.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.041 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -39.01 77.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.887 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.44 ' HA ' HG13 ' A' ' 2' ' ' ILE . 1.3 tt0 -114.78 87.42 2.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.597 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -101.26 167.68 10.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.253 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.535 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.9 pp -130.32 121.95 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.048 HG23 HG11 ' A' ' 3' ' ' VAL . 74.4 t -117.05 136.2 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.083 0.468 . . . . 0.0 111.734 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 10.5 m-70 -93.42 106.56 18.52 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.006 ' CG2' HG21 ' A' ' 30' ' ' VAL . 3.2 mp -100.1 140.39 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 42' ' ' ARG . 44.2 t . . . . . 0 N--CA 1.436 -1.127 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.166 175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.556 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.271 0.557 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.954 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.3 mt -143.7 112.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.091 HG11 HG23 ' A' ' 67' ' ' VAL . 14.2 t -137.27 150.5 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 118.836 -1.146 . . . . 0.0 112.562 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.521 ' HB2' HG23 ' A' ' 66' ' ' ILE . 2.5 m-85 -84.26 137.04 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.847 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.66 116.55 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.518 0.675 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 2.9 mmt85 -104.4 148.82 25.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.636 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -123.71 157.49 33.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 121.766 0.794 . . . . 0.0 110.552 -178.702 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 CA--C 1.518 0.242 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.5 t80 -121.75 107.0 36.45 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 117.201 0.5 . . . . 0.0 110.73 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 17.0 Cg_exo -66.8 122.85 10.28 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.533 2.155 . . . . 0.0 112.338 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 3' ' ' VAL . 5.2 m -127.86 148.64 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.057 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.954 ' HA ' HG23 ' A' ' 2' ' ' ILE . 25.8 tt0 -91.48 77.7 5.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.017 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER 178.86 152.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 21' ' ' THR . 4.1 m-20 -67.38 119.09 11.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 12.9 t -87.88 -22.89 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.91 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -92.09 -19.56 22.2 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.68 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -35.34 154.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.296 0.373 . . . . 0.0 110.903 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.582 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.4 t -18.12 142.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.101 HD12 HD11 ' A' ' 26' ' ' LEU . 11.1 tp -40.71 -36.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.049 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.465 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 28.3 m-85 -70.08 -47.94 59.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.32 0.581 . . . . 0.0 109.48 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 5.3 mm100 -64.4 -50.55 67.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.379 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.101 HD11 HD12 ' A' ' 23' ' ' ILE . 1.9 pp -59.93 -57.76 11.46 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.058 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.85 ' N ' HD12 ' A' ' 26' ' ' LEU . 20.5 pttt -51.8 -32.46 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.086 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -68.01 -60.71 2.29 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.694 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 17' ' ' VAL . 25.5 t -54.65 -52.67 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.573 0.225 . . . . 0.0 111.394 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 69' ' ' ILE . 1.2 p -57.12 -75.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.452 0.644 . . . . 0.0 111.548 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.959 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -46.89 -31.39 3.08 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.756 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 28' ' ' GLU . 1.5 ttpm? -66.81 -57.12 7.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.977 0.418 . . . . 0.0 110.069 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 -5.23 59.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.065 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 45.8 tp60 -77.97 -10.42 59.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.654 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.55 37.71 34.6 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.805 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.8 m -147.65 -169.65 0.22 Allowed Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.077 -1.561 . . . . 0.0 108.281 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.911 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 55.0 Cg_endo -70.03 -148.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.097 0 C-N-CA 122.131 1.887 . . . . 0.0 110.649 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.683 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -122.22 -46.93 2.16 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.851 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.463 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -68.77 -5.79 22.8 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.318 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.795 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 1.9 tp60 -56.27 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.705 0.764 . . . . 0.0 110.102 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.848 ' HG ' HD11 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -69.9 -161.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.369 -176.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.653 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 21.4 mmt-85 70.58 44.74 0.65 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.078 HG13 HG23 ' A' ' 69' ' ' ILE . 2.8 t -103.54 143.02 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.741 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.678 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.3 mp -140.51 156.18 23.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.941 ' CD1' HG22 ' A' ' 67' ' ' VAL . 16.2 t80 -129.46 151.11 50.44 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.821 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 27.41 35.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 87.82 -13.71 60.31 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.839 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.821 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -90.97 122.37 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.148 0.474 . . . . 0.0 110.013 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 44' ' ' ILE . 3.2 tt0 -69.04 135.13 50.36 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.046 HD13 HD13 ' A' ' 23' ' ' ILE . 1.1 pp -14.14 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.879 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -119.5 115.37 23.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 1.6 p-10 -49.1 -46.65 45.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.936 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -16.46 11.74 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.664 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 10.9 m-90 -98.54 -28.17 13.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.733 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.1 m -107.01 -25.21 11.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.91 HG12 ' O ' ' A' ' 20' ' ' ASP . 2.9 m -82.89 -136.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.747 ' N ' HG23 ' A' ' 56' ' ' VAL . 6.5 pt20 -67.08 -33.83 76.35 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.681 ' H ' HG23 ' A' ' 56' ' ' VAL . 6.7 m-80 -74.04 3.66 6.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.128 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.807 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.6 t -104.08 -78.33 0.56 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.541 ' C ' HD23 ' A' ' 61' ' ' LEU . 20.8 t70 -167.04 77.6 0.18 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.96 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.813 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.31 149.05 39.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 112.974 -178.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -120.82 172.41 7.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.873 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -56.47 -38.91 72.34 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.301 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -115.03 83.25 1.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.615 ' C ' HG13 ' A' ' 3' ' ' VAL . 5.8 m -102.85 172.15 6.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 61.9 mt -131.51 121.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.091 HG23 HG11 ' A' ' 3' ' ' VAL . 60.4 t -117.61 132.86 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.678 ' O ' ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -92.2 109.85 21.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.71 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.078 HG23 HG13 ' A' ' 43' ' ' VAL . 3.1 mp -103.16 149.35 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.653 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 24.6 t . . . . . 0 N--CA 1.434 -1.24 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.713 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.623 0.249 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -131.14 115.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.12 HG11 HG23 ' A' ' 67' ' ' VAL . 19.0 t -134.87 148.5 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 118.814 -1.154 . . . . 0.0 112.582 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -83.51 128.95 34.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.901 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.656 ' CB ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.99 118.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.428 0.633 . . . . 0.0 110.803 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.47 147.46 27.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.734 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 8' ' ' ASN . 7.0 t80 -137.89 145.76 42.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 10.1 p-10 . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 121.845 0.831 . . . . 0.0 108.968 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.247 0 CA-C-O 120.561 -0.022 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.445 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.0 m-85 -118.98 142.65 32.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.73 0.3 . . . . 0.0 111.192 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 95.7 Cg_endo -80.45 133.27 9.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.644 2.229 . . . . 0.0 112.341 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 3' ' ' VAL . 10.5 m -121.67 149.0 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.894 ' HA ' HG23 ' A' ' 2' ' ' ILE . 5.2 tt0 -91.75 72.48 5.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.953 HG21 HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -172.81 156.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.903 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.555 ' OD1' HD12 ' A' ' 61' ' ' LEU . 1.4 m-20 -68.09 114.55 6.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.656 ' O ' HG11 ' A' ' 67' ' ' VAL . 3.6 m -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.95 ' OD2' HD11 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -114.61 -24.01 8.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.49 0.586 . . . . 0.0 112.452 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.71 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -32.79 153.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.715 0.634 . . . . 0.0 111.58 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -20.69 143.95 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.783 0.801 . . . . 0.0 113.061 -174.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.604 ' HA ' HD21 ' A' ' 26' ' ' LEU . 13.5 tt -40.03 -39.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.822 -177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 78.9 m-85 -68.69 -49.25 60.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 18.4 mm100 -59.21 -65.56 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.945 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.5 pt? -58.47 -50.17 74.68 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.537 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.782 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -48.39 -38.39 19.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.82 0.343 . . . . 0.0 110.616 178.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 13.8 tt0 -65.83 -62.47 1.48 Allowed 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.97 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.953 HG21 HG21 ' A' ' 17' ' ' VAL . 2.7 t -50.68 -48.6 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.62 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.978 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.9 p -67.03 -74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.978 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -52.5 -33.29 44.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.619 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 8.6 tttp -67.1 -51.69 51.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -80.53 -9.21 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.48 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.697 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 3.0 tp-100 -81.08 -10.16 59.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.5 36.4 49.36 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.844 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.2 m -145.23 -174.51 0.41 Allowed Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 113.584 -1.308 . . . . 0.0 109.188 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.934 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 98.0 Cg_endo -66.62 -142.36 0.01 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.837 2.358 . . . . 0.0 109.824 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -104.68 -73.07 0.69 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.935 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.469 ' HB3' ' CD ' ' A' ' 27' ' ' LYS . 26.7 p-10 -120.15 26.54 9.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.577 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 36.9 tp60 -46.4 -59.26 3.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.305 0.502 . . . . 0.0 111.057 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 9.7 tp -83.2 -138.74 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.426 -0.11 . . . . 0.0 110.749 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.559 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 11.4 mtt85 -128.54 119.16 24.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.286 0.565 . . . . 0.0 111.878 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.017 HG13 HG23 ' A' ' 69' ' ' ILE . 2.2 t -96.03 135.68 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.959 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 68' ' ' HIS . 3.3 mp -137.67 163.19 31.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.948 ' CD1' HG22 ' A' ' 67' ' ' VAL . 8.6 t80 -136.19 154.01 51.07 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.623 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 24.25 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.19 -15.42 39.25 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.742 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.623 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -93.61 119.73 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.317 0.558 . . . . 0.0 109.732 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 44' ' ' ILE . 17.6 tt0 -64.83 134.26 53.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.005 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.684 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -21.46 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.827 ' H ' ' HB ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -121.72 117.59 27.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -40.22 -48.4 2.57 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -119.92 -14.24 8.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.716 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 11.2 t90 -97.21 -30.28 13.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.827 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -107.06 -26.3 11.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.902 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.0 m -83.81 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.721 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.77 -34.91 78.87 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.649 ' H ' HG23 ' A' ' 56' ' ' VAL . 3.3 m-80 -73.75 1.87 9.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.014 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.839 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 3.2 t -101.45 -77.47 0.55 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.288 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.43 ' O ' HD22 ' A' ' 61' ' ' LEU . 10.4 t0 -165.68 78.53 0.28 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.022 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.95 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -117.74 149.22 41.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.76 173.43 7.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.734 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -57.22 -38.11 73.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.788 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.96 84.81 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.627 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.61 171.45 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 7.2 pt -129.9 121.93 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.12 HG23 HG11 ' A' ' 3' ' ' VAL . 98.8 t -119.71 139.69 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.467 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 3.6 t-80 -97.84 105.39 17.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.317 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.017 HG23 HG13 ' A' ' 43' ' ' VAL . 3.0 mp -97.84 115.31 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 45.8 t . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.722 ' HE3' ' C ' ' A' ' 17' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.894 HG22 ' HA ' ' A' ' 16' ' ' GLU . 11.6 pt -136.37 124.66 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.748 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 15' ' ' VAL . 94.1 t -139.54 156.41 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.453 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 3.2 m-85 -89.92 136.28 33.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.647 HG22 ' HB3' ' A' ' 13' ' ' PHE . 3.0 m -101.88 118.77 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 111.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -107.98 130.82 55.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.518 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -114.22 162.57 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 . . . . . 0 N--CA 1.465 0.324 0 CA-C-O 121.814 0.816 . . . . 0.0 110.75 -178.371 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.536 ' CA ' ' HD2' ' A' ' 6' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.647 ' HB3' HG22 ' A' ' 5' ' ' VAL . 35.7 t80 -124.6 116.09 26.66 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.937 0.368 . . . . 0.0 110.741 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 19.2 Cg_exo -65.42 115.64 3.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.132 1.888 . . . . 0.0 111.524 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 3' ' ' VAL . 18.1 m -121.63 146.5 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.894 ' HA ' HG22 ' A' ' 2' ' ' ILE . 8.1 tt0 -84.85 81.93 8.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -167.37 -169.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.138 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.774 ' N ' HG23 ' A' ' 17' ' ' VAL . 33.2 m-20 -113.75 112.92 24.22 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.954 ' OG ' HD11 ' A' ' 69' ' ' ILE . 23.3 t -90.01 8.32 33.12 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.928 ' OD2' HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -122.05 -19.04 6.75 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.915 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.943 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.19 175.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 179.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 32.7 t -40.18 154.93 0.03 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.679 -0.638 . . . . 0.0 112.431 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.833 HG13 HD22 ' A' ' 50' ' ' LEU . 5.0 tt -45.43 -41.15 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.701 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.589 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 49.5 m-85 -63.2 -48.66 77.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.444 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.633 ' HB2' HG23 ' A' ' 21' ' ' THR . 5.8 mm100 -58.82 -71.3 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.946 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -49.79 -55.14 15.22 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.022 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -43.3 -40.3 3.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 110.58 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.2 tt0 -66.77 -61.43 1.96 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.69 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 17' ' ' VAL . 60.5 t -49.01 -53.16 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.946 HG12 ' O ' ' A' ' 26' ' ' LEU . 1.2 p -62.09 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.945 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -55.0 -40.26 69.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.89 -176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 1.4 ttpm? -61.98 -46.91 87.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.254 0.55 . . . . 0.0 109.524 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -12.16 59.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.68 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -85.14 -1.42 56.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.095 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.92 34.93 88.64 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.846 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 m -140.26 -172.87 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 113.771 -1.215 . . . . 0.0 109.219 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.919 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 83.3 Cg_endo -65.48 -140.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 122.493 2.129 . . . . 0.0 109.625 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -110.8 -74.89 0.63 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.391 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.57 ' HB2' ' CD ' ' A' ' 27' ' ' LYS . 28.7 t70 -113.03 37.82 3.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.662 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 15.7 tp60 -42.54 -68.48 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.355 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.78 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 6.6 tp -91.83 -136.25 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.155 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' VAL . 1.6 mtt85 -113.27 130.43 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.052 HG13 HG23 ' A' ' 69' ' ' ILE . 2.3 t -105.84 133.86 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.604 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.748 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.5 mt -140.12 162.76 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.967 ' HB2' HG13 ' A' ' 67' ' ' VAL . 7.3 t80 -135.52 88.55 2.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.963 0.411 . . . . 0.0 111.669 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.744 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 77.21 31.85 0.48 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.375 0.607 . . . . 0.0 109.979 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.2 47.3 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.024 -0.989 . . . . 0.0 114.053 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.744 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -90.35 117.04 28.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.697 0.749 . . . . 0.0 110.048 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.55 133.55 45.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.833 HD22 HG13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -14.64 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.996 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.3 mmp_? -112.76 118.76 35.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.49 ' O ' HG21 ' A' ' 56' ' ' VAL . 5.9 t-20 -49.38 -39.84 33.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.08 -15.05 9.92 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.623 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.9 m-90 -101.76 -30.28 11.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.919 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.5 m -109.86 -30.19 7.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.996 HG13 ' O ' ' A' ' 51' ' ' ARG . 11.1 m -51.65 -129.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.668 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -92.8 -44.39 8.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.485 ' H ' HG23 ' A' ' 56' ' ' VAL . 4.9 m-80 -59.96 -16.07 27.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.952 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.623 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -63.73 -72.15 0.15 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.92 179.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.719 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.4 t0 -166.4 74.94 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.928 HD21 ' OD2' ' A' ' 20' ' ' ASP . 10.7 mp -130.99 166.28 21.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.52 -173.48 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.042 -1.89 . . . . 0.0 108.857 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -63.54 -30.83 71.89 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.768 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.492 ' HA ' HG13 ' A' ' 2' ' ' ILE . 11.1 tt0 -123.46 95.34 4.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.6 ' OG ' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -102.51 169.52 8.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.685 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.48 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.7 pp -132.26 123.01 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.967 HG13 ' HB2' ' A' ' 45' ' ' PHE . 96.8 t -116.23 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.06 0.457 . . . . 0.0 111.769 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.748 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -101.21 107.19 18.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.033 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.052 HG23 HG13 ' A' ' 43' ' ' VAL . 3.7 mp -104.55 141.85 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.78 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 41.3 t . . . . . 0 N--CA 1.432 -1.34 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.627 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.663 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.947 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -138.61 112.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.986 HG11 HG23 ' A' ' 67' ' ' VAL . 14.7 t -133.96 150.43 31.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.705 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.4 m-85 -83.7 129.76 34.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.973 HG23 HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -95.18 114.78 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.557 0.694 . . . . 0.0 110.858 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.86 145.3 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 17.9 t80 -139.99 148.02 41.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.598 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 121.907 0.861 . . . . 0.0 109.108 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.19 0 N-CA-C 112.941 -0.064 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.448 ' CG ' ' HD2' ' A' ' 14' ' ' PRO . 58.7 t80 -112.99 140.5 24.21 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.597 0.237 . . . . 0.0 111.116 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 32.2 Cg_endo -64.02 132.52 34.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.232 1.954 . . . . 0.0 111.652 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.851 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -118.11 138.16 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.633 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.947 ' HA ' HG23 ' A' ' 2' ' ' ILE . 17.9 tt0 -97.4 72.34 2.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.609 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.098 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 179.61 156.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.959 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 21' ' ' THR . 8.6 p30 -65.0 112.56 3.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 1.6 m -83.6 0.5 46.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.955 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -116.45 -17.52 10.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.725 0.693 . . . . 0.0 112.697 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.716 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -33.17 154.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.066 0.546 . . . . 0.0 111.375 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 t -20.63 143.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.726 0.774 . . . . 0.0 113.036 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.668 ' HA ' HD21 ' A' ' 26' ' ' LEU . 17.3 tt -37.48 -44.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.275 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.475 ' N ' HG23 ' A' ' 23' ' ' ILE . 3.4 m-85 -69.08 -49.22 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 19.3 mm-40 -56.23 -62.69 1.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.971 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.9 pt? -58.92 -53.04 62.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.466 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.7 ' H ' HD23 ' A' ' 26' ' ' LEU . 7.4 mttt -50.67 -36.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.962 0.41 . . . . 0.0 110.455 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.35 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.4 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.098 HG21 HG21 ' A' ' 17' ' ' VAL . 2.2 t -52.54 -55.83 9.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 111.255 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.027 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.5 p -55.42 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.428 0.632 . . . . 0.0 112.029 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.144 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -50.24 -26.44 4.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.777 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -69.49 -54.32 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.6 -5.79 58.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.252 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.97 -5.7 54.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.79 37.48 75.81 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.812 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.43 -174.47 0.41 Allowed Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.212 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.144 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 88.6 Cg_endo -66.72 -149.79 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.559 0 C-N-CA 122.395 2.063 . . . . 0.0 109.671 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -105.83 -69.9 0.8 Allowed 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.237 0.961 . . . . 0.0 113.255 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.45 25.0 10.74 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.6 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 3.1 tp60 -52.26 -73.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.626 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -82.13 -135.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -132.5 139.16 47.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 111.957 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.916 HG13 HG23 ' A' ' 69' ' ' ILE . 10.9 t -113.1 141.78 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.053 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.676 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.6 mp -138.16 162.12 31.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.92 ' CD1' HG22 ' A' ' 67' ' ' VAL . 10.0 t80 -132.52 153.74 50.64 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.781 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 22.53 37.91 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.16 -15.67 37.73 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.789 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.781 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -92.15 118.58 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' HA ' HG23 ' A' ' 44' ' ' ILE . 48.7 tt0 -66.04 136.64 56.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.858 ' O ' HD12 ' A' ' 50' ' ' LEU . 2.0 pp -22.7 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.836 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -122.09 118.32 28.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -39.22 -48.24 1.75 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -122.18 -13.32 8.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.736 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 13.8 t90 -97.15 -29.35 13.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.765 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.21 -25.7 10.93 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.955 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.4 m -81.81 -133.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.761 ' N ' HG23 ' A' ' 56' ' ' VAL . 1.9 mm100 -73.45 -34.85 65.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.687 ' H ' HG23 ' A' ' 56' ' ' VAL . 2.7 m-20 -72.98 0.07 12.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.919 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.797 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -95.9 -78.03 0.47 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.883 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.664 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.5 t70 -168.41 76.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.053 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.785 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.72 151.63 36.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.723 0.773 . . . . 0.0 112.908 -178.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.82 174.31 6.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.046 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.437 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -57.55 -39.21 76.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.349 -179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.22 83.62 1.95 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.732 ' C ' HG13 ' A' ' 3' ' ' VAL . 15.1 m -102.81 171.87 7.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.152 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.6 pp -129.58 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.986 HG23 HG11 ' A' ' 3' ' ' VAL . 91.4 t -118.6 135.99 57.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 111.363 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 6.8 t60 -92.74 106.64 18.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.002 HG21 HG21 ' A' ' 30' ' ' VAL . 4.2 mp -103.06 140.35 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 13.4 t . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.791 ' HE3' ' N ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.794 HG23 ' HA ' ' A' ' 16' ' ' GLU . 2.4 mt -122.99 118.63 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.01 HG11 HG23 ' A' ' 67' ' ' VAL . 10.5 t -138.02 158.39 32.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.45 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.1 m-85 -94.18 119.78 33.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.698 HG23 HD13 ' A' ' 69' ' ' ILE . 1.5 p -86.72 118.3 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -111.58 144.85 40.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.922 179.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 2.1 p90 -138.04 151.04 47.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.133 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.79 0.805 . . . . 0.0 109.215 179.677 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.154 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -123.6 142.37 38.89 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.788 0.328 . . . . 0.0 111.323 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 36.1 Cg_endo -65.04 124.79 13.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.362 2.042 . . . . 0.0 111.212 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.734 HG22 HG13 ' A' ' 17' ' ' VAL . 3.4 p -122.49 119.54 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.081 0.467 . . . . 0.0 111.433 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.794 ' HA ' HG23 ' A' ' 2' ' ' ILE . 7.7 tm-20 -77.35 86.3 3.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.343 0.592 . . . . 0.0 109.919 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.895 HG21 HG21 ' A' ' 29' ' ' VAL . 1.4 m -167.84 -166.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.191 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.791 ' N ' ' HE3' ' A' ' 1' ' ' MET . 2.7 p30 -103.58 104.79 14.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.914 ' O ' HG11 ' A' ' 67' ' ' VAL . 72.0 m -88.25 4.32 46.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.953 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -122.96 -19.81 5.99 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.296 178.047 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -36.14 169.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.527 0.517 . . . . 0.0 110.752 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 21' ' ' THR . 32.2 t -33.88 148.2 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.685 0.755 . . . . 0.0 112.491 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.759 ' HA ' HD11 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -46.08 -36.72 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.293 -177.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.688 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 14.2 m-85 -63.65 -45.22 91.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.652 ' HB2' HG23 ' A' ' 21' ' ' THR . 9.6 mm100 -67.26 -66.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.963 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.6 pp -49.48 -45.32 46.77 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.489 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.902 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -57.62 -37.47 73.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.481 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -63.96 -56.46 14.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.797 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.895 HG21 HG21 ' A' ' 17' ' ' VAL . 99.3 t -55.57 -53.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.139 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.977 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.3 p -57.67 -75.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.381 0.61 . . . . 0.0 112.358 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.278 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -48.67 -39.12 23.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.963 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -61.42 -45.35 94.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.76 -11.27 45.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.128 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.656 ' O ' HG13 ' A' ' 36' ' ' VAL . 5.7 tt0 -84.34 -5.46 59.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.405 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.27 37.41 94.48 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.873 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -138.31 -171.79 0.29 Allowed Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 113.853 -1.174 . . . . 0.0 109.438 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.278 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 78.0 Cg_endo -63.51 -147.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.702 0 C-N-CA 122.377 2.051 . . . . 0.0 109.066 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.74 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -108.79 -77.78 0.6 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 123.844 0.715 . . . . 0.0 112.272 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 27' ' ' LYS . 29.0 t70 -112.62 34.54 4.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.627 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 8.7 tp-100 -46.43 -71.1 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.762 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.8 tp -90.12 -138.6 0.14 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.582 ' O ' ' O ' ' A' ' 70' ' ' VAL . 3.5 mpp_? -112.98 135.41 53.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.392 0.615 . . . . 0.0 112.657 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 69' ' ' ILE . 2.8 t -102.13 141.95 17.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.24 0.543 . . . . 0.0 111.096 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.812 HG23 ' CA ' ' A' ' 49' ' ' GLU . 2.6 mp -138.3 161.08 31.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.992 ' CD1' HG22 ' A' ' 67' ' ' VAL . 6.6 t80 -136.25 155.91 49.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.489 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 40.61 28.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 111.583 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 -10.13 9.48 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.622 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.489 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 15.3 mtmt -105.69 110.41 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.306 0.553 . . . . 0.0 110.838 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.812 ' CA ' HG23 ' A' ' 44' ' ' ILE . 3.0 tm-20 -74.84 127.75 33.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 49' ' ' GLU . 1.6 mm? -150.05 -164.35 2.0 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -105.88 175.7 5.41 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.722 0.772 . . . . 0.0 113.071 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.432 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 4.5 p-10 -47.25 -20.08 0.17 Allowed 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.699 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -16.74 11.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.41 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.675 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 0.3 OUTLIER -108.3 -20.23 13.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -106.64 -27.41 10.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.953 HG12 ' O ' ' A' ' 20' ' ' ASP . 1.5 m -79.88 -140.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.839 ' N ' HG23 ' A' ' 56' ' ' VAL . 3.8 mp0 -65.81 -42.68 90.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.594 ' H ' HG23 ' A' ' 56' ' ' VAL . 3.4 m-80 -59.54 -14.0 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.037 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.921 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 8.4 t -84.72 -73.67 0.42 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.283 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.617 ' O ' HD22 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -170.66 84.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.658 176.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.826 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -119.58 157.03 29.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.92 -178.8 5.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.718 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.71 -34.16 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.526 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -124.33 91.93 3.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.148 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.76 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.32 170.29 8.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.915 0.388 . . . . 0.0 111.447 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 2.0 pp -130.43 116.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.01 HG23 HG11 ' A' ' 3' ' ' VAL . 60.4 t -116.12 142.79 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.075 0.464 . . . . 0.0 111.577 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' ILE . 64.9 t-80 -106.65 108.07 19.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.087 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.906 HG23 HG13 ' A' ' 43' ' ' VAL . 3.0 mp -100.79 138.68 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.762 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 52.7 t . . . . . 0 N--CA 1.436 -1.158 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.11 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.597 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.828 0.347 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.776 HG22 ' HA ' ' A' ' 16' ' ' GLU . 12.9 pt -132.94 114.72 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.282 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.073 HG11 HG23 ' A' ' 67' ' ' VAL . 21.4 t -129.37 145.58 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.4 m-85 -81.63 126.36 31.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.944 HG23 HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -93.28 113.41 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.752 0.786 . . . . 0.0 110.641 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.416 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 4.7 mmt180 -103.88 151.88 22.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.474 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 8' ' ' ASN . 65.6 t80 -136.0 171.88 13.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.514 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.642 ' O ' ' O ' ' A' ' 7' ' ' PHE . 3.4 t30 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.135 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.425 ' CE2' HG11 ' A' ' 5' ' ' VAL . 9.0 p90 -126.71 144.32 49.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.667 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 39.1 Cg_endo -66.67 134.66 35.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.361 2.041 . . . . 0.0 111.467 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -117.65 135.78 56.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.827 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.776 ' HA ' HG22 ' A' ' 2' ' ' ILE . 1.4 tt0 -92.52 69.56 4.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.989 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 176.39 156.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.615 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' O ' HG22 ' A' ' 21' ' ' THR . 3.0 m-20 -65.85 120.37 12.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.785 ' OG ' HD11 ' A' ' 69' ' ' ILE . 1.2 t -87.28 -26.21 23.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.926 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -87.48 -23.33 24.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.736 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -34.09 151.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.311 0.382 . . . . 0.0 111.079 179.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.581 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -17.96 143.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.577 ' HA ' HD21 ' A' ' 26' ' ' LEU . 6.6 tt -40.81 -39.45 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.016 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.53 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 79.7 m-85 -66.97 -47.86 70.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.267 0.556 . . . . 0.0 109.591 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 54.9 mm-40 -65.17 -55.46 18.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.224 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.953 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.4 pp -55.93 -56.73 17.16 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.887 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.86 -36.93 59.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.314 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -66.18 -59.29 3.89 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.544 -179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.989 HG21 HG21 ' A' ' 17' ' ' VAL . 43.0 t -52.98 -52.45 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.623 0.249 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.057 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -62.53 -74.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 1.057 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -51.61 -29.58 18.03 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.941 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 10.2 ttmt -68.27 -54.07 20.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -7.54 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.96 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -80.2 -5.4 56.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.572 0.225 . . . . 0.0 111.407 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 37.66 67.23 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.775 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -145.35 -173.63 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 113.512 -1.344 . . . . 0.0 109.237 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.949 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 95.0 Cg_endo -66.93 -144.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.331 2.021 . . . . 0.0 109.88 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -107.09 -68.05 0.91 Allowed 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.621 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -113.62 35.27 4.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.713 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 6.2 tp-100 -48.53 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.733 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp -87.33 -126.18 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 70' ' ' VAL . 20.7 mtt85 -129.01 147.95 50.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.203 0.525 . . . . 0.0 111.929 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.042 HG13 HG23 ' A' ' 69' ' ' ILE . 4.0 t -116.74 146.35 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.671 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.0 mp -143.57 159.2 16.81 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.94 ' CD1' HG22 ' A' ' 67' ' ' VAL . 21.9 t80 -135.0 156.13 49.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 26.62 37.89 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 78.71 -12.44 22.24 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.978 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 0.0 OUTLIER -92.82 121.82 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.179 0.489 . . . . 0.0 109.735 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG2' ' CD2' ' A' ' 50' ' ' LEU . 1.2 tt0 -62.56 130.74 46.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.7 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.552 HD13 ' H ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -21.66 103.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.758 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -125.06 117.75 24.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.211 176.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -39.87 -46.6 2.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.5 OUTLIER -121.33 -13.56 8.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.73 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 6.2 t90 -97.59 -29.18 13.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.741 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.64 -25.21 10.99 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.926 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.9 m -80.75 -132.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.519 1.304 . . . . 0.0 114.519 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.748 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -74.42 -34.99 63.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.699 ' H ' HG23 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -72.09 0.79 8.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.771 177.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.809 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -97.21 -78.24 0.48 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.88 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.657 ' C ' HD23 ' A' ' 61' ' ' LEU . 8.6 t0 -168.68 76.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.075 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.795 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.12 151.63 35.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.567 0.698 . . . . 0.0 112.836 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -120.26 177.19 5.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.32 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -58.24 -38.29 76.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.255 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.71 85.61 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.768 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.35 165.79 10.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -127.84 120.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.073 HG23 HG11 ' A' ' 3' ' ' VAL . 72.0 t -117.94 135.95 56.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.018 0.437 . . . . 0.0 111.668 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.671 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -91.14 106.18 18.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.012 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 1.042 HG23 HG13 ' A' ' 43' ' ' VAL . 4.5 mp -106.62 145.26 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 11.1 t . . . . . 0 N--CA 1.435 -1.196 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.648 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.789 0.328 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 64' ' ' GLN . 1.0 OUTLIER -132.46 115.41 25.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.495 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.933 HG11 HG23 ' A' ' 67' ' ' VAL . 19.3 t -127.94 145.92 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.046 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 6.1 m-85 -80.8 126.59 31.51 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.1 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.009 HG23 HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -95.34 112.66 28.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.41 0.624 . . . . 0.0 110.807 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HD2' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -107.11 139.76 41.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.415 179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.602 ' O ' ' N ' ' A' ' 9' ' ' SER . 25.7 t80 -101.32 155.18 18.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 7.8 t-20 -63.01 69.22 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.734 0.778 . . . . 0.0 110.195 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.602 ' N ' ' O ' ' A' ' 7' ' ' PHE . 14.2 t -172.0 163.55 6.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.361 -1.291 . . . . 0.0 107.743 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.89 71.59 1.53 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.158 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -160.52 115.51 2.23 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.406 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 6' ' ' ARG . . . -125.52 140.6 12.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.175 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -122.41 131.34 24.41 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.958 0.379 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 37.7 Cg_endo -66.23 123.09 10.74 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.273 1.982 . . . . 0.0 112.312 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -114.1 136.68 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.444 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 2' ' ' ILE . 1.9 tt0 -93.09 70.25 4.5 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.8 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 177.1 154.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.781 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.459 ' HA ' ' CG2' ' A' ' 3' ' ' VAL . 1.2 p-10 -64.93 118.36 8.95 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 12.9 t -88.01 -24.11 23.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 1.025 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -89.76 -18.45 26.31 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.71 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -37.18 154.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.287 0.235 . . . . 0.0 110.767 178.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.553 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.7 t -18.26 142.73 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -173.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.816 HD12 HD13 ' A' ' 50' ' ' LEU . 19.8 tt -39.7 -39.43 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 CA-C-N 113.813 -1.539 . . . . 0.0 111.684 -177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -68.15 -49.52 60.49 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 20.0 mm-40 -63.13 -54.87 31.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.538 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.015 HD13 ' HB ' ' A' ' 43' ' ' VAL . 2.1 pp -55.31 -56.15 23.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 111.063 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.88 ' N ' HD12 ' A' ' 26' ' ' LEU . 7.3 mttt -56.13 -36.9 68.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.08 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.8 mm-40 -62.3 -60.57 3.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.594 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.014 HG21 HG21 ' A' ' 17' ' ' VAL . 7.9 t -54.05 -53.81 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.4 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.013 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -58.46 -71.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.307 0.575 . . . . 0.0 112.349 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.027 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -54.06 -30.88 49.79 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 114.931 -1.032 . . . . 0.0 113.17 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 33.8 tttt -66.91 -52.44 43.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.085 0.469 . . . . 0.0 109.8 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.91 -7.2 58.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.447 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.537 ' HG2' HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.53 -4.6 54.55 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.617 0.246 . . . . 0.0 111.58 -179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.47 37.5 78.8 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.809 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -142.78 -172.65 0.32 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 113.371 -1.415 . . . . 0.0 108.867 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.027 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 86.2 Cg_endo -65.17 -152.24 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.569 0 C-N-CA 122.083 1.856 . . . . 0.0 109.388 177.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.568 ' O ' ' HB3' ' A' ' 27' ' ' LYS . . . -106.54 -70.44 0.79 Allowed 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.272 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 3.8 p-10 -118.02 22.72 12.07 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.514 ' CB ' ' HG3' ' A' ' 37' ' ' PRO . 10.2 tp60 -55.29 -63.44 1.16 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 72' ' ' ARG . 6.9 tp -82.67 -143.33 0.06 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -129.08 142.04 51.02 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.212 0.529 . . . . 0.0 111.159 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.015 ' HB ' HD13 ' A' ' 26' ' ' LEU . 9.5 t -116.82 148.84 19.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.688 ' O ' ' O ' ' A' ' 68' ' ' HIS . 46.2 mt -140.93 159.37 23.52 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.409 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.961 ' HB2' HG13 ' A' ' 67' ' ' VAL . 23.2 t80 -136.34 157.14 47.5 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HE2' ' A' ' 48' ' ' LYS . . . 23.62 36.28 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 83.4 -14.63 39.31 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.869 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -92.1 119.84 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.325 0.562 . . . . 0.0 109.494 178.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HA ' HG23 ' A' ' 44' ' ' ILE . 16.2 tt0 -67.61 134.43 51.18 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.816 HD13 HD12 ' A' ' 23' ' ' ILE . 1.3 pp -9.77 87.81 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.891 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -118.16 120.58 38.14 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 52.3 t-20 -46.24 -47.81 17.97 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.1 -14.14 8.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.758 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.4 t90 -95.39 -25.49 16.25 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.754 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.3 m -109.2 -30.63 7.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.025 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.2 m -70.66 -133.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -175.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.794 ' N ' HG23 ' A' ' 56' ' ' VAL . 1.5 mm100 -78.32 -36.79 45.95 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.696 ' H ' HG23 ' A' ' 56' ' ' VAL . 15.7 t-20 -65.78 -12.02 50.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.765 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.758 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 1.6 t -81.36 -78.66 0.18 Allowed 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.097 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.619 ' C ' HD23 ' A' ' 61' ' ' LEU . 32.1 t70 -168.73 76.02 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.993 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.83 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.65 150.82 37.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.591 0.71 . . . . 0.0 112.907 -178.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -115.25 178.19 4.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.779 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' O ' HG13 ' A' ' 2' ' ' ILE . 4.4 mm-40 -57.33 -39.48 75.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.999 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.801 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.5 pt20 -115.05 88.67 2.92 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.674 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.78 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.56 165.57 11.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.503 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -128.93 121.97 55.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.961 HG13 ' HB2' ' A' ' 45' ' ' PHE . 98.7 t -117.76 137.01 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.067 0.461 . . . . 0.0 111.408 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.688 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -92.29 106.84 18.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.173 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.009 HD13 HG23 ' A' ' 5' ' ' VAL . 4.4 mp -99.7 138.87 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 42' ' ' ARG . 48.8 t -120.54 67.09 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.595 ' HG3' ' HB2' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -85.05 164.71 18.06 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.468 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HA ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -63.11 126.17 88.48 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.535 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.34 155.72 44.91 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.733 2.289 . . . . 0.0 112.775 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -87.84 138.59 31.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.634 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -109.8 104.6 13.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.943 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.7 mttm . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.976 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.667 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.654 0.264 . . . . 0.0 110.792 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.934 HG23 ' HA ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -132.61 114.48 22.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.03 HG11 HG23 ' A' ' 67' ' ' VAL . 20.4 t -133.15 145.5 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.372 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 3.5 m-85 -85.9 130.54 34.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.566 HG12 HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -103.95 120.45 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.258 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -100.64 129.75 46.6 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.907 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 9' ' ' SER . 8.4 t80 -100.77 155.28 18.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.418 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 4.1 t-20 -63.73 68.9 0.02 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.679 0.752 . . . . 0.0 110.293 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 7' ' ' PHE . 3.0 t -171.42 161.74 6.46 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.459 -1.246 . . . . 0.0 107.933 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -74.56 71.75 1.88 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.076 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.65 134.47 7.93 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.542 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.495 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -125.85 140.78 12.41 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.835 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.502 ' O ' HG13 ' A' ' 5' ' ' VAL . 20.2 t80 -122.42 106.53 35.29 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.911 0.355 . . . . 0.0 110.978 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 16.8 Cg_exo -67.6 120.73 7.76 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.478 2.119 . . . . 0.0 111.94 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.9 HG22 ' O ' ' A' ' 3' ' ' VAL . 3.9 m -121.45 148.17 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.934 ' HA ' HG23 ' A' ' 2' ' ' ILE . 30.3 tt0 -93.07 75.11 4.71 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.783 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.041 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 178.88 152.4 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.891 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.516 ' O ' HG22 ' A' ' 21' ' ' THR . 8.5 m-20 -65.41 119.63 11.35 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.497 ' OG ' HD11 ' A' ' 69' ' ' ILE . 1.4 t -85.83 -30.54 22.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.97 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -86.75 -21.52 26.52 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.701 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -33.51 150.58 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 O-C-N 123.253 0.346 . . . . 0.0 111.096 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.2 t -17.3 142.99 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.549 ' HA ' HD21 ' A' ' 26' ' ' LEU . 19.5 tt -39.69 -39.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-N 113.837 -1.528 . . . . 0.0 111.887 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -67.56 -49.2 64.35 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 2.2 mm-40 -63.0 -55.61 24.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.582 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.037 HD13 ' HB ' ' A' ' 43' ' ' VAL . 1.9 pp -55.2 -57.23 12.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 111.237 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.876 ' N ' HD12 ' A' ' 26' ' ' LEU . 12.1 mttt -56.55 -35.36 68.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.146 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.97 -59.85 4.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.62 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.041 HG21 HG21 ' A' ' 17' ' ' VAL . 4.3 t -54.04 -53.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.777 0.322 . . . . 0.0 111.197 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.977 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.0 OUTLIER -58.78 -73.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.464 0.65 . . . . 0.0 112.224 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.125 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -50.03 -27.75 6.0 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.607 -1.179 . . . . 0.0 112.939 -176.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HE3' ' HG2' ' A' ' 33' ' ' ARG . 8.1 ttpp -69.83 -52.5 24.4 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.404 ' HG2' ' HE3' ' A' ' 32' ' ' LYS . 2.4 mtt180 -88.66 -5.75 57.93 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.395 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.4 OUTLIER -79.73 -6.31 56.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.573 0.225 . . . . 0.0 111.589 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.47 37.2 69.31 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 108.866 -1.693 . . . . 0.0 108.866 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.803 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.41 -173.65 0.37 Allowed Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.193 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.125 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 83.0 Cg_endo -66.3 -148.87 0.02 OUTLIER 'Trans proline' 0 CA--C 1.494 -1.484 0 C-N-CA 122.219 1.946 . . . . 0.0 109.719 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.646 ' O ' ' HB3' ' A' ' 27' ' ' LYS . . . -105.31 -68.02 0.89 Allowed 'General case' 0 N--CA 1.426 -1.656 0 O-C-N 124.277 0.986 . . . . 0.0 113.279 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 7.5 p30 -112.62 29.47 7.91 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.764 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 7.3 tp-100 -53.2 -76.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.655 HD23 ' HG3' ' A' ' 72' ' ' ARG . 2.9 tp -84.74 -138.36 0.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -131.45 139.41 49.37 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.366 0.603 . . . . 0.0 112.495 -178.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.037 ' HB ' HD13 ' A' ' 26' ' ' LEU . 5.2 t -109.61 144.28 18.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.53 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.695 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.4 mp -138.28 159.01 32.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.438 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.934 ' CD1' HG22 ' A' ' 67' ' ' VAL . 21.9 t80 -133.89 154.2 51.22 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.771 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 26.03 34.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 85.8 -14.73 51.12 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.783 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.771 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -90.9 117.23 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.308 -0.626 . . . . 0.0 109.308 178.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 6.6 tt0 -65.4 135.12 54.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 43' ' ' VAL . 0.4 OUTLIER -14.52 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.857 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -120.35 119.12 32.18 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 17.0 p-10 -44.87 -47.17 11.13 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -119.38 -14.23 9.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.328 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.741 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.2 t90 -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.764 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -109.43 -26.01 10.22 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -178.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.97 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.2 m -82.29 -133.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.773 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -73.18 -35.8 66.47 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.682 ' H ' HG23 ' A' ' 56' ' ' VAL . 4.0 m-20 -71.22 -0.17 9.27 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.909 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.82 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -96.71 -76.99 0.5 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.818 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.682 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -169.94 76.65 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.064 176.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.798 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -117.17 152.19 35.29 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.14 177.21 4.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.157 178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.51 ' O ' HD12 ' A' ' 2' ' ' ILE . 8.5 mt-30 -58.89 -38.75 79.56 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.002 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -116.53 86.7 2.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.666 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -101.66 168.2 9.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.371 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.513 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.8 pp -127.96 119.78 52.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.03 HG23 HG11 ' A' ' 3' ' ' VAL . 76.4 t -117.71 137.37 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 111.834 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.695 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -91.06 108.24 19.73 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.109 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.024 HG23 HG13 ' A' ' 43' ' ' VAL . 6.5 mt -102.9 140.99 19.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.65 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 17.0 t -133.76 70.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.776 ' HB3' HG21 ' A' ' 30' ' ' VAL . 6.4 tp-100 -119.41 86.53 2.57 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.172 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.655 ' HG3' HD23 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -126.43 149.57 67.92 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.322 -178.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 23.6 Cg_endo -61.14 145.36 98.88 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.432 2.088 . . . . 0.0 111.476 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.98 105.8 17.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.951 0.405 . . . . 0.0 111.321 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -107.14 105.76 15.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.861 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.4 tttp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.872 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.585 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.701 0.286 . . . . 0.0 110.711 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.869 HG22 ' HA ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -134.09 114.27 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.141 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.952 HG11 HG23 ' A' ' 67' ' ' VAL . 17.9 t -130.34 147.11 33.18 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.326 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.749 ' CD1' HG22 ' A' ' 66' ' ' ILE . 31.5 m-85 -85.69 124.63 32.43 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.108 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.875 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -94.14 120.39 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.516 0.674 . . . . 0.0 110.594 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.495 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.7 mmt85 -101.79 149.1 24.52 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.264 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' O ' ' N ' ' A' ' 9' ' ' SER . 29.9 t80 -115.44 156.67 25.18 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -63.91 69.39 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.735 0.779 . . . . 0.0 110.192 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 7' ' ' PHE . 1.4 t -170.85 162.23 7.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.972 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m -73.9 72.83 1.6 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.125 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.56 136.59 10.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.529 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.495 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -129.91 134.44 7.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.841 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' HB3' HG13 ' A' ' 5' ' ' VAL . 1.2 t80 -114.54 118.44 41.39 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 117.186 0.493 . . . . 0.0 110.731 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 4' ' ' PHE . 36.2 Cg_endo -65.4 120.96 8.26 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.031 1.82 . . . . 0.0 111.876 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -115.62 139.53 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.597 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.869 ' HA ' HG22 ' A' ' 2' ' ' ILE . 3.9 tt0 -93.71 69.71 4.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 119.844 -0.743 . . . . 0.0 109.421 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 175.41 157.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.723 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.689 ' OD1' HG21 ' A' ' 21' ' ' THR . 3.5 p30 -65.62 119.84 11.85 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.449 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -87.58 -24.88 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -177.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.814 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -91.16 -23.54 20.22 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.755 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -35.19 153.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.267 0.354 . . . . 0.0 111.41 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.3 t -16.62 144.27 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -174.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.822 HD11 ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -41.0 -39.9 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 CA-C-N 113.982 -1.463 . . . . 0.0 111.906 -177.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.48 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 49.9 m-85 -66.92 -48.14 69.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.247 0.546 . . . . 0.0 109.604 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HB2' HG23 ' A' ' 21' ' ' THR . 36.2 mm-40 -64.81 -54.95 23.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.369 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.972 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.5 pp -57.14 -58.61 7.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.68 0.276 . . . . 0.0 111.178 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.837 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -51.19 -36.47 41.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.484 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 27.1 tt0 -68.7 -59.93 2.76 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.899 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 17' ' ' VAL . 52.2 t -51.95 -52.65 21.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.751 0.31 . . . . 0.0 111.463 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.061 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -61.88 -73.53 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.263 0.554 . . . . 0.0 112.409 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.121 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -53.14 -25.84 14.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.06 -0.973 . . . . 0.0 113.368 -176.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 4.8 tttp -72.19 -52.02 18.47 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -85.96 -7.85 58.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.567 ' HG2' HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -80.62 -6.58 58.52 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.525 0.202 . . . . 0.0 111.542 -179.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.79 39.58 85.68 Favored Glycine 0 CA--C 1.507 -0.426 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.92 HG21 ' O ' ' A' ' 71' ' ' GLN . 1.3 m -144.02 -172.3 0.31 Allowed Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 113.488 -1.356 . . . . 0.0 109.464 -176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.121 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 96.0 Cg_endo -67.04 -147.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.496 -1.379 0 C-N-CA 122.403 2.069 . . . . 0.0 109.826 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -105.96 -69.82 0.81 Allowed 'General case' 0 N--CA 1.427 -1.611 0 O-C-N 124.177 0.923 . . . . 0.0 112.871 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.822 ' CG ' HD11 ' A' ' 23' ' ' ILE . 38.5 t70 -121.97 31.52 6.18 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.652 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -49.02 -77.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 4.6 tp -81.94 -124.71 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.548 ' O ' ' O ' ' A' ' 70' ' ' VAL . 17.9 mmt180 -131.51 162.36 30.44 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 118.449 0.568 . . . . 0.0 112.016 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 69' ' ' ILE . 6.1 t -130.69 147.55 33.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.047 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 68' ' ' HIS . 37.6 mt -143.3 159.01 17.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.921 ' CD1' HG22 ' A' ' 67' ' ' VAL . 14.0 t80 -134.51 153.29 52.02 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.765 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 26.87 37.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 79.72 -12.51 28.32 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.835 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.765 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 10.3 mtmt -91.43 123.41 34.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.189 0.495 . . . . 0.0 109.966 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' HA ' HG23 ' A' ' 44' ' ' ILE . 0.9 OUTLIER -60.69 122.39 14.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.122 -178.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.663 ' HB2' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -25.05 107.64 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.1 mmp_? -126.66 118.94 25.8 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -41.76 -44.89 3.38 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.732 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -118.81 -14.36 9.49 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.659 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 14.9 m-90 -100.07 -31.83 11.23 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.617 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -107.28 -24.07 12.01 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.826 ' O ' ' HB3' ' A' ' 59' ' ' CYS . 4.2 m -82.26 -135.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -175.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.72 ' N ' HG23 ' A' ' 56' ' ' VAL . 3.6 mm-40 -68.52 -35.12 77.03 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.696 ' H ' HG23 ' A' ' 56' ' ' VAL . 1.2 m-20 -74.02 6.06 3.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.146 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.826 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 4.8 t -106.22 -79.1 0.57 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.216 178.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.546 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.4 t70 -165.39 76.46 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.289 176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -115.69 148.55 39.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.454 0.645 . . . . 0.0 112.464 -178.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.61 175.01 5.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.098 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -56.82 -39.72 74.7 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.129 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 2' ' ' ILE . 2.8 pm0 -114.43 85.62 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.793 ' C ' HG13 ' A' ' 3' ' ' VAL . 50.5 m -101.1 166.58 10.72 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.498 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.749 HG22 ' CD1' ' A' ' 4' ' ' PHE . 1.8 pp -128.96 121.07 53.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.952 HG23 HG11 ' A' ' 3' ' ' VAL . 92.9 t -118.42 135.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.037 0.446 . . . . 0.0 111.566 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -91.88 107.49 19.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.119 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.019 HG21 HG21 ' A' ' 30' ' ' VAL . 4.0 mp -106.21 148.21 10.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.655 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 39.1 t -131.94 67.98 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.92 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -109.49 81.12 1.39 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.976 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.49 144.53 51.36 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.726 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 26.5 Cg_endo -60.92 154.66 54.75 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.558 2.172 . . . . 0.0 111.795 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.454 ' CZ2' ' NE2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -96.28 106.99 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.97 0.414 . . . . 0.0 111.176 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.19 117.39 34.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.909 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mtmm . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.983 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.704 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.672 0.272 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.91 HG22 ' HA ' ' A' ' 16' ' ' GLU . 20.3 pt -133.09 115.91 24.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.048 HG11 HG23 ' A' ' 67' ' ' VAL . 22.2 t -129.23 149.28 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 119.232 -0.987 . . . . 0.0 112.147 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 3.4 m-85 -88.84 127.22 35.62 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -105.87 117.99 52.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.498 0.666 . . . . 0.0 111.024 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.508 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 3.8 mmt85 -102.59 144.82 30.51 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -108.52 158.87 17.16 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.198 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -64.13 68.53 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.729 0.776 . . . . 0.0 110.121 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 7' ' ' PHE . 1.9 t -172.23 162.73 5.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.371 -1.286 . . . . 0.0 107.944 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.1 75.11 1.25 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.141 -1.023 . . . . 0.0 109.096 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -156.69 136.8 12.75 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.647 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -129.92 135.09 8.17 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.829 178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.451 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.8 t80 -119.62 105.86 42.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 117.164 0.482 . . . . 0.0 110.941 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 47.4 Cg_endo -69.06 119.4 6.39 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.198 1.932 . . . . 0.0 112.062 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 3' ' ' VAL . 6.4 m -117.4 147.86 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.174 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.91 ' HA ' HG22 ' A' ' 2' ' ' ILE . 3.1 tt0 -91.22 71.83 6.22 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.4 178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.003 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 178.99 154.71 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.058 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 21' ' ' THR . 8.4 p30 -65.07 118.76 9.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.502 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -85.5 -25.11 27.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -177.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.978 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.56 -19.76 23.39 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.689 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -34.35 152.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 122.454 0.302 . . . . 0.0 110.836 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.5 t -18.87 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -174.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.532 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 17.5 tt -40.98 -38.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 CA-C-N 114.128 -1.397 . . . . 0.0 111.917 -177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.552 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 43.8 m-85 -68.39 -46.98 68.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 44.4 mm-40 -65.97 -54.44 26.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.083 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.0 HD13 ' HB ' ' A' ' 43' ' ' VAL . 2.7 pp -57.07 -56.05 26.77 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.909 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.901 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.22 -36.93 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.163 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 2.2 mt-10 -66.3 -60.15 3.04 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.003 HG21 HG21 ' A' ' 17' ' ' VAL . 32.5 t -53.35 -56.13 9.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.749 0.309 . . . . 0.0 111.607 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.067 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.0 p -59.05 -74.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.32 0.581 . . . . 0.0 112.547 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.067 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -48.83 -31.01 6.42 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.928 -177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 28' ' ' GLU . 6.9 ttmt -67.03 -52.31 44.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.102 0.477 . . . . 0.0 109.719 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -85.76 -6.78 59.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -79.46 -6.96 58.02 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.626 0.25 . . . . 0.0 111.571 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.42 36.84 59.03 Favored Glycine 0 CA--C 1.505 -0.581 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.778 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -145.79 -173.41 0.36 Allowed Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 113.272 -1.464 . . . . 0.0 108.987 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.054 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 90.9 Cg_endo -68.2 -145.19 0.02 OUTLIER 'Trans proline' 0 CA--C 1.499 -1.263 0 C-N-CA 122.262 1.974 . . . . 0.0 110.004 177.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.804 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -104.58 -65.68 1.02 Allowed 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.951 -1.022 . . . . 0.0 113.002 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 5.3 t0 -115.28 39.39 2.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.614 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 2.8 tp-100 -43.95 -85.26 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.696 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 48.5 mt -94.19 -113.89 0.11 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' O ' ' A' ' 70' ' ' VAL . 7.6 mtp180 -130.44 126.37 36.8 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-O 121.432 0.634 . . . . 0.0 112.072 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.002 HG13 HG23 ' A' ' 69' ' ' ILE . 1.4 t -96.98 139.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.993 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.676 ' O ' ' O ' ' A' ' 68' ' ' HIS . 2.9 mp -138.52 159.64 31.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.35 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.925 ' HB2' HG13 ' A' ' 67' ' ' VAL . 15.7 t80 -134.76 154.57 51.53 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.748 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 25.21 38.02 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 80.97 -12.98 33.67 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.903 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.748 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 4.4 mtmt -90.12 118.16 29.44 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.266 0.533 . . . . 0.0 109.764 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HA ' ' CG1' ' A' ' 44' ' ' ILE . 24.7 tt0 -64.78 130.02 41.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.681 HD23 ' H ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -10.89 87.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.899 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -115.48 118.69 33.87 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 10.3 p30 -46.05 -48.75 16.82 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.49 -14.17 9.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.746 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 8.8 t90 -95.91 -26.49 15.57 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.761 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.2 m -109.14 -27.15 9.75 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.978 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.1 m -78.63 -134.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.785 ' N ' HG23 ' A' ' 56' ' ' VAL . 8.1 pt20 -73.49 -35.88 65.7 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.709 ' H ' HG23 ' A' ' 56' ' ' VAL . 2.0 m120 -70.56 -0.72 9.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.087 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.8 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -96.09 -78.17 0.47 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.017 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.668 ' C ' HD23 ' A' ' 61' ' ' LEU . 6.0 t0 -169.27 76.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.015 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.796 HD11 ' CG ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.19 151.48 35.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.638 0.732 . . . . 0.0 112.793 -178.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -118.69 177.37 4.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.041 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -39.01 77.02 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.887 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.44 ' HA ' HG13 ' A' ' 2' ' ' ILE . 1.3 tt0 -114.78 87.42 2.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.899 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.597 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.5 OUTLIER -101.26 167.68 10.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.253 -179.62 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.535 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.9 pp -130.32 121.95 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.048 HG23 HG11 ' A' ' 3' ' ' VAL . 74.4 t -117.05 136.2 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.083 0.468 . . . . 0.0 111.734 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 10.5 m-70 -93.42 106.56 18.52 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.011 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.006 ' CG2' HG21 ' A' ' 30' ' ' VAL . 3.2 mp -100.1 140.39 19.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 42' ' ' ARG . 44.2 t -140.98 72.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.166 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.798 ' OE1' ' HB2' ' A' ' 31' ' ' ALA . 3.7 pp0? -128.7 60.48 1.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 122.103 0.954 . . . . 0.0 109.197 177.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.49 135.22 26.28 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.391 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' N ' ' HG2' ' A' ' 40' ' ' GLN . 30.5 Cg_endo -63.0 151.85 82.52 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.363 2.042 . . . . 0.0 111.716 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 17.9 t90 -122.11 136.47 54.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -82.95 105.34 13.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.836 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 tttt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.901 -179.873 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.556 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.271 0.557 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.954 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.3 mt -143.7 112.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.091 HG11 HG23 ' A' ' 67' ' ' VAL . 14.2 t -137.27 150.5 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 118.836 -1.146 . . . . 0.0 112.562 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.521 ' HB2' HG23 ' A' ' 66' ' ' ILE . 2.5 m-85 -84.26 137.04 33.68 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.847 HG23 HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -107.66 116.55 51.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.518 0.675 . . . . 0.0 110.779 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HD2' ' HA2' ' A' ' 12' ' ' GLY . 2.9 mmt85 -104.4 148.82 25.99 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.636 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.658 ' O ' ' N ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -123.71 157.49 33.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -59.28 71.45 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.766 0.794 . . . . 0.0 110.552 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.658 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -169.73 161.13 9.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.08 179.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.23 73.49 5.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.224 -0.991 . . . . 0.0 109.513 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.476 ' HB3' ' CE2' ' A' ' 7' ' ' PHE . 1.3 t60 -161.41 141.07 10.4 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.647 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA2' ' HD2' ' A' ' 6' ' ' ARG . . . -130.04 143.23 14.47 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.794 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.5 t80 -121.75 107.0 36.45 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 117.201 0.5 . . . . 0.0 110.73 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 17.0 Cg_exo -66.8 122.85 10.28 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.533 2.155 . . . . 0.0 112.338 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 3' ' ' VAL . 5.2 m -127.86 148.64 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.21 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.057 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.954 ' HA ' HG23 ' A' ' 2' ' ' ILE . 25.8 tt0 -91.48 77.7 5.72 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.017 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER 178.86 152.73 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.753 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.504 ' O ' HG22 ' A' ' 21' ' ' THR . 4.1 m-20 -67.38 119.09 11.64 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 12.9 t -87.88 -22.89 24.15 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.91 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -92.09 -19.56 22.2 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.68 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -35.34 154.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.296 0.373 . . . . 0.0 110.903 179.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.582 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.4 t -18.12 142.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.101 HD12 HD11 ' A' ' 26' ' ' LEU . 11.1 tp -40.71 -36.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.12 -1.4 . . . . 0.0 112.049 -177.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.465 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . 28.3 m-85 -70.08 -47.94 59.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.32 0.581 . . . . 0.0 109.48 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 5.3 mm100 -64.4 -50.55 67.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.379 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.101 HD11 HD12 ' A' ' 23' ' ' ILE . 1.9 pp -59.93 -57.76 11.46 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.058 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.85 ' N ' HD12 ' A' ' 26' ' ' LEU . 20.5 pttt -51.8 -32.46 31.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.086 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 0.7 OUTLIER -68.01 -60.71 2.29 Favored 'General case' 0 C--O 1.23 0.055 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.694 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 17' ' ' VAL . 25.5 t -54.65 -52.67 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.573 0.225 . . . . 0.0 111.394 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.005 HG21 HG21 ' A' ' 69' ' ' ILE . 1.2 p -57.12 -75.01 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.452 0.644 . . . . 0.0 111.548 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.959 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -46.89 -31.39 3.08 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.756 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 28' ' ' GLU . 1.5 ttpm? -66.81 -57.12 7.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.977 0.418 . . . . 0.0 110.069 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.75 -5.23 59.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.065 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 45.8 tp60 -77.97 -10.42 59.58 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.654 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.55 37.71 34.6 Favored Glycine 0 CA--C 1.507 -0.466 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.805 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.8 m -147.65 -169.65 0.22 Allowed Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 113.077 -1.561 . . . . 0.0 108.281 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.911 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 55.0 Cg_endo -70.03 -148.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.502 -1.097 0 C-N-CA 122.131 1.887 . . . . 0.0 110.649 178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.683 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -122.22 -46.93 2.16 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.851 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.463 ' HA ' ' HE3' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -68.77 -5.79 22.8 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.318 -178.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.795 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 1.9 tp60 -56.27 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.705 0.764 . . . . 0.0 110.102 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.848 ' HG ' HD11 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -69.9 -161.16 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.369 -176.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.653 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 21.4 mmt-85 70.58 44.74 0.65 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.279 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.078 HG13 HG23 ' A' ' 69' ' ' ILE . 2.8 t -103.54 143.02 16.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.741 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.678 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.3 mp -140.51 156.18 23.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.941 ' CD1' HG22 ' A' ' 67' ' ' VAL . 16.2 t80 -129.46 151.11 50.44 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.821 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 27.41 35.79 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 87.82 -13.71 60.31 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.85 -0.691 . . . . 0.0 113.839 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.821 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -90.97 122.37 33.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.148 0.474 . . . . 0.0 110.013 179.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 44' ' ' ILE . 3.2 tt0 -69.04 135.13 50.36 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.046 HD13 HD13 ' A' ' 23' ' ' ILE . 1.1 pp -14.14 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.879 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -119.5 115.37 23.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 1.6 p-10 -49.1 -46.65 45.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.936 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.83 -16.46 11.74 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.664 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 10.9 m-90 -98.54 -28.17 13.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.733 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 2.1 m -107.01 -25.21 11.7 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.91 HG12 ' O ' ' A' ' 20' ' ' ASP . 2.9 m -82.89 -136.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.747 ' N ' HG23 ' A' ' 56' ' ' VAL . 6.5 pt20 -67.08 -33.83 76.35 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.681 ' H ' HG23 ' A' ' 56' ' ' VAL . 6.7 m-80 -74.04 3.66 6.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.128 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.807 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 5.6 t -104.08 -78.33 0.56 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.221 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.541 ' C ' HD23 ' A' ' 61' ' ' LEU . 20.8 t70 -167.04 77.6 0.18 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.96 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.813 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.31 149.05 39.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.651 0.738 . . . . 0.0 112.974 -178.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -120.82 172.41 7.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.873 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -56.47 -38.91 72.34 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.301 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -115.03 83.25 1.88 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.615 ' C ' HG13 ' A' ' 3' ' ' VAL . 5.8 m -102.85 172.15 6.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 61.9 mt -131.51 121.56 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.091 HG23 HG11 ' A' ' 3' ' ' VAL . 60.4 t -117.61 132.86 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.678 ' O ' ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -92.2 109.85 21.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.71 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.078 HG23 HG13 ' A' ' 43' ' ' VAL . 3.1 mp -103.16 149.35 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.653 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 24.6 t -136.24 86.96 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 174.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.545 ' HB3' ' HB3' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -67.11 102.29 1.0 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.716 -178.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' N ' ' HG3' ' A' ' 40' ' ' GLN . 1.5 ptm180 -105.33 142.09 23.97 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.031 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.91 155.0 11.76 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.375 2.05 . . . . 0.0 112.033 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -86.98 143.44 27.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.278 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -71.83 109.56 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.965 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.713 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.623 0.249 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -131.14 115.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.12 HG11 HG23 ' A' ' 67' ' ' VAL . 19.0 t -134.87 148.5 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 C-N-CA 118.814 -1.154 . . . . 0.0 112.582 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -83.51 128.95 34.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.901 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.656 ' CB ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -104.99 118.9 53.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.428 0.633 . . . . 0.0 110.803 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -104.47 147.46 27.55 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.734 179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' O ' ' N ' ' A' ' 9' ' ' SER . 7.0 t80 -137.89 145.76 42.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.675 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 10.1 p-10 -66.38 71.53 0.07 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.845 0.831 . . . . 0.0 108.968 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 7' ' ' PHE . 2.9 t -163.93 -160.77 0.58 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.42 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 9' ' ' SER . 58.7 p -49.41 177.09 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -53.27 143.36 18.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.282 0.563 . . . . 0.0 111.398 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.35 170.29 54.78 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.316 -0.856 . . . . 0.0 113.081 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.445 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.0 m-85 -118.98 142.65 32.35 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-O 120.73 0.3 . . . . 0.0 111.192 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 95.7 Cg_endo -80.45 133.27 9.48 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.644 2.229 . . . . 0.0 112.341 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.781 HG22 ' O ' ' A' ' 3' ' ' VAL . 10.5 m -121.67 149.0 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.377 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.894 ' HA ' HG23 ' A' ' 2' ' ' ILE . 5.2 tt0 -91.75 72.48 5.78 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.953 HG21 HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -172.81 156.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.903 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' OD1' HD12 ' A' ' 61' ' ' LEU . 1.4 m-20 -68.09 114.55 6.7 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.656 ' O ' HG11 ' A' ' 67' ' ' VAL . 3.6 m -87.29 -0.46 56.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.95 ' OD2' HD11 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -114.61 -24.01 8.98 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 118.49 0.586 . . . . 0.0 112.452 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.71 ' O ' HD22 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -32.79 153.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.715 0.634 . . . . 0.0 111.58 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.551 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -20.69 143.95 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.783 0.801 . . . . 0.0 113.061 -174.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.604 ' HA ' HD21 ' A' ' 26' ' ' LEU . 13.5 tt -40.03 -39.75 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.822 -177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 78.9 m-85 -68.69 -49.25 60.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 18.4 mm100 -59.21 -65.56 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.945 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.5 pt? -58.47 -50.17 74.68 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.537 -178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.782 ' H ' HD23 ' A' ' 26' ' ' LEU . 0.8 OUTLIER -48.39 -38.39 19.34 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.82 0.343 . . . . 0.0 110.616 178.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 13.8 tt0 -65.83 -62.47 1.48 Allowed 'General case' 0 C--O 1.227 -0.119 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.97 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.953 HG21 HG21 ' A' ' 17' ' ' VAL . 2.7 t -50.68 -48.6 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.62 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.978 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.9 p -67.03 -74.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.978 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -52.5 -33.29 44.24 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.619 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 8.6 tttp -67.1 -51.69 51.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -80.53 -9.21 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.48 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.697 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 3.0 tp-100 -81.08 -10.16 59.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.5 36.4 49.36 Favored Glycine 0 CA--C 1.507 -0.458 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.844 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.2 m -145.23 -174.51 0.41 Allowed Pre-proline 0 N--CA 1.445 -0.705 0 CA-C-N 113.584 -1.308 . . . . 0.0 109.188 -177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.934 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 98.0 Cg_endo -66.62 -142.36 0.01 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.837 2.358 . . . . 0.0 109.824 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -104.68 -73.07 0.69 Allowed 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.935 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.469 ' HB3' ' CD ' ' A' ' 27' ' ' LYS . 26.7 p-10 -120.15 26.54 9.18 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.577 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 36.9 tp60 -46.4 -59.26 3.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.305 0.502 . . . . 0.0 111.057 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.504 ' HB2' ' N ' ' A' ' 72' ' ' ARG . 9.7 tp -83.2 -138.74 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 121.426 -0.11 . . . . 0.0 110.749 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.559 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 11.4 mtt85 -128.54 119.16 24.29 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.286 0.565 . . . . 0.0 111.878 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.017 HG13 HG23 ' A' ' 69' ' ' ILE . 2.2 t -96.03 135.68 29.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.959 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.682 ' O ' ' O ' ' A' ' 68' ' ' HIS . 3.3 mp -137.67 163.19 31.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.425 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.948 ' CD1' HG22 ' A' ' 67' ' ' VAL . 8.6 t80 -136.19 154.01 51.07 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.623 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 24.25 35.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.19 -15.42 39.25 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.742 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.623 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -93.61 119.73 33.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.317 0.558 . . . . 0.0 109.732 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 44' ' ' ILE . 17.6 tt0 -64.83 134.26 53.7 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.005 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.684 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -21.46 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -179.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.827 ' H ' ' HB ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -121.72 117.59 27.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -40.22 -48.4 2.57 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -119.92 -14.24 8.96 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.716 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 11.2 t90 -97.21 -30.28 13.09 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.827 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -107.06 -26.3 11.2 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.902 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.0 m -83.81 -137.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.721 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.77 -34.91 78.87 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.649 ' H ' HG23 ' A' ' 56' ' ' VAL . 3.3 m-80 -73.75 1.87 9.49 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.014 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.839 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 3.2 t -101.45 -77.47 0.55 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.288 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.43 ' O ' HD22 ' A' ' 61' ' ' LEU . 10.4 t0 -165.68 78.53 0.28 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.022 176.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.95 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.2 OUTLIER -117.74 149.22 41.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.76 173.43 7.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.734 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -57.22 -38.11 73.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.788 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -116.96 84.81 2.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.627 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -100.61 171.45 7.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.523 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 7.2 pt -129.9 121.93 53.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.12 HG23 HG11 ' A' ' 3' ' ' VAL . 98.8 t -119.71 139.69 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.018 0.437 . . . . 0.0 111.467 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.682 ' O ' ' O ' ' A' ' 44' ' ' ILE . 3.6 t-80 -97.84 105.39 17.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.317 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.017 HG23 HG13 ' A' ' 43' ' ' VAL . 3.0 mp -97.84 115.31 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 42' ' ' ARG . 45.8 t -104.09 74.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 175.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.458 ' O ' ' CE2' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -86.49 168.96 13.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.266 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.511 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -71.59 132.74 85.22 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.949 -179.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.45 154.53 46.96 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.589 2.193 . . . . 0.0 112.452 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -87.11 140.19 29.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.668 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.02 105.41 14.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.867 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.941 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.722 ' HE3' ' C ' ' A' ' 17' ' ' VAL . 1.8 mtp . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.741 0.305 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.894 HG22 ' HA ' ' A' ' 16' ' ' GLU . 11.6 pt -136.37 124.66 35.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.748 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 15' ' ' VAL . 94.1 t -139.54 156.41 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.453 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 3.2 m-85 -89.92 136.28 33.14 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.647 HG22 ' HB3' ' A' ' 13' ' ' PHE . 3.0 m -101.88 118.77 49.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.561 0.696 . . . . 0.0 111.594 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -107.98 130.82 55.03 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.518 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.671 ' O ' ' N ' ' A' ' 9' ' ' SER . 8.0 p90 -114.22 162.57 16.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -58.43 70.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.814 0.816 . . . . 0.0 110.75 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.671 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -171.43 162.66 6.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.855 179.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.94 71.14 10.66 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.823 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -160.46 131.56 5.66 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.587 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.536 ' CA ' ' HD2' ' A' ' 6' ' ' ARG . . . -125.58 150.84 17.49 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.148 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.647 ' HB3' HG22 ' A' ' 5' ' ' VAL . 35.7 t80 -124.6 116.09 26.66 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.937 0.368 . . . . 0.0 110.741 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 19.2 Cg_exo -65.42 115.64 3.46 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.132 1.888 . . . . 0.0 111.524 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 3' ' ' VAL . 18.1 m -121.63 146.5 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.894 ' HA ' HG22 ' A' ' 2' ' ' ILE . 8.1 tt0 -84.85 81.93 8.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -167.37 -169.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.138 179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.774 ' N ' HG23 ' A' ' 17' ' ' VAL . 33.2 m-20 -113.75 112.92 24.22 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.954 ' OG ' HD11 ' A' ' 69' ' ' ILE . 23.3 t -90.01 8.32 33.12 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.928 ' OD2' HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -122.05 -19.04 6.75 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.915 178.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.943 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -40.19 175.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.172 0.589 . . . . 0.0 111.106 179.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 32.7 t -40.18 154.93 0.03 OUTLIER 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.679 -0.638 . . . . 0.0 112.431 -176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.833 HG13 HD22 ' A' ' 50' ' ' LEU . 5.0 tt -45.43 -41.15 2.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.701 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.589 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 49.5 m-85 -63.2 -48.66 77.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.444 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.633 ' HB2' HG23 ' A' ' 21' ' ' THR . 5.8 mm100 -58.82 -71.3 0.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.946 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -49.79 -55.14 15.22 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.022 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 24' ' ' PHE . 0.8 OUTLIER -43.3 -40.3 3.47 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 110.58 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.2 tt0 -66.77 -61.43 1.96 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.69 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 17' ' ' VAL . 60.5 t -49.01 -53.16 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.322 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.946 HG12 ' O ' ' A' ' 26' ' ' LEU . 1.2 p -62.09 -74.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.945 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -55.0 -40.26 69.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.89 -176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 1.4 ttpm? -61.98 -46.91 87.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.254 0.55 . . . . 0.0 109.524 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -12.16 59.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.441 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.68 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -85.14 -1.42 56.86 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.095 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.92 34.93 88.64 Favored Glycine 0 CA--C 1.508 -0.405 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.846 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.4 m -140.26 -172.87 0.33 Allowed Pre-proline 0 N--CA 1.448 -0.575 0 CA-C-N 113.771 -1.215 . . . . 0.0 109.219 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.919 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 83.3 Cg_endo -65.48 -140.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 122.493 2.129 . . . . 0.0 109.625 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -110.8 -74.89 0.63 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.391 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.57 ' HB2' ' CD ' ' A' ' 27' ' ' LYS . 28.7 t70 -113.03 37.82 3.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.662 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 15.7 tp60 -42.54 -68.48 0.19 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.355 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.78 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 6.6 tp -91.83 -136.25 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.155 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' VAL . 1.6 mtt85 -113.27 130.43 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.052 HG13 HG23 ' A' ' 69' ' ' ILE . 2.3 t -105.84 133.86 49.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.604 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.748 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.5 mt -140.12 162.76 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.967 ' HB2' HG13 ' A' ' 67' ' ' VAL . 7.3 t80 -135.52 88.55 2.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.963 0.411 . . . . 0.0 111.669 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.744 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 77.21 31.85 0.48 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.375 0.607 . . . . 0.0 109.979 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.99 -21.2 47.3 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.024 -0.989 . . . . 0.0 114.053 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.744 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -90.35 117.04 28.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.697 0.749 . . . . 0.0 110.048 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -71.55 133.55 45.86 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.833 HD22 HG13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -14.64 82.16 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.996 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.3 mmp_? -112.76 118.76 35.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.49 ' O ' HG21 ' A' ' 56' ' ' VAL . 5.9 t-20 -49.38 -39.84 33.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -118.08 -15.05 9.92 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.623 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 12.9 m-90 -101.76 -30.28 11.39 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.919 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 1.5 m -109.86 -30.19 7.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.996 HG13 ' O ' ' A' ' 51' ' ' ARG . 11.1 m -51.65 -129.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -175.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.668 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -92.8 -44.39 8.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.485 ' H ' HG23 ' A' ' 56' ' ' VAL . 4.9 m-80 -59.96 -16.07 27.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.952 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.623 ' HB2' ' C ' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -63.73 -72.15 0.15 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.92 179.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.719 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.4 t0 -166.4 74.94 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 175.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.928 HD21 ' OD2' ' A' ' 20' ' ' ASP . 10.7 mp -130.99 166.28 21.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.52 -173.48 2.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 113.042 -1.89 . . . . 0.0 108.857 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -63.54 -30.83 71.89 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.768 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.492 ' HA ' HG13 ' A' ' 2' ' ' ILE . 11.1 tt0 -123.46 95.34 4.55 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.6 ' OG ' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -102.51 169.52 8.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.951 0.405 . . . . 0.0 111.685 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.48 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.7 pp -132.26 123.01 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.967 HG13 ' HB2' ' A' ' 45' ' ' PHE . 96.8 t -116.23 146.69 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.06 0.457 . . . . 0.0 111.769 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.748 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -101.21 107.19 18.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.033 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.052 HG23 HG13 ' A' ' 43' ' ' VAL . 3.7 mp -104.55 141.85 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.78 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 41.3 t -143.98 77.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.627 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.524 ' NE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -118.57 60.51 0.8 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.746 0.784 . . . . 0.0 109.504 178.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.737 ' O ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -120.86 140.51 30.87 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.286 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' N ' ' HG2' ' A' ' 40' ' ' GLN . 20.4 Cg_endo -60.01 153.2 59.5 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.377 2.052 . . . . 0.0 111.534 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -125.13 138.63 54.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.77 0.319 . . . . 0.0 110.902 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -105.41 133.63 49.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.774 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.133 -0.936 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.663 ' HE2' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.966 0.412 . . . . 0.0 110.735 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.947 HG23 ' HA ' ' A' ' 16' ' ' GLU . 1.4 mp -138.61 112.33 7.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.986 HG11 HG23 ' A' ' 67' ' ' VAL . 14.7 t -133.96 150.43 31.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.705 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.4 m-85 -83.7 129.76 34.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.973 HG23 HD13 ' A' ' 69' ' ' ILE . 0.4 OUTLIER -95.18 114.78 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.557 0.694 . . . . 0.0 110.858 179.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.86 145.3 33.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.265 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.582 ' HA ' ' O ' ' A' ' 69' ' ' ILE . 17.9 t80 -139.99 148.02 41.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.598 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -64.46 72.72 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.907 0.861 . . . . 0.0 109.108 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.9 OUTLIER -163.76 -161.15 0.62 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.044 -1.434 . . . . 0.0 108.284 -179.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.38 175.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -53.97 143.35 21.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.282 0.563 . . . . 0.0 111.309 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.3 168.53 54.59 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.941 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' CG ' ' HD2' ' A' ' 14' ' ' PRO . 58.7 t80 -112.99 140.5 24.21 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.597 0.237 . . . . 0.0 111.116 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 32.2 Cg_endo -64.02 132.52 34.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.232 1.954 . . . . 0.0 111.652 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.851 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -118.11 138.16 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.633 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.947 ' HA ' HG23 ' A' ' 2' ' ' ILE . 17.9 tt0 -97.4 72.34 2.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.609 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.098 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 179.61 156.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.959 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.604 ' O ' HG22 ' A' ' 21' ' ' THR . 8.6 p30 -65.0 112.56 3.38 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.592 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 1.6 m -83.6 0.5 46.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.955 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -116.45 -17.52 10.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.725 0.693 . . . . 0.0 112.697 179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.716 ' O ' HD22 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -33.17 154.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.066 0.546 . . . . 0.0 111.375 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 21' ' ' THR . 1.8 t -20.63 143.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.726 0.774 . . . . 0.0 113.036 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.668 ' HA ' HD21 ' A' ' 26' ' ' LEU . 17.3 tt -37.48 -44.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 114.121 -1.399 . . . . 0.0 112.275 -177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.475 ' N ' HG23 ' A' ' 23' ' ' ILE . 3.4 m-85 -69.08 -49.22 59.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 19.3 mm-40 -56.23 -62.69 1.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.971 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.9 pt? -58.92 -53.04 62.85 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.466 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.7 ' H ' HD23 ' A' ' 26' ' ' LEU . 7.4 mttt -50.67 -36.21 34.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.962 0.41 . . . . 0.0 110.455 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.35 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.4 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.098 HG21 HG21 ' A' ' 17' ' ' VAL . 2.2 t -52.54 -55.83 9.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 120.677 0.275 . . . . 0.0 111.255 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.027 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.5 p -55.42 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.428 0.632 . . . . 0.0 112.029 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.144 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -50.24 -26.44 4.72 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.777 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -69.49 -54.32 14.82 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.6 -5.79 58.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.252 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -78.97 -5.7 54.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 -179.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.79 37.48 75.81 Favored Glycine 0 CA--C 1.505 -0.59 0 N-CA-C 108.869 -1.693 . . . . 0.0 108.869 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.812 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.1 m -144.43 -174.47 0.41 Allowed Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.212 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.144 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 88.6 Cg_endo -66.72 -149.79 0.02 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.559 0 C-N-CA 122.395 2.063 . . . . 0.0 109.671 177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . . . -105.83 -69.9 0.8 Allowed 'General case' 0 N--CA 1.426 -1.654 0 O-C-N 124.237 0.961 . . . . 0.0 113.255 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -117.45 25.0 10.74 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.6 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 3.1 tp60 -52.26 -73.01 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.692 HD23 ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -82.13 -135.03 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -132.5 139.16 47.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.39 0.614 . . . . 0.0 111.957 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.916 HG13 HG23 ' A' ' 69' ' ' ILE . 10.9 t -113.1 141.78 27.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.053 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.676 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.6 mp -138.16 162.12 31.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.92 ' CD1' HG22 ' A' ' 67' ' ' VAL . 10.0 t80 -132.52 153.74 50.64 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.781 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . . . 22.53 37.91 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 84.16 -15.67 37.73 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.899 -0.667 . . . . 0.0 113.789 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.781 ' HE3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -92.15 118.58 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 178.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' HA ' HG23 ' A' ' 44' ' ' ILE . 48.7 tt0 -66.04 136.64 56.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.858 ' O ' HD12 ' A' ' 50' ' ' LEU . 2.0 pp -22.7 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.836 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -122.09 118.32 28.43 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -39.22 -48.24 1.75 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HA ' ' HB2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -122.18 -13.32 8.15 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -178.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.736 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 13.8 t90 -97.15 -29.35 13.65 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -177.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.765 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.21 -25.7 10.93 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.955 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.4 m -81.81 -133.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.761 ' N ' HG23 ' A' ' 56' ' ' VAL . 1.9 mm100 -73.45 -34.85 65.6 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.687 ' H ' HG23 ' A' ' 56' ' ' VAL . 2.7 m-20 -72.98 0.07 12.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.919 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.797 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.7 t -95.9 -78.03 0.47 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.883 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.664 ' C ' HD23 ' A' ' 61' ' ' LEU . 1.5 t70 -168.41 76.01 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.053 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.785 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.72 151.63 36.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.723 0.773 . . . . 0.0 112.908 -178.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.82 174.31 6.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.046 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.437 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -57.55 -39.21 76.14 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.349 -179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.22 83.62 1.95 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.732 ' C ' HG13 ' A' ' 3' ' ' VAL . 15.1 m -102.81 171.87 7.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.152 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 1.6 pp -129.58 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.986 HG23 HG11 ' A' ' 3' ' ' VAL . 91.4 t -118.6 135.99 57.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 111.363 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.676 ' O ' ' O ' ' A' ' 44' ' ' ILE . 6.8 t60 -92.74 106.64 18.58 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.278 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.002 HG21 HG21 ' A' ' 30' ' ' VAL . 4.2 mp -103.06 140.35 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 13.4 t -125.32 69.67 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 173.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.928 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 17.3 tp60 -107.91 87.76 2.57 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.245 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.692 ' HG3' HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -130.0 143.01 47.38 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.33 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 55.7 Cg_endo -69.97 151.39 67.87 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.334 2.022 . . . . 0.0 111.513 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -90.77 105.27 17.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 111.177 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -109.04 104.91 14.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.791 ' HE3' ' N ' ' A' ' 18' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.908 0.385 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.794 HG23 ' HA ' ' A' ' 16' ' ' GLU . 2.4 mt -122.99 118.63 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.01 HG11 HG23 ' A' ' 67' ' ' VAL . 10.5 t -138.02 158.39 32.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.45 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.1 m-85 -94.18 119.78 33.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.698 HG23 HD13 ' A' ' 69' ' ' ILE . 1.5 p -86.72 118.3 32.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.619 0.723 . . . . 0.0 111.506 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -111.58 144.85 40.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.922 179.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.1 p90 -138.04 151.04 47.47 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.133 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -66.76 71.92 0.09 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.79 0.805 . . . . 0.0 109.215 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -163.91 -159.43 0.5 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.085 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 9' ' ' SER . 11.7 m -48.95 175.8 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.91 144.73 22.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.337 0.589 . . . . 0.0 111.424 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.1 172.59 53.34 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.717 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -123.6 142.37 38.89 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.788 0.328 . . . . 0.0 111.323 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 36.1 Cg_endo -65.04 124.79 13.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.362 2.042 . . . . 0.0 111.212 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.734 HG22 HG13 ' A' ' 17' ' ' VAL . 3.4 p -122.49 119.54 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.081 0.467 . . . . 0.0 111.433 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.794 ' HA ' HG23 ' A' ' 2' ' ' ILE . 7.7 tm-20 -77.35 86.3 3.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.343 0.592 . . . . 0.0 109.919 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.895 HG21 HG21 ' A' ' 29' ' ' VAL . 1.4 m -167.84 -166.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.191 179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.791 ' N ' ' HE3' ' A' ' 1' ' ' MET . 2.7 p30 -103.58 104.79 14.88 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.914 ' O ' HG11 ' A' ' 67' ' ' VAL . 72.0 m -88.25 4.32 46.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -175.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.953 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -122.96 -19.81 5.99 Favored 'General case' 0 C--O 1.225 -0.237 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.296 178.047 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -36.14 169.45 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.527 0.517 . . . . 0.0 110.752 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 21' ' ' THR . 32.2 t -33.88 148.2 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.685 0.755 . . . . 0.0 112.491 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.759 ' HA ' HD11 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -46.08 -36.72 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.293 -177.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.688 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 14.2 m-85 -63.65 -45.22 91.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.152 0.501 . . . . 0.0 110.245 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.652 ' HB2' HG23 ' A' ' 21' ' ' THR . 9.6 mm100 -67.26 -66.99 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.963 ' O ' HG12 ' A' ' 30' ' ' VAL . 1.6 pp -49.48 -45.32 46.77 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.489 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.902 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -57.62 -37.47 73.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.774 0.321 . . . . 0.0 110.481 179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -63.96 -56.46 14.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.797 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.895 HG21 HG21 ' A' ' 17' ' ' VAL . 99.3 t -55.57 -53.16 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.139 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.977 HG13 ' H ' ' A' ' 31' ' ' ALA . 1.3 p -57.67 -75.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.381 0.61 . . . . 0.0 112.358 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.278 ' HB1' ' O ' ' A' ' 37' ' ' PRO . . . -48.67 -39.12 23.2 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.963 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -61.42 -45.35 94.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 0.0 109.766 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -88.76 -11.27 45.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.128 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.656 ' O ' HG13 ' A' ' 36' ' ' VAL . 5.7 tt0 -84.34 -5.46 59.27 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.405 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.27 37.41 94.48 Favored Glycine 0 CA--C 1.508 -0.362 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.873 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 1.3 m -138.31 -171.79 0.29 Allowed Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 113.853 -1.174 . . . . 0.0 109.438 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.278 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 78.0 Cg_endo -63.51 -147.3 0.01 OUTLIER 'Trans proline' 0 CA--C 1.49 -1.702 0 C-N-CA 122.377 2.051 . . . . 0.0 109.066 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.74 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -108.79 -77.78 0.6 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 123.844 0.715 . . . . 0.0 112.272 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 27' ' ' LYS . 29.0 t70 -112.62 34.54 4.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.627 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 8.7 tp-100 -46.43 -71.1 0.08 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.762 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.8 tp -90.12 -138.6 0.14 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.582 ' O ' ' O ' ' A' ' 70' ' ' VAL . 3.5 mpp_? -112.98 135.41 53.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.392 0.615 . . . . 0.0 112.657 -178.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 69' ' ' ILE . 2.8 t -102.13 141.95 17.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-O 121.24 0.543 . . . . 0.0 111.096 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.812 HG23 ' CA ' ' A' ' 49' ' ' GLU . 2.6 mp -138.3 161.08 31.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.992 ' CD1' HG22 ' A' ' 67' ' ' VAL . 6.6 t80 -136.25 155.91 49.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.489 ' HB3' ' CE ' ' A' ' 48' ' ' LYS . . . 40.61 28.69 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 111.583 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.69 -10.13 9.48 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.622 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.489 ' CE ' ' HB3' ' A' ' 46' ' ' ALA . 15.3 mtmt -105.69 110.41 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.306 0.553 . . . . 0.0 110.838 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.812 ' CA ' HG23 ' A' ' 44' ' ' ILE . 3.0 tm-20 -74.84 127.75 33.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.221 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.758 HD22 ' O ' ' A' ' 49' ' ' GLU . 1.6 mm? -150.05 -164.35 2.0 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -105.88 175.7 5.41 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.722 0.772 . . . . 0.0 113.071 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.432 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 4.5 p-10 -47.25 -20.08 0.17 Allowed 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.699 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -16.74 11.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.41 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.675 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 0.3 OUTLIER -108.3 -20.23 13.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.562 ' OG1' ' HB2' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -106.64 -27.41 10.85 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.953 HG12 ' O ' ' A' ' 20' ' ' ASP . 1.5 m -79.88 -140.55 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.839 ' N ' HG23 ' A' ' 56' ' ' VAL . 3.8 mp0 -65.81 -42.68 90.33 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.594 ' H ' HG23 ' A' ' 56' ' ' VAL . 3.4 m-80 -59.54 -14.0 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.037 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.921 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 8.4 t -84.72 -73.67 0.42 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.283 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.617 ' O ' HD22 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -170.66 84.14 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.658 176.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.826 HD11 ' OD2' ' A' ' 20' ' ' ASP . 0.6 OUTLIER -119.58 157.03 29.23 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -133.92 -178.8 5.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.78 -1.554 . . . . 0.0 108.718 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.71 -34.16 76.58 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.526 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -124.33 91.93 3.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.148 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.76 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.32 170.29 8.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.915 0.388 . . . . 0.0 111.447 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 2.0 pp -130.43 116.98 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.01 HG23 HG11 ' A' ' 3' ' ' VAL . 60.4 t -116.12 142.79 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.075 0.464 . . . . 0.0 111.577 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.655 ' O ' ' O ' ' A' ' 44' ' ' ILE . 64.9 t-80 -106.65 108.07 19.4 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.087 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.906 HG23 HG13 ' A' ' 43' ' ' VAL . 3.0 mp -100.79 138.68 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.445 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.762 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 52.7 t -141.51 74.23 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.11 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.962 ' NE2' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -123.5 58.28 1.14 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.823 0.821 . . . . 0.0 109.279 177.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' O ' HD22 ' A' ' 41' ' ' LEU . 9.3 ptm180 -124.49 137.86 30.04 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.139 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.453 ' N ' ' HG2' ' A' ' 40' ' ' GLN . 28.6 Cg_endo -62.52 153.52 70.79 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.371 2.047 . . . . 0.0 112.096 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -107.31 148.6 28.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.654 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -91.39 108.27 19.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.877 0.37 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.066 -0.968 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.597 ' CE ' ' HA ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.828 0.347 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.776 HG22 ' HA ' ' A' ' 16' ' ' GLU . 12.9 pt -132.94 114.72 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.282 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.073 HG11 HG23 ' A' ' 67' ' ' VAL . 21.4 t -129.37 145.58 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.343 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 14' ' ' PRO . 4.4 m-85 -81.63 126.36 31.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.944 HG23 HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -93.28 113.41 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 121.752 0.786 . . . . 0.0 110.641 179.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.416 ' HB2' ' HA ' ' A' ' 68' ' ' HIS . 4.7 mmt180 -103.88 151.88 22.6 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.256 -1.338 . . . . 0.0 111.474 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 8' ' ' ASN . 65.6 t80 -136.0 171.88 13.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.514 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.758 ' O ' ' N ' ' A' ' 10' ' ' SER . 3.4 t30 -42.76 178.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.17 79.86 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.238 1.018 . . . . 0.0 110.682 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.758 ' N ' ' O ' ' A' ' 8' ' ' ASN . 9.5 p -144.84 174.68 10.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.995 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -86.44 109.93 19.39 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.43 158.4 37.6 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.438 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.425 ' CE2' HG11 ' A' ' 5' ' ' VAL . 9.0 p90 -126.71 144.32 49.5 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.697 0.284 . . . . 0.0 111.667 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 4' ' ' PHE . 39.1 Cg_endo -66.67 134.66 35.94 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.361 2.041 . . . . 0.0 111.467 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -117.65 135.78 56.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.757 -0.202 . . . . 0.0 110.827 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.776 ' HA ' HG22 ' A' ' 2' ' ' ILE . 1.4 tt0 -92.52 69.56 4.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.989 HG21 HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER 176.39 156.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.615 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' O ' HG22 ' A' ' 21' ' ' THR . 3.0 m-20 -65.85 120.37 12.94 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.785 ' OG ' HD11 ' A' ' 69' ' ' ILE . 1.2 t -87.28 -26.21 23.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.926 ' O ' HG12 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -87.48 -23.33 24.47 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.736 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -34.09 151.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.311 0.382 . . . . 0.0 111.079 179.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.581 ' O ' ' O ' ' A' ' 21' ' ' THR . 2.9 t -17.96 143.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -173.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.577 ' HA ' HD21 ' A' ' 26' ' ' LEU . 6.6 tt -40.81 -39.45 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 CA-C-N 114.082 -1.417 . . . . 0.0 112.016 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.53 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 79.7 m-85 -66.97 -47.86 70.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.267 0.556 . . . . 0.0 109.591 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.446 ' HG2' ' HB3' ' A' ' 22' ' ' SER . 54.9 mm-40 -65.17 -55.46 18.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.224 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.953 ' O ' HG12 ' A' ' 30' ' ' VAL . 2.4 pp -55.93 -56.73 17.16 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.887 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.86 -36.93 59.67 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.314 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 32' ' ' LYS . 1.0 OUTLIER -66.18 -59.29 3.89 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.544 -179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.989 HG21 HG21 ' A' ' 17' ' ' VAL . 43.0 t -52.98 -52.45 28.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.623 0.249 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.057 HG13 ' H ' ' A' ' 31' ' ' ALA . 2.1 p -62.53 -74.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 1.057 ' H ' HG13 ' A' ' 30' ' ' VAL . . . -51.61 -29.58 18.03 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.941 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 10.2 ttmt -68.27 -54.07 20.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -7.54 59.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.96 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -80.2 -5.4 56.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.572 0.225 . . . . 0.0 111.407 -179.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.69 37.66 67.23 Favored Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.865 HG21 ' O ' ' A' ' 71' ' ' GLN . 1.1 m -145.35 -173.63 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 113.512 -1.344 . . . . 0.0 109.237 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.949 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 95.0 Cg_endo -66.93 -144.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.205 0 C-N-CA 122.331 2.021 . . . . 0.0 109.88 177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.746 ' HB1' ' CD ' ' A' ' 27' ' ' LYS . . . -107.09 -68.05 0.91 Allowed 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.621 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -113.62 35.27 4.12 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 -177.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.713 ' HB2' ' HG3' ' A' ' 37' ' ' PRO . 6.2 tp-100 -48.53 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.733 ' HB3' ' O ' ' A' ' 70' ' ' VAL . 3.4 tp -87.33 -126.18 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 70' ' ' VAL . 20.7 mtt85 -129.01 147.95 50.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.203 0.525 . . . . 0.0 111.929 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.042 HG13 HG23 ' A' ' 69' ' ' ILE . 4.0 t -116.74 146.35 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.956 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.671 ' O ' ' O ' ' A' ' 68' ' ' HIS . 4.0 mp -143.57 159.2 16.81 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.94 ' CD1' HG22 ' A' ' 67' ' ' VAL . 21.9 t80 -135.0 156.13 49.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' PHE . . . 26.62 37.89 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' PHE . . . 78.71 -12.44 22.24 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.978 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 0.0 OUTLIER -92.82 121.82 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.179 0.489 . . . . 0.0 109.735 179.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG2' ' CD2' ' A' ' 50' ' ' LEU . 1.2 tt0 -62.56 130.74 46.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.7 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.552 HD13 ' H ' ' A' ' 43' ' ' VAL . 0.3 OUTLIER -21.66 103.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.758 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -125.06 117.75 24.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.211 176.361 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -39.87 -46.6 2.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 0.5 OUTLIER -121.33 -13.56 8.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.73 ' C ' ' HB2' ' A' ' 59' ' ' CYS . 6.2 t90 -97.59 -29.18 13.58 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.741 ' HB ' ' H ' ' A' ' 51' ' ' ARG . 0.9 OUTLIER -108.64 -25.21 10.99 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -178.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.926 HG12 ' O ' ' A' ' 20' ' ' ASP . 3.9 m -80.75 -132.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.519 1.304 . . . . 0.0 114.519 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.748 ' N ' HG23 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -74.42 -34.99 63.39 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.699 ' H ' HG23 ' A' ' 56' ' ' VAL . 0.8 OUTLIER -72.09 0.79 8.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.771 177.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.809 ' HB3' ' O ' ' A' ' 56' ' ' VAL . 1.8 t -97.21 -78.24 0.48 Allowed 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.88 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.657 ' C ' HD23 ' A' ' 61' ' ' LEU . 8.6 t0 -168.68 76.39 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.075 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.795 HD11 ' OD1' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -116.12 151.63 35.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.567 0.698 . . . . 0.0 112.836 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -120.26 177.19 5.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.32 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -58.24 -38.29 76.59 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.255 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.71 85.61 2.31 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.768 ' C ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -102.35 165.79 10.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -127.84 120.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.073 HG23 HG11 ' A' ' 3' ' ' VAL . 72.0 t -117.94 135.95 56.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.018 0.437 . . . . 0.0 111.668 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.671 ' O ' ' O ' ' A' ' 44' ' ' ILE . 0.9 OUTLIER -91.14 106.18 18.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.012 179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 1.042 HG23 HG13 ' A' ' 43' ' ' VAL . 4.5 mp -106.62 145.26 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.733 ' O ' ' HB3' ' A' ' 41' ' ' LEU . 11.1 t -133.93 72.35 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.865 ' O ' HG21 ' A' ' 36' ' ' VAL . 1.6 tp-100 -117.39 70.69 0.79 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.229 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' ' CE1' ' A' ' 7' ' ' PHE . 13.0 mtt180 -135.66 138.7 28.9 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.179 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 34.6 Cg_endo -63.41 160.95 33.06 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.962 2.441 . . . . 0.0 111.97 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.38 109.75 21.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 0.0 110.464 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.05 109.27 20.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.033 -0.984 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 stop_ save_